See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Research Area · Cancer

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
71220 1,4-DPCA 331830-20-7 ≥98% 2007-06-22 41.895096685083 1-4-dpca 1,4-dihydrophenonthrolin-4-one-3-Carboxylic acid HIF-1.alpha. normoxic HIF-.alpha. prolyl HIF-PH inhibitors collagen fibrosis 4-hydroxylase normoxia hypoxic hypoxia-inducible factor HIF1.alpha. HIF1alpha HIFPH inhibition inhibits 41.895096685083
12700 15-deoxy-Δ12,14-Prostaglandin D2 85235-11-6 >95% 146.284972375691 15-deoxy-12-14-prostaglandin-d2 15-deoxy-Δ12,14-PGD2 PPARs prostaglandins peroxisome proliferator-activated receptors 15-deoxy-DELTA12,14-PGD2 15-deoxy-.DELTA.12,14-PGD2 15-deoxy-d12,14-PGD2 leukemia cells cancer 15d-pgd2 146.284972375691
10009742 15-hydroxy Prostaglandin Dehydrogenase Western Ready Control - ≥90% by SDS-PAGE 2007-04-03 48.727963693764 15-hydroxy-prostaglandin-dehydrogenase-western-ready-control 15-hydroxy PGDH blotting blots western WB oxidation enzymes tumors suppression cells proliferation 48.727963693764
10011263 15-Lipoxygenase-2 (human recombinant) - >95% 2008-03-25 46.301184775936 15-lipoxygenase-2-human-recombinant 15-LO-2; 15-LOX-2 arachidonic acids recombinant proteins 15-HETE 15-HpETE 46.301184775936
10011500 15-Lipoxygenase-2 Western Ready Control - 2008-06-25 21.053114013058 15-lipoxygenase-2-western-ready-control 15-LO-2; 15-LOX-2 WBs lipoxygenases 15LOX 15LO arachidonic acid AA 15(S)-hydroxyeicosatetraenoic acid 15(S)-HETE 15S-HETE western blots immunoblotting blotting 21.053114013058
34720 15(S)-HETE 54845-95-3 ≥98% 32.952900552485 15-s-hete soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated 15HETEs 32.952900552485
334720 15(S)-HETE-d8 84807-87-4 ≥99% deuterated product 38.782394106813 15-s-hete-d8 GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE 38.782394106813
534721 15(S)-HETE EIA Kit - 70.856224677715 15-s-hete-eia-kit 15(S)-HETE ELISA Kit solid plates 15(S)-HETEs 15S-HETEs measures kits eias enzyme immunoassays ELISAs 15(S)HETEs 15HETEs assays 70.856224677715
10007251 15(S)-HETE Lipid Maps MS Standard 54845-95-3 ≥98% 2009-02-17 17.528338291542 15-s-hete-lipid-maps-ms-standard soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE 17.528338291542
10009799 17(S)-HDoHE - ≥98% 2007-03-12 10.232854511970 17-s-hdohe 17(S)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe 10.232854511970
13812 17β-hydroxy Wortmannin Exclusive - ≥98% ✓ 2010-05-18 31.627546961325 17-hydroxy-wortmannin phosphoinositide 3-kinase PI3K mTOR inhibitors inhibits inhibition inhibitory cancers 17-hydroxywortmannins 17-hydroxy wortmannins hydroxywortmannins PI3-K HWT phosphatidylinositol 31.627546961325
10954 1-NA-PP1 New 221243-82-9 ≥98% 2011-09-30 65.977551481668 1-na-pp1 PP1 Analog; 1-Naphthyl-PP1 inhibitors inhibits inhibition kinases mutated analogs sensitive v-Src vSrc c-Fyn cFyn CDK2 c-Abl cAbl mammalian yeast 1NMPP1 1NA-PP1 cells permeable tyrosine cell-permeable AS Src-family Src I338G v-Src-AS1 65.977551481668
10010093 1-Oleoyl Lysophosphatidic Acid Exclusive 65528-98-5 >95% ✓ 2007-08-29 19.591289134438 1-oleoyl-lysophosphatidic-acid Oleoyl-sn-3-Glycerophosphate; 1-Oleoyl LPA LPAS 1-oleoyl-LPAS agonists GPCR G-proteins cell proliferation smooth muscle contraction platelet aggregation reurite retraction 19.591289134438
10010094 1-Palmitoyl Lysophosphatidic Acid 22002-85-3 ≥98% 2010-11-29 5.657329650092 1-palmitoyl-lysophosphatidic-acid 1-Palmitoyl LPA (free acid) GPCR G-proteins cells proliferation smooth muscles contractions platelets aggregation 5.657329650092
10010290 1-Palmitoyl Lysophosphatidic Acid (sodium salt) Exclusive - >98% ✓ 2007-09-05 9.883348066298 1-palmitoyl-lysophosphatidic-acid-sodium-salt 1-Palmitoyl LPA 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate monopalmitoylphosphatidic acid MPPA LPAS GPCRs biological responses 9.883348066298
10009962 2-(14,15-Epoxyeicosatrienoyl) Glycerol 848667-56-1 ≥95% 2008-04-03 28.092320441988 2-14-15-epoxyeicosatrienoyl-glycerol 2-14,15-EG 2-AG CYP450 metabolism mitogens cancers kidneys endocannabinoids cannabinoids cbs synthetic 28.092320441988
13373 2',3',5'-triacetyl-5-Azacytidine 10302-78-0 ≥95% 2010-08-05 7.173394215144 2-3-5-triacetyl-5-azacytidine inhibitors inhibits inhibition DNA methyltransferases epigenetics methylation myelodysplastic syndromes cancers prodrugs 5-azacytidine 5-azacitidine vidaza azacytidine azacitidine rapid absorption o rally 7.173394215144
10005229 2,3-DCPE (hydrochloride) - ≥98% 2006-09-15 13.960662983425 2-3-dcpe-hydrochloride apoptosis Bcl-XL p21 ERK cancers cells cycles proapoptotic in vitro S-phase arrest upregulate activates activation 13.960662983425
71200 2,4-DPD 41438-38-4 ≥98% 55.238324125230 2-4-dpd 2,4-Diethylpyridine dicarboxylate inhibits inhibition inhibitors proline-hydroxylases P564 HIF-PH HIF-1alpha HIF-1.alpha. alpha-keto glutarate .alpha.-keto a-keto cancer 55.238324125230
10008887 (+)-2,5-epi Goniothalesdiol Exclusive - ≥98% ✓ 2009-03-02 0E-12 -2-5-epi-goniothalesdiol tetrahydrofuran cytotoxic pesticide anticancers drugs antitumor styryl lactone 0E-12
11097 25-hydroxy Cholesterol New 2140-46-7 ≥98% 2012-02-08 14.459361571516 25-hydroxy-cholesterol 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages 14.459361571516
11099 25-hydroxy Cholesterol-d6 New 88247-69-2 ≥99% deuterated form (d1-d6) 2012-01-27 86.679452775585 25-hydroxy-cholesterol-d6 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages 86.679452775585
13019 2-Hydroxyestradiol 362-05-0 ≥95% 2009-01-20 22.429042357274 2-hydroxyestradiol 2-HE2; NSC 61711 estradiols steroids metabolism catechol-O-methyltransferase COMT pre-eclampsia preeclampsia angiogenesis cancers anticancer HIF-1α HIF1α 22.429042357274
13021 2-Methoxyestradiol 362-07-2 ≥98% 2009-01-06 74.349368587214 2-methoxyestradiol Panzem; NSC 659853; 2-ME2; 2-Hydroxyestradiol 2-methyl ether estradiol steroids catechol-O-methyltransferase COMT pre-eclampsia preeclampsia angiogenesis cancers anticaner HIF-1α HIF1α 2-methoxyestradiol 74.349368587214
582261 2-Methoxyestradiol EIA Kit - 2010-12-09 166.952381829343 2-methoxyestradiol-eia-kit 2-Hydroxyestradiol 2-methyl ester; 2-ME2 metabolites estradiols antitumors antiangiogenics breast prostate cancers cardioprotective cytochromes P450 CYP450 P450-dependent hydroxylation 17β-estradiols 2-position O-methylation catechol-O-methyltransferases pre-eclampsia plasma urine urinary markers therapeutics supplements estrogen receptors pregnancy ELISAs EIAs enzymes immunoassays kits competitive quantification measures measurements sample matrices 166.952381829343
11046 2-NBDG New 186689-07-6 ≥98% (mixture of α and β) 2011-10-07 51.210928299570 2-nbdg NBD-Glucose fluorescence fluorescent probes glucose uptake cells viability contrast reagents neoplasia cancers diabetes flow cytometry microscopy 213484-93-6 51.210928299570
10010494 2-PCPA (hydrochloride) - >98% 2008-05-09 0.453985793211 2-pcpa-hydrochloride trans-2-Phenylcyclopropylamine; Tranylcypromine 2 PCPA 2PCPA LSD1 histones chromatin nucleosomes post-translational modifications posttranslational methylation demethylation inhibitors inhibits inhibition MAO A B I MAOA MAOB MAOI MAO-A MAO-B MAO-I depression anxiety parkinsons disease epigenetics monoamine oxidases lysine-specific demethylase 0.453985793211
10009651 2-thio-Acetyl MAGE 112014-15-0 ≥97% 2007-02-22 19.210096685083 2-thio-acetyl-mage KIAA1363 cancers colorimetric substrates activity inhibition inhibits inhibitory enzymatic activity 19.210096685083
10004185 3,4',5-Trismethoxybenzophenone Exclusive 94709-12-3 >95% ✓ 2004-07-21 34.352670349908 3-4-5-trismethoxybenzophenone antimitotics antimitosis resveratrol analogs phenolic antioxidants antiproliferative antiproliferatory inhibits inhibition inhibitors cell growth 34.352670349908
10727 3,5-dimethyl PIT-1 701947-53-7 ≥98% 2011-05-25 16.291853898097 3-5-dimethyl-pit-1 PIP3 PtdIns-(3,4,5)-P3 PH domain cancers inhibitors Akts PDK1 PTENs proteins binding inhibits inhibited inhibition DM-PIT-1 16.291853898097
10397 3-amino Benzamide New 3544-24-9 ≥98% 2011-10-07 3.032032876338 3-amino-benzamide 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated 3.032032876338
13574 3-bromo-5-phenyl Salicylic Acid Exclusive 4906-68-7 ≥95% ✓ 2010-08-10 12.552475138121 3-bromo-5-phenyl-salicylic-acid NSC 109116 Aldo-keto reductases AKR, oxidoreductases hydroxysteroid dehydrogenases HSDs 20α-HSD progesterones cancers steroids brain functions AKR1C1 AKR1C2 AKR1C3 AKR1C4 endothelial cells 12.552475138121
13828 3-Deazaneplanocin A 102052-95-9 ≥98% 2011-02-18 205.282959747435 3-deazaneplanocin-a NSC 617989; DZNep EZH2 KMT6 methyltransferases histones cancer epigenetics panobinostat 3deazaneplanocin 3-cyclopentene-1,2-diol deriv Adenosine Adenocard 205.282959747435
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 120.869183548189 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 120.869183548189
10495 4-iodo-SAHA 1219807-87-0 ≥98% 2011-01-10 29.885270718232 4-iodo-saha anti-cancers HDACs inhibitors anti-proliferation 4-Hydroxy-5-iodo-3-nitrophenyl)acetyl 4-Hydroxy-3-iodo-5-nitrophenyl)acetyl 5-Iodo-4-hydroxy-3-nitrophenacetyl 5 Iodo 4 hydroxy 3 nitrophenacetyl Nitrohydroxyiodophenylacetate Hydroxyiodonitrophenylacetate Hapten NIP Acetyl Acetyl Hapten NIP NIP Acetyl Hapten NIP-Hapten NIP Hapten 29.885270718232
10185 4-oxo-2-Nonenal Exclusive 103560-62-9 >98% ✓ 2004-01-21 65.065966850828 4-oxo-2-nonenal 4-ONE ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 65.065966850828
10004174 4-oxo 2-Nonenal-d3 Exclusive - ≥99% deuterated product ✓ 2004-03-10 33.350589318600 4-oxo-2-nonenal-d3 4-ONE-d3 ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-2-nonenal-d3 4-hydroxy2nonenald3 internal standards mass spectrometry GC/MS LC/MS gc-ms ic-ms deuterium deuterateds 33.350589318600
10011049 4-phenyl-5-methyl-1,2,3-Thiadiazole 64273-28-5 ≥98% 2009-03-14 0.168508287293 4-phenyl-5-methyl-1-2-3-thiadiazole NSC 358739 cytochrome P450 CYP450 CYP2B4 CYP2E1 CYP1A2 inhibitors inhibits inhibition thiadiazoles fungicide herbicide plant growth regulator 0.168508287293
13379 5-bromo-3-phenyl Salicylic Acid 99514-99-5 ≥95% 2010-08-10 12.518662983425 5-bromo-3-phenyl-salicylic-acid Aldo-keto reductases AKR oxidoreductases hydroxysteroid dehydrogenases HSD 20α-HSD progesterone cancers steroids brain functions AKR1C1 AKR1C2 AKR1C3 AKR1C4 endothelial cells 12.518662983425
10009315 6-Aminonicotinamide 329-89-5 ≥98% 2008-11-21 2.086464088398 6-aminonicotinamide 6-AN; NSC 21206; SR 4388 inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular 2.086464088398
10009856 7-AAD Cell Viability Assay Kit - 2008-10-29 28.090324524247 7-aad-cell-viability-assay-kit 7-Amino Actinomycin D Cell Viability Kit kits 7AAD measurement cells fixation blocking cytoxicity effects environmental toxins drug fluorescence fluorescent cell-based assays cell based assay cba 28.090324524247
600120 7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit - 2009-08-05 58.193531965272 7-aad-cfse-cell-mediated-cytotoxicity-assay-kit 7-Amino Actinomycin D/5-(6)-Carboxyfluorescein Diacetate Succinimidyl Ester 7-amino actinomycin D/5-(6)-carboxyfluorescein diacetates succinimidyls esters assays kits measuring measurement kits 5-(6) 5,6 5-6 7AAD cells cytoxicity cell-based cba cytolysis target effector T lymphocytes NK natural killer autoimmune systems pathological cancers multiple sclerosis granule exocytosis pathways Fas diseases graft host 51chromium 51Cr green fluorescent fluorescence probes red propidium iodide dead effector carboxyfluorescein succinimidyl esters dyes damaged DNA deoxyribonucleic acids quantify quantification single staining 58.193531965272
589320 8-hydroxy-2-deoxy Guanosine EIA Kit - 2008-05-21 617.661185685487 8-hydroxy-2-deoxy-guanosine-eia-kit 8-OH-dG ELISA Kit; DNA Damage EIA Kit solid plates oxidative injury stress aging cancers diabetes hypertension hydroxyl radicals peroxynitrite plasmas cells lysates tissues urine creatinine LC-MS liquid DNA damage kits EIAs chormatography mass spectrometry kits enzyme immunoassays elisas 8-OH-2-d 8OH2d 8 oxo deoxyguanine deoxyguanosine hydroxy ohdg 2 EIA/ELISA assays 617.661185685487
89300 8-hydroxy Guanosine - ≥98% 8.885138121547 8-hydroxy-guanosine oxidative injury RNA stress damage 7,8-dihydro-8-oxo-guanosine markers inhibitors growth 3868-31-3 8.885138121547
13653 ABT-869 796967-16-3 ≥98% 2010-12-09 33.340759266813 abt-869 Linifanib inhibitors RTK tyrosine kinases VEGF PDGF cancers KDR Flt1 Flt3 Flt4 CSF-1R KIT acute myeloid leukemia antiproliferative anti-proliferative ABT 869 ABT869 Indazoles 33.340759266813
10008051 Acid Phosphatase Assay Kit - 2006-09-20 5.593591160221 acid-phosphatase-assay-kit aps hydrolase eznymes prostate pap tartrate resistant assays 5.593591160221
10006908 Adipogenesis Assay Kit - 2006-08-18 79.669723700328 adipogenesis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines endocrinology cell-based assays cell based assay cba 79.669723700328
10009381 Adipolysis Assay Kit - 2007-07-30 59.217517839684 adipolysis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines lipolysis 3T3L1 kits assays FFA adipocytes endocrinology cell-based assay cell based assay cba 59.217517839684
11293 Aflatoxin B1 New 1162-65-8 ≥9% 2012-01-30 151.029310926949 aflatoxin-b1 HSDB 3453; NSC 529592; AFB1 11003-08-0 13214-11-4 27261-02-5 toxicology pathogens mycotoxins Aspergillus cancers HCC hepatocellular carcinomas p53 DNA adduct mold carcinogenic metabolism liver epoxide tumoors suppression genes food contaminant contamination D03.438.150.119.075 D03.830.219.119.07 NSC-529592 HSDB-3453 151.029310926949
11294 Aflatoxin B2 New 7220-81-7 ≥98% 2012-01-30 151.029310926949 aflatoxin-b2 Dihydroaflatoxin B1 dihydroaflatoxine B1 toxicology pathogens mycotoxins Aspergillus cancers HCC hepatocellular carcinoma p53 DNA adduct molds carcinogenic carcinogens liver epoxide tumors genes food contamination contaminants pathogens 151.029310926949
10010129 AG-041R Exclusive 199800-49-2 ≥98% ✓ 2008-12-16 39.456408839779 ag-041r CCKs gastrin receptors antagonist cancers proliferations apoptosis NS-398 NS398 NS 398 39.456408839779
10010592 AG-1296 146535-11-7 >98% 2008-05-09 4.945071823203 ag-1296 Tyrphostin AG-1296 tyrphostins AG1296 PDGFR PTK SCF inhibitors inhibits inhibition receptors kinases proteins platelet-derived platelet derived growth factors in vitro cancer glioma athrosclerosis restenosis AG1296 AG 1296 4.945071823203
10010244 AG-1478 153436-53-4 >98% 2008-04-22 9.118983425413 ag-1478 NSC 693255; Tyrphostin AG-1478 NSC 693255 EGFR PTK inhibitors inhibits inhibition kinases receptors cancers antitumor leioyoma myometrium 175178-82-2 AG1478 AG 1478 9.118983425413
10010248 AG-17 10537-47-0 >98% 2007-09-18 1.662962175945 ag-17 NSC 242557; Tyrphostin 9; Malonoben; Tyrphostin AG-17; SF 6847; GCP 5126; RG 50872 proteins tyrosine kinases PTK inhibitors inhibits antiproliferative epidermal growth factor EGF receptors proliferations carcinomas AG17 AG 17 SF6847 SF-6847 GCP-5126 GCP5126 1.662962175945
10010300 AG-18 118409-57-7 >98% 2007-12-20 2.376995325116 ag-18 RG-50810; Tyrphostin AG-18; Tyrphostin 23; TX 825; RG-50858 proteins tyrosines kinases PTKs inhibitors inhibition inhibits antiproliferative epidermal growth factors EGF receptors proliferations carcinoma cancers epidermoid cell lines A431 AG18 AG 18 A23 A-23 A23 RG50810 RG 50810 RG50858 RG 50858 TX-825 TX825 2.376995325116
10010315 AG-183 122520-90-5 >98% 2007-09-07 1.414852670349 ag-183 Tyrphostin 51 proteins tyrosine kinases PTKs inhibitors inhibition inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas cancers epidermoid AG183 AG 183 1.414852670349
10010314 AG-213 122520-86-9 >97% 2008-02-05 2.100818684078 ag-213 Tyrphostin AG-213; Tyrphostin 47 protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas A431 epidermal AG213 Ag 213 118409-60-2 2.100818684078
10010568 AG-370 134036-53-6 >95% (cis/trans mixture) 2009-01-09 1.245041436464 ag-370 NSC 651712 PTK inhibitor tyrphostin tyrosine PDGF receptor kinase EGF receptor antiproliferative 1.245041436464
10010311 AG-490 133550-30-8 >98% 2007-12-01 9.630989871086 ag-490 PTK tyrosine kinase inhibitors inhibition inhibits antiproliferatives tyrphostins leukemia Jak-2 Jak2 AG490 9.630989871086
10010242 AG-494 133550-35-3 >98% 2008-02-08 1.801542357274 ag-494 protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative RG-13022 epidermal growth factors EGFs receptrors cancers proliferation 1.801542357274
10010312 AG-82 118409-58-8 >95% 2008-03-14 4.188158379373 ag-82 Tyrphostin AG-82; NSC 676484; RG-50875; Tyrphostin 25 proteins tyrosines kinases PTKs inhibitors inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas blockers A431 AG82 AG 82 RG-50875 RG50875 A25 A-25 4.188158379373
10010243 AG-825 149092-50-2 >98% 2008-01-24 4.705682715074 ag-825 Tyrphostin AG-825 Her-2 Her-2/neu erbB tyrosine kinases EGF EGFR cancers anti-cancer prostate breast signal transduction inhibitors inhibition inhibits AG825 AG 825 4.705682715074
10793 AG-879 148741-30-4 ≥95% 2011-05-06 1.784425414364 ag-879 Tyrphostin AG-879 PTKs inhibitors tyrphostins tyrosine kinases antiproliferative NGF TrkA ErbB2 FLK-1 AG879 AG 879 inhibited inhibition 1.784425414364
10010313 AG-99 122520-85-8 >98% 2007-12-19 1.252790055248 ag-99 Tyrphostin 46 protein tyrosine kinase PTKs inhibitor inhibits inhibition antiproliferatives epidermal growth factors EGFs receptors proliferation carcinoma cancers blochers EGF-dependent A431 cell lines AG99 AG 99 1.252790055248
13145 AGK2 304896-28-4 ≥98% 2009-10-22 12.457375690607 agk2 sirtuins SIRT2 histones deacetylase HDAC cells cycle progression tumorigenesis cancers SIRT1 SIRT3 dopamine neurons α-synuclein Parkinson's diseases neurodegeneration 12.457375690607
19023 AH 23848 (calcium salt, hydrate) - ≥90% 2009-02-26 55.475823204420 ah-23848-calcium-salt-hydrate AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 55.475823204420
10010241 AICAR 2627-69-2 >98% 2008-02-25 138.708972375691 aicar NSC 105823; Acadesine; AICA Riboside AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide 138.708972375691
160773 AIF Polyclonal Antibody - 0E-12 aif-polyclonal-antibody Programmed Cell Death Protein 8; Apoptosis-Inducing Factor Polyclonal Antibody apoptosis antibodies western blots blotting WB antisera antiserum factors cancers immunoblotting 0E-12
13733 Akt1 (Phospho-Ser473) Monoclonal Antibody (Clone 104A282) - 2010-01-11 1.178847671665 akt1-phospho-ser473-monoclonal-antibody-clone-104a282 antibodies Akts PKBs peptides Akt-1 Akt 1 protein kinase B serine threonine western blots blotting immunoblotting WB IP Immunoprecipitation IP 1.178847671665
13732 Akt1 Polyclonal Antibody - 2010-01-11 1.178847671665 akt1-polyclonal-antibody antibodies Akts PKBs peptides Akt-1 Akt 1 protein kinase B serine threonine western blots blotting immunoblotting WB 1.178847671665
13735 Akt2/3 Polyclonal Antibody - 2010-01-12 1.178847671665 akt2-3-polyclonal-antibody Akt-2 Akt 2 PKB proteins kinase B serine threonine signaling PI3-kinase cancers Western blots blotting immunoblotting WB Akt-3 Akt 3 2-3 1.178847671665
13734 Akt2 Monoclonal Antibody (Clone 95C567.1.2) - 2010-01-12 1.178847671665 akt2-monoclonal-antibody-clone-95c567-1-2 Akt-2 Akt 2 PKB proteins kinase B serine threonine signaling PI#-kinase cancers Western blots blotting immunoblotting WB 1.178847671665
13736 Akt3 Monoclonal Antibody (Clone 66C1247.1) - 2010-01-19 1.178847671665 akt3-monoclonal-antibody-clone-66c1247-1 Akt-3 Akt 3 western blot blotting immunoblotting WB Akts protein kinase B PKB serin threonine signaling proteins 1.178847671665
10010079 Akt (human recombinant) Western Ready Control Exclusive - ✓ 2008-08-26 6.245646408839 akt-human-recombinant-western-ready-control Protein Kinase B; PKB; AKT1 western blots proteins antibodies antiserum antisera WB kinases serine threonine hexahistidine his-tag his-tagged N-terminal immunoblotting blotting 6.245646408839
10009350 Aldehyde Reactive Probe (trifluoroacetate salt) 627090-10-2 ≥98% 2008-08-26 9.402541436464 aldehyde-reactive-probe-trifluoroacetate-salt O-(Biotinylcarbazoylmethyl) Hydroxylamine; ARP DNA damages AP sites synthesis mutations ROS biotin oxidative stress detection detecting 139585-03-8 9.402541436464
13144 Anacardic Acid 16611-84-0 ≥98% 2010-02-12 3.769052143189 anacardic-acid 6-pentadecyl Salicylic Acid HAT histones acetylation P300 pCAF transcription NF-κB IκBα p65 6-pentadecyl salicyclic acids NSC 623096 cyclogallipharic 229596 333857 3.769052143189
600300 Annexin V FITC Assay Kit - 2010-05-11 80.758771814435 annexin-v-fitc-assay-kit assays kits measures measurements apoptosis cells death cycles tissues homeostasis dysregulation neurodegenerative diseases ischemic damages autoimmune disorders cancers drugs discovery signaling pathways membranes phospholipids phosphatidylserines phosphatidylethanolamines leaflets bilayers externalizations residues plasma phospholipids binding proteins fluorochrome-labeled fluorochromes fluorescence microscopy flow cytometry FC plate readers TUNEL TdT-mediated dUTP Nick-End Labeling analysis ISEL in situ end labeling DNA laddering detection fragmentation FITC-conjugated fluoresceins 80.758771814435
160780 Apaf-1 Polyclonal Antibody - 2.007955801104 apaf-1-polyclonal-antibody Apoptosis Protease-Activating Factor 1 apoptosis cell death caspases CED-4 Apaf2 Apaf3 Apaf-2 Apaf-3 Apafs antibodies Apaf1 CED4 western blots blotting WB protease-activating factors proteases antisera antiserum cancers immunoblotting 2.007955801104
10575 Apicidin New 183506-66-3 ≥98% 2012-01-27 108.531279926335 apicidin OSI 2040 funfal toxins malaria HDAC HAT histones deacetylase transcriptions epigenetics anticancer anti-cancer antiproliferation antiparasitic anti-proliferation anti-parasitic apicomplexan parasites HDAC3 HDAC-3 NcoR HDAC3/NcoR class I HDACs p21 WAF1/Cip1 WAF1 Cip1 gelsolin cells cycle morphology inhibits inhibitors inhibitions chromatin cancers deacetylase modification 108.531279926335
10006797 Araguspongin B 123000-02-2 >90% 2005-09-09 52.007292817679 araguspongin-b membrane-permeable antagonists inositols inositol-1,4,5-triphosphates receptors marine products Pacific basin sponges vasodilatory properties signal transductions messengers IP3 promotes mobilization calcium Ca2+ intracellular stores antagonizes calcium-releasing actions cerebral microsomes Xestospongin C neuroscience 52.007292817679
160737 ARC Polyclonal Antibody - 10.826063535911 arc-polyclonal-antibody Apoptosis Repressor with CARD apoptosis cell death domain DD CARD caspase antibodies western blots blotting WB antisera antiserum cancers immunoblotting IP immunoprecipitation 10.826063535911
13321 ARP 100 704888-90-4 ≥98% 2009-10-07 1.460589318600 arp-100 MMP-2 Inhibitor III; CAY10609 matrix metalloproteinases MMP-2 MMP2 MMP 2 ECM cancers cells migration inhibitors gelatinase A MMPs proteases HT1080 tumors invasive 1.460589318600
13250 (−)-AS 115 926657-43-4 ≥98% 2009-05-18 4.425230202578 -as-115 KIAA1363 MAGE monoacylglycerol LPA LPC lysophosphatidylcholine lysophosphatidic acid lipids signaling cancers signalling 4.425230202578
10009650 (+)-AS 115 - ≥98% 2009-05-19 2.409834254143 -as-115 KIAA1363 MAGE monoacylglycerol LPA LPC lysophosphatidylcholine lysophosphatidic acid lipids signaling cancer 2.409834254143
700420 Ascorbate Assay Kit - 2010-09-01 194.962433926273 ascorbate-assay-kit L-Ascorbic Acid Assay Kit; Vitamin C Assay Kit kits assays measures measurements ascorbates six-carbon 6-carbon six 6 carbons lactones glucose livers mammalian species humans non-human primates guinea pigs gulonolactones oxidases acids 2-keto-1-gulonolactone diets dietary scurvy electrons donors enzymes collagen hydroxylations hydroxyls groups prolines lysines molecules carnitines fatty mitochondrias ATP adenosine triphosphates generations biosynthesis norepinephrines dopamines amides groups peptides hormones tyrosines metabolisms antioxidants chronics diseases cancers cardiovascular cataracts foods industry colors tastes odors plasmas serums urines fruits juices condensations reactions dehydroascorbic DHA o-phenylenediamines OPDA fluorescent fluorescences 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy TEMPOL condensed DFQ 3-(dihydroxyethyl)-furo[34-b]-quinoxaline-1-one OPD 194.962433926273
10946 Ash2L (human recombinant) - ≥90% 2011-06-29 40.186152036013 ash2l-human-recombinant Set1/Ash2 Histone Methyltransferase Complex Subunit Ash2 Isoform A; Absent, small, or homeotic discs 2-like epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex human homolog Drosophilia ash2 transcription 40.186152036013
13375 Atrazine 1912-24-9 ≥98% 2010-02-11 0.182320441989 atrazine herbicides plants cancers reproductive systems reproduction homones endocrines frogs genes expressions humans animals Gesamprim Atrazine 0.182320441989
600140 Autophagy/Cytotoxicity Dual Staining Kit - 2009-07-14 83.632276558800 autophagy-cytotoxicity-dual-staining-kit assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis 83.632276558800
10803 Autotaxin (human recombinant) - ≥95% 2011-04-04 23.951723756906 autotaxin-human-recombinant ENPP-2; Ectonucleotide Pyrophosphatase/Phosphodiesterase-2; Lysophospholipase D lipids hydrolysis lysophophatidyl choline lysophophatidic acids secreated glycosylated 23.951723756906
700580 Autotaxin Inhibitor Screening Assay Kit - 2011-06-28 25.878751381215 autotaxin-inhibitor-screening-assay-kit ATX Inhibitor Screening Assay Kit kits assays measures measurements Ectonucleotides Pyrophosphatase-2 ENPP-2 Lysopholipases D hydrolysis lysophosphatidylcholines LPC lysophosphatidic acid LPA lipids mediators G protein-coupled receptors GPCRs neurogenesis angiogenesis smooth-muscles contraction platelets aggregations wounds healings ATX-LPA signaling tumors progression inflammation serums proteolytically peptides proteins N-glycosylation Asn53 Asn410 adipocytes cerebrospinal fluid multiple sclerosis livers fibrosis cancers genes chips analysis upregulated metastatic inhibits inhibition human 25.878751381215
10009644 BAY 43-9006 New 284461-73-0 ≥98% 2011-09-13 30.976821999332 bay-43-9006 Sorafenib; Nexovar® inhibitors raf-1 b-raf receptors tyrosine kinases VEGF VEGFR PDGF PDGFR cancers angiogenesis apoptosis tumors cells cellular proliferation Flt-3 c-KIT carcinoma growth factor tosylate 30.976821999332
11022 BIBF 1120 New 928326-83-4 ≥95% 2011-11-10 3.753846153846 bibf-1120 Vargatef™ receptors tyrosine kinases inhibitors vascular endothelial growth factor VEGFR platelet-derived growth PDGFR fibroblasts FGFR angiogenesis cancers pulmonary fibrosis diseases 3.753846153846
10011385 Bim/BOD (IN) Polyclonal Antibody - 2008-04-10 2.224364640884 bim-bod-in-polyclonal-antibody apotosis BH3 Bcl-2 Bcl-XL cancer immunoblotting WB IHC antibodies western blotting antiserum blots immunohistochemistry 2.224364640884
10960 Bisdemethoxycurcumin 24939-16-0 ≥98% 2011-08-09 5.459478251652 bisdemethoxycurcumin BDMC curcumin activators macrophages phagocytosis 1α,25-dihydroxyvitamin D, amyloid-β Alzheimer’s diseases cancers transcription genes expression p300 Wnt/β-catenin iNOS inflammation bisdemethoxy curcumin 33171-05-0 5.459478251652
11071 BRD2 bromodomain 1 (human recombinant) New - ≥95% 2011-10-21 29.308910953585 brd2-bromodomain-1-human-recombinant RNF3; Bromodomain containing 4; RING3 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host 29.308910953585
11070 BRD2 bromodomain 2 (human recombinant) New - ≥95% 2011-10-21 29.308910953585 brd2-bromodomain-2-human-recombinant RNF3; RING3; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host 29.308910953585
11069 BRD2 bromodomains 1 and 2 (human recombinant) New - ≥90% 2011-12-20 57.282172670371 brd2-bromodomains-1-and-2-human-recombinant Bromodomain containing 2; RNF3; RING3 BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases 57.282172670371
11068 BRD4 bromodomain 1 (human recombinant) New - ≥60% 2011-10-21 40.116658701333 brd4-bromodomain-1-human-recombinant MCAP; HUNK1; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts 40.116658701333
11066 BRD4 bromodomain 2 (human recombinant) New - ≥95% 2011-10-21 31.673775818450 brd4-bromodomain-2-human-recombinant MCAP; Bromodomain containing 4; HUNK1 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts 31.673775818450
11052 BRD4 bromodomains 1 and 2 (human recombinant) New - ≥90% 2011-12-20 60.013265107346 brd4-bromodomains-1-and-2-human-recombinant HUNK1; MCAP; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases 60.013265107346
10005270 C75 191282-48-1 >98% 2004-09-22 38.384939226519 c75 inhibits inhibitors inhibition fatty acids synthases FAS cerulenin cytotoxicity apoptosis cancers anorexigenic stable weight loss feeding endocrinology 38.384939226519
13285 Cannabidiol dimethyl ether 1242-67-7 ≥98% 2009-05-19 12.557320441989 cannabidiol-dimethyl-ether Cannabidiol-2',6'-dimethyl ether; CBDD 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic 12.557320441989
10487 Capecitabine 154361-50-9 ≥98% 2010-08-16 7.976427255985 capecitabine Ro 09-1978; Xeloda® Capecitibine Capecytabine Captabin 5-Fluorouracil 5-FU cancers prodrugs thymidine phosphorylase fluoropyrimidine carbamate inhibits inhibition inhibitors thymidylate synthase liver enzymes 158798-73-2 958887-39-3 Deoxyribonucleoside Cytosine Cytosine Deoxyribonucleoside Deoxyriboside Cytosine Cytosine Deoxyriboside Deoxycytidine CDR 7.976427255985
89800 Carnosol 5957-80-2 >96% 114.516290449882 carnosol antioxidants tumors herbs carcinogenesis rosemary Rosmarinus officinalis extracts polyphenolic inhibits inhibitors inhibition 114.516290449882
360745 Caspase-3 (human) Blocking Peptide - 0.575291117722 caspase-3-human-blocking-peptide Yama; ICE3; CPP32; Apopain control peptides blots blotting western cpp-32 ice-3 apoptosis effectors caspases cell death wb antibodies 0.575291117722
160790 Caspase-9 Polyclonal Antibody - 10.596523020257 caspase-9-polyclonal-antibody MCH6 Polyclonal Antibody; ICE-LAP6 Polyclonal Antibody; Apaf-3 Polyclonal Antibody apoptosis cell death Apaf-1 apafs caspase-3 caspases antibodies Apaf1 western blots blotting WB an tisera antiserum cancers immunoblotting 10.596523020257
13704 Cav3.2 Calcium Channel Monoclonal Antibody (Clone S55-10) - 2009-11-12 1.922651933701 cav3-2-calcium-channel-monoclonal-antibody-clone-s55-10 antibodies CACNA1H genes epilepsy up-regulations up regulations upregulations prostate cancers androgen-independent androgen independent western blotting blots WB fusion protein immunohistochemistry IHC immunocytochemistry ICC 1.922651933701
89740 CAY10398 Exclusive - >98% ✓ 47.348926335175 cay10398 reversible inhibitors histone deacetylase HD1 inhibits inhibitions CAY-10398 hdacs HDAC-1 HDACs HDAC 1 HDAC1 HDACIS 47.348926335175
70635 CAY10416 443919-96-8 >95% 2007-07-24 28.635676795580 cay10416 COX-2 cyclooxygenases 5-LO lipoxygenases inflammation inhibitors prostates cancers PC3 LNCaP carcinomas apoptosis inhibition inhibits chemotherapy cells lines 28.635676795580
10005019 CAY10433 537034-17-6 >98% 2005-01-05 53.032385921833 cay10433 BML-210; N-phenyl-N'-(2-Aminophenyl)hexamethylenediamide HDAC deacetylases histone inhibits inhibitors inhibition cancer cells differentiation gene expression regulation Trichostatin A nuclear extracts deacetylation transcription factors FOXO3 SIRT1 H2O2 hydrogen peroxides BML210 53.032385921833
10005033 CAY10444 Exclusive 298186-80-8 >98% ✓ 2004-10-05 67.050662983425 cay10444 BML-241 receptors antagonists S1P3 EDG3 sphingosines sphingosine-1 sphingosine1 phosphates Hela cells G-proteins CAY-10444 BML241 67.050662983425
10006546 CAY10465 Exclusive 688348-33-6 >98% ✓ 2005-09-09 22.942331491712 cay10465 resveratrol analogs analogues aryl hydrocarbons receptors agonists AhRs ligand-dependents ligands xenobiotics PDM 11 PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar 22.942331491712
10008872 CAY10503 - >98% 2007-08-02 87.804419889503 cay10503 apoptosis antiproliferation cancers differentiation HL60 cells cycles proliferative positive markers CD14 CD11b CD11c monocytic granulocytic 87.804419889503
10009078 CAY10505 328960-84-5 ≥98% 2009-11-04 8.324254143646 cay10505 phosphoinositide 3-kinase immunity autoimmune inflammation PI3Kγ PI3Kα PI3Kβ PI3Kδ casein kinases 2 CK2 phosphorylation PKB/Akt macrophages neutrophil recruitment cancer PI3s T2Ds PI3Ks PI3K.gamma. PI3Kg 8.324254143646
10009536 CAY10512 Exclusive 139141-12-1 >97% ✓ 2007-07-18 34.820911602210 cay10512 analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis 34.820911602210
10010301 CAY10554 267654-00-2 >95% 2007-12-01 8.596372007366 cay10554 BML-259 cell cycle cdk5 cdk2 inhibitors inhibits inhibition cancers BML 259 BML259 CDKs neurodegenerative diseases 8.596372007366
10010043 CAY10561 Exclusive 933786-58-4 >98% ✓ 2008-03-06 27.155911602210 cay10561 Pyrazolylpyrrole ERK Inhibitor MEK Ras Raf ERK2 proliferation cell cycles cancers apoptosis inhibition inhibit inhibitors 27.155911602210
18218 CAY10572 845714-00-3 ≥98% 2009-03-02 11.105580110497 cay10572 PHA 767491 inhibits inhibition inhibitors cdc7 kinases pyrrolopyridinone DNA synthesis cells death cycles apoptosis p53 cancers cdk9 antitumor agents anti-tumor 11.105580110497
10011247 CAY10574 140651-18-9 >95% 2008-09-04 12.350784530386 cay10574 CDK2 cyclin E CDK9 inhibitors inhibits inhibition anticancer cell cycle CAN508 12.350784530386
10011256 CAY10577 300675-28-9 ≥95% 2008-09-02 0.867403314917 cay10577 inhibitors inhibits inhibition CK2 kinase cell signaling apoptosis cancers 0.867403314917
10011264 CAY10578 19231-60-8 ≥95% 2008-08-26 0.867403314917 cay10578 inhibitors inhibits inhibition kinase cell signaling CK2 apoptosis cancers isoindolineacetic acids 0.867403314917
16835 CAY10580 Exclusive 64054-40-6 ≥96% ✓ 2009-03-16 67.510957642725 cay10580 PGEs PGE2 receptors inhibitors inhibits inhibition antagonist blockers EP4 cAMPs bones fromation resorption cancers atherosclerosis 67.510957642725
16838 CAY10581 Exclusive 1018340-07-2 ≥97% ✓ 2009-05-08 2.949171270718 cay10581 indoleamine 2,3-dioxygenase IDO cancers inhibitors tumors inhibition inhibited naphthoquinones 2.949171270718
10012682 CAY10585 934593-90-5 ≥97% 2008-11-06 47.833692449356 cay10585 Hypoxia Inducible Factor-1α Inhibitor HIF-1α HIF1α hypoxia cancers transcriptions factors VEGFs erythropoietin inhibitors inhibits inhibition 47.833692449356
10009797 CAY10591 Exclusive 839699-72-8 >98% ✓ 2008-04-21 47.567808471454 cay10591 Sirtuin 1 Activator 3; SIRT1 Activator 3 p53 HDACs inhibits inhibitors inhibitions SIRTs sirtuins class III TNFalpha TNF.alpha. THP-1 cells anti-obesity anti-diabetic 47.567808471454
13206 CAY10593 Exclusive - ≥95% ✓ 2009-09-03 20.268552486188 cay10593 VU0155069 inhibitors inhibits inhibitions phospholipases D PLD PLD1 PLD2 phosphatidic acids PAs chemotaxis cells migration cancers breast lines tumors trans well assays 1130067-06-9 20.268552486188
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 67.648983425414 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 67.648983425414
10009796 CAY10602 374922-43-7 ≥95% 2009-07-15 19.135260896255 cay10602 SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB 19.135260896255
13146 CAY10603 1045792-66-2 ≥95% 2009-06-18 60.720644567219 cay10603 HDAC 6 inhibitors inhibits inhibition tubulin microtubule pancreatic cancers SAHA HDAC6 HDAC-6 HDACs HDACIs potent selective cells 60.720644567219
13291 CAY10616 Exclusive 586410-08-4 ≥98% ✓ 2009-12-01 20.556751381215 cay10616 resveratrols apoptosis cancers leukemia HL-60 cells HL60 HL 60 multidrug-resistance multidrug resistance multi-drug multi-drug-resistant daunorubicin etoposides citarabines phenols cytarabines HL60R 20.556751381215
13670 CAY10618 Exclusive 1202580-59-3 ≥95% ✓ 2011-03-18 14.200497237569 cay10618 NMPRTase Inhibitor nicotinamides phosphoribosyltransferases NAMPTs NAD+ cancers inhibitors autophagy inhibited inhibition inhibits 14.200497237569
13371 CAY10621 120005-55-2 ≥98% 2010-02-16 15.232748618784 cay10621 SKI 5C; SPHK 1 Inhibitor 5C sphingosines kinases Sphk sphingosine-1-phosphates S1P SphK1 SphK2 cancers inhibitors inhibits U937 cells proteins kinase C PKC SKI5C SKI-5C 15.232748618784
13836 CAY10625 137346-42-0 ≥95% 2010-06-23 1.298044198895 cay10625 apoptosis Smac Diablo Survivin cancers antagonists INCENP doxorubicin caspase-3 caspase-7 Aurora B kinases Borealin caspases cell-permeable antagonists smac/diable smac-diablo 1.298044198895
13838 CAY10626 Exclusive 1202884-94-3 ≥98% ✓ 2010-08-23 19.538557397176 cay10626 PI3Kα mTOR cancers signal transduction inhibitors inhibits inhibition phosphatidylinositol 3-kinase PtdIns PIs 19.538557397176
10743 CAY10650 Exclusive 1233706-88-1 ≥98% ✓ 2011-06-14 23.657458563536 cay10650 cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 23.657458563536
10004985 Caylin-1 - >98% 2005-09-09 14.819715864246 caylin-1 caylin1 mdm-2 cancer Nutlin-3 analogs p53 inhibits inhibitors inhibition interaction Mdm2 negative regulators activity chlorine substituents phenyl rings growth HCT-116 cells promotes 14.819715864246
10005002 Caylin-2 - >98% 2004-07-12 13.521464088397 caylin-2 apoptosis cancer p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts HCT-116 caylin2 13.521464088397
13172 CBHA 174664-65-4 ≥98% 2009-06-24 33.611250043028 cbha Histone Deacetylase Inhibitor II; m-Carboxycinnamic Acid bis-Hydroxamide histones deacetylase HDACs HDAC1 HDAC3 apoptosis cancers neuroblastoma tumors retinoic acids inhibitors inhibits inhibition 33.611250043028
10787 CCG-100602 New 1207113-88-9 ≥98% 2011-11-22 17.172882136279 ccg-100602 Rho signaling signal transduction cancers inhibitors SRF serum response factors transcription CCG-1423 megakaryoblastic leukemia 1 MKL1 prostate analogs PC-3 CCG100602 CCG 100602 CCG1423 CCG 1423 cells DNA binding RHOA/C-mediated MKL-1 17.172882136279
10010350 CCG-1423 285986-88-1 >98% 2007-09-20 12.361991581162 ccg-1423 Rho signaling transduction cancers proliferations anti-proliferation anti-tumor serum response factor GTPase inhibits inhibitors inhibition signalling 12.361991581162
10012591 CCT018159 171009-07-7 ≥98% 2008-12-09 0.626408839779 cct018159 inhibitors inhibits inhibition cancers Hsp90s Hsp72 kinases tumor cells 17-AAG 17AAG CCT 018159 CCT-018159 0.626408839779
10004804 CD150 Monoclonal Antibody (Clone IPO-3) - 2005-03-21 1.395603130754 cd150-monoclonal-antibody-clone-ipo-3 SLAM; IPO-3; CDw150 type transmembrane glycoproteins signals signalling transduction neoplastic cells antibodies antisera antiserum antioncogenic immunohistochemistry IHC flow cytometry immunoprecipitation IP immunocytochemistry ICC receptors ligation Hodgkins lymphoma leukemia tumors cancer ipo3 cd-150 b-cells t-cells tonsils cancers FC 1.395603130754
10004837 CD27 Monoclonal Antibody (Clone 203.6) - 2005-09-16 7.419065796082 cd27-monoclonal-antibody-clone-203-6 antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type II transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC 7.419065796082
10004835 CD34 Monoclonal Antibody (Clone ICO-115) - 2005-09-16 4.512881427964 cd34-monoclonal-antibody-clone-ico-115 antibodies antisera antiserum ICC immunocytochemistry FACS flow cytometry type I transmembranes glycoproteins proteins antigens isoforms stem cells embryonic fibroblasts neurons Anti-CD34 differential staining acute leukemias cancers malignant malignancies ICO115 FC 4.512881427964
10208 CD34 Monoclonal FITC Antibody (Clone ICO-115) - 2008-07-23 28.190000000000 cd34-monoclonal-fitc-antibody-clone-ico-115 antibodies antiserum antisera flow cytometry immunofluorescence FC IF transmembranes glycoproteins leukemias stem cell lines 28.190000000000
10004718 CD37 Monoclonal Antibody (Clone IPO-24) - 2005-09-16 4.867584128578 cd37-monoclonal-antibody-clone-ipo-24 antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type III transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC 4.867584128578
10004597 CD45 Monoclonal Antibody (Clone BRA-55) - 2005-08-23 4.867584128578 cd45-monoclonal-antibody-clone-bra-55 antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type transmembranes glycoproteins leukocytes antigens alternative splicing isoforms CD45RA CD45RB CD45RC CD45RO expression lymphocytes cells NK activated memory monocytes granulocytes dendritic anti-CD45 mAB lymphoid malignancies malignant cancer BRA55 immunoblotting FC 4.867584128578
10009852 CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT-8) - 2008-09-03 0.485303867403 cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8 antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 IF immunofluorescence 0.485303867403
10004604 CD95 Monoclonal Antibody (Clone IPO-4) - 2004-06-17 1.484942909760 cd95-monoclonal-antibody-clone-ipo-4 APO-1; Fas; Tumor Necrosis Factor Receptor Superfamily, Member 6; TNFRSF6; Apoptosis Antigen; APT glycoproteins blots blotting antibodies antisera antiserum DNA binding anti-oncogenic apoptosis cancers p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic immunocytochemistry immunohistochemistry IHC icc FC flow cytometry 1.484942909760
10009349 Cell Cycle Phase Determination Kit - 2007-04-20 58.381291022099 cell-cycle-phase-determination-kit assays kits measures measurements microscopy flow cytometry plate readers regulators cells transcription factors DNA proteins division proliferation induction inhibition fixation permeabilization staining sub-G1 G0 G2 S propidium iodide apoptosis cancer cell-based assay cell based assay cba 58.381291022099
11092 Ceranib-2 New - ≥98% 2011-12-19 47.722494687633 ceranib-2 ceramides ceramidase sphingosines sphingosine-1-phosphate S1P cells proliferation cancers paclitaxel tumors inhibitors lipids inhibits inhibition endogenous ovarian SKOV3 growth toxicity fatty acids N-acyl malignant apoptosis S1P non-lipid increases increased 47.722494687633
10005647 Cerulenin 17397-89-6 ≥98% 2004-09-01 59.642348066298 cerulenin tumor cells fatty acid synthases FAS inhibits inhibitors inhibition cytotoxicity apoptosis cancer diet obesity D02.065.327 59.642348066298
10009853 CFSE Cell Division Assay Kit - 2010-01-15 61.222571185720 cfse-cell-division-assay-kit derivative carboxyfluorescein diacetate, succinimidyl ester CFDA-SE cells proliferation growth factors receptors surfaces signaling molecules transcription factors DNA deoxyribonucleases proteins divisions cascades human pathological diseases cancers cell-tracing fluorescent fluorescence dyes proliferative activity parent generations daughter acetate groups molecules cleaved background unstained staining CFSE-labeled radioactivity radioactive labeling divisions inductions inhibitors inhibits inhibitions in vitro models flow cytometry fluorochromes fluorescein 61.222571185720
13156 Chaetocin 28097-03-2 ≥95% 2010-10-18 13.478398959337 chaetocin histones methyltransferases HMTs genes expressions epigenetics inhibitors oxidative stress cancers theoredoxin reductase-1 TrxR1 inhibits inhibition chetocin chaetocin A (+)-chaetocin piperazines 13.478398959337
10011286 Chenodeoxycholic Acid 474-25-9 ≥95% 2009-02-25 25.944618784530 chenodeoxycholic-acid CDCA; Fluibil; Hekbilin; Anthropodeoxycholic Acid; Kebilis; Ulmenide FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA 25.944618784530
13686 Chidamide 743420-02-2 ≥98% 2010-08-10 74.911060773480 chidamide HDACs histones deacetylase H3 acetylation colons cancers cells inhibitors inhibits inhibiton LoVo HT-29 HT29 HT 29 cycle arrest chidamides oncogenic signalling signaling kinases Benzamides 74.911060773480
70930 Chlorogenic Acid 327-97-9 ≥95% 27.538545119705 chlorogenic-acid NSC 407296; Heriguard; 3-O-Caffeoylquinic acid antioxidants acids plants metabolism polyphenolic 27.538545119705
13501 Chromosome Associated Protein-C Polyclonal Antibody (aa 281-297) - 2009-09-22 0E-12 chromosome-associated-protein-c-polyclonal-antibody-aa-281-297 CAP-C antibodies SMC WB western blots immunoblotting blotting hCAP-C hCAPC hCAP C hSMC1 hCAP-E hCAP E hCAPE hSMC3 chromosomes structured maintenance 0E-12
13503 Chromosome Associated Protein-C Polyclonal Antibody (aa 47-61) - 2009-09-22 0E-12 chromosome-associated-protein-c-polyclonal-antibody-aa-47-61 CAP-C antibodies SMC WB western blots immunoblotting blotting hCAP-C hCAPC hCAP C hSMC1 hCAP-E hCAP E hCAPE hSMC3 structural maintenance chromosomes 0E-12
10012583 cis-ACCP 777075-44-2 ≥95% 2009-02-10 0E-12 cis-accp MMP2 MMPs MMP 2 MMP9 MMP-9 9 tumors cancers extracellular matrix type IV collagen cell migration artritis osteoprosis 0E-12
13199 cis-trismethoxy Resveratrol 94608-23-8 ≥98% 2009-03-25 19.856975138121 cis-trismethoxy-resveratrol cis-Trimethoxy Stilbene resveratrol anti-mitotic growth inhibitors colon cancers tubulin polymerization polyamines putrescine spermidine cis-Trimethoxy resveratrol 3,5,4'-trimethoxystilbene 3,5,4'-trimethoxy-cis-stilbene trismethoxy inhibitor inhibition caco-2 caco 2 cells AHR antagonists aryl hydrocarbon receptors 19.856975138121
10599 Cl-Amidine Exclusive New 913723-61-2 ≥95% ✓ 2011-08-29 30.463881942552 cl-amidine inhibitors PAD4 PAD-4 cancers epigenetics amidines proteins arginine deiminase 4 arthritis PADs cytotoxic HL-60 HL60 HT-29 mice joints auto antibodies HL 60 MCF7 MCF-7 MCF 7 HT29 citrulline IgG HT 29 cells lines ClA mouse serum autoantibodies auto-antibodies PAD3 PAD-3 3 PAD1 PAD-1 1 30.463881942552
580110 Clusterin (human) EIA Kit - 2011-08-02 2.154696132597 clusterin-human-eia-kit pADHC-9; KUB-1; CLI; SGP-2; AAG4; TRPM-2; Apo-J; Apolipoprotein J apolipoproteins Up-regulated in Azheimer's diseases brains Ku70-binding proteins 1 sulfated glycoproteins 2 aging-associated genes 4 complement lysis inhibitors testosterone-repressed prostate messages secreted disulfide-linked heterodimeric amyloid lipids bacteria leptin immunoglobulins endocytic receptors LDLs low-density lipoprotein-related LPR2 LPR8 8 endocytosis tissues mammals mammalian cells plasma serums semen cultures media medium developmental remodeling apoptotic neurodegeneration injury stress inhibits inhibition apoptosis carcinogenesis genes CLU ELISAs EIAs enzymes immunoassays kits measures measurements human supernatants 2.154696132597
9000760 Colchicine 64-86-8 ≥98% 2011-05-25 1.970441988950 colchicine microtubules polymerization mitosis anti-proliferation anti-inflammatory gout uric acids antiinflammatory antiproliferation 1.970441988950
10007412 Combrestatin A4 117048-59-6 ≥98% 2007-07-26 22.599992633517 combrestatin-a4 CRC 87-09; Combretastatin A4; CA4 inhibitors inhibition inhibits tubulin polymerization tumors CSA4 CSA-4 IMR32 neuroblastomas Hs746T carcinomas CFPAC-1 CFPAC1 MCF-7 MCF7 cancers inhibitory CA4 cells growth pancreatic breast gastric CA-4 combretastin 22.599992633517
360107 COX-2 (human) Blocking Peptide - 33.646132596685 cox-2-human-blocking-peptide Prostaglandin H Synthase 2; Cyclooxygenase 2; PGHS-2 peptides prostaglandins PGHS-2 COX2 PGHS2 western blots blotting synthases controls immunohistochemistry IHC cyclooxygenases WB antibodies 33.646132596685
160112 COX-2 Monoclonal Antibody (Clone CX229) - 91.736294659300 cox-2-monoclonal-antibody-clone-cx229 PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2 prostaglandins inflammation cancers arthritis western blots blotting immunohistochemistry IHC WB immunocytochemistry ICC antibodies cox2 pghs2 pghs-2 synthases cyclooxygenases antisera antiserum cyclooxygenase immunoblotting 91.736294659300
160126 COX-2 (mouse) Polyclonal Antibody - 114.877594843462 cox-2-mouse-polyclonal-antibody PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2 immunohistochemistry IHC Western blotting WB antibodies blots cox2 PGHS2 PGHS-2 synthases prostaglandins mouse cyclooxygenases antisera antiserum cancers immunoblotting 114.877594843462
10010096 COX-2 (mouse) Polyclonal FITC Antibody Exclusive - ✓ 2008-04-23 30.792569060773 cox-2-mouse-polyclonal-fitc-antibody Prostaglandin H Synthase 2; PGHS2; Cyclooxygenase 2 antibodies prostaglandins thromboxanes prostacyclins arachidonic acids FC flow cytometry ICC immmunocytochemistry WB western blots blotting immunoblotting IF immunofluorescence 30.792569060773
700200 COX Fluorescent Activity Assay Kit - 2008-07-24 74.909558011049 cox-fluorescent-activity-assay-kit Cyclooxygenase Fluorescent Activity Assay Kit cyclooxygenases synthases enzymes cox-1 cox1 cox-2 cox2 prostaglandins PGs synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity cellular homeostasis antiinflammatory NSAIDs nonsteroidal anti-inflammatory drugs fluorescence human recombinant ovine isozyme-specific inhibits inhibitors inhibition ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 74.909558011049
81025 Curcumin 458-37-7 ≥90% 16.418902420605 curcumin Turmeric Yellow; Indian Saffron anti-oxidant anti-imflammatory NOS nitric oxide synthase 16.418902420605
81025.1 Curcumin (technical grade) 458-37-7 ≥65% 7.585303867404 curcumin-technical-grade Turmeric Yellow; Indian Saffron anti-oxidant anti-imflammatory NOS nitric oxide synthase 7.585303867404
10011388 Cu/Zn SOD (human) Polyclonal Antibody - 23 kDa 2008-04-03 146.316950276243 cu-zn-sod-human-polyclonal-antibody SOD1; Cu/Zn Superoxide Dimutase SOD1 SOD2 SOD3 EC-SOD oxidative stress ROS superoxide antibodies antiserum WB western blots immunoblotting IP EIA IHC immunohistochemistry neurochemistry immunoprecipitation enzyme immunoassays neurochemistry blotting 146.316950276243
10004600 Cytokeratin Monoclonal Antibody (Clone C-11) - 2008-06-05 19.639745856353 cytokeratin-monoclonal-antibody-clone-c-11 pan-Cytokeratin cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms western blots WB flow cytometry FC immunocytochemistry ICC immunohistochemistry IHC immunoblotting proteins blotting 19.639745856353
10568 Cytokeratin Monoclonal APC Antibody (Clone C-11) - 2011-03-04 14.601144435675 cytokeratin-monoclonal-apc-antibody-clone-c-11 pan-Cytokeratin cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms flow cytometry FC proteins immunofluorescence IF 14.601144435675
10349 Cytokeratin Monoclonal FITC Antibody (Clone C-11) - 2010-04-14 18.471082872928 cytokeratin-monoclonal-fitc-antibody-clone-c-11 pan-Cytokeratin cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms western blots WB flow cytometry FC immunofluorescence IF immunoblotting proteins blotting 18.471082872928
10478 Cytokeratin Monoclonal PE Antibody (Clone C-11) - 2010-10-28 2.473370165746 cytokeratin-monoclonal-pe-antibody-clone-c-11 pan-Cytokeratin cytokeratins pan-cytokeratins antibodies antiserum antisera anti-serum anti serum anti-ser anti sera isoforms flow cytometry FC immunoblotting proteins blotting IF immunofluorescence 2.473370165746
63500 Cytotrienin A 189010-85-3 ≥95% 2009-07-06 18.435524861878 cytotrienin-a anti-tumor anti-cancer apoptosis ROS caspace-3 p36 MBP kinase JNK 18.435524861878
13305 D 4476 301836-43-1 ≥98% 2009-07-29 37.402209944751 d-4476 Casein Kinase I Inhibitor inhibitors inhibits inhibition casein kinases 1 CK1 Ck1δ TGF-β TGFβ type-1 receptors ALK5 PKD1 p38α MAPK kinases phosphorylation FOXO1a RhoB p53 Smad3 D4476 37.402209944751
13202 Daidzin New 552-66-9 ≥98% 2011-09-30 3.065827892181 daidzin NPI 031D; Daidzoside isoflavones soy kudzu anti-oxidants cancers oxidants stress atherosclerosis inhibitor inhibits inhibition mitochondrial aldehydes dehydrogenases 2 alcohols plants anticarcinogenic anti-carcinogenic anti carcinogenic antioxidants antidipsotropic dipsotropic anti-dipsotropic anti-atherosclerosis antiatherosclerosis atherosclerosis 1329-08-4 28572-56-7 NPI-031D NPI031D 7-glucoside glucosides 3.065827892181
160755 DcR2 Polyclonal Antibody - 0E-12 dcr2-polyclonal-antibody TRUNDD; TRAIL-R4 apoptosis cell death TNF DR4 DR5 DcR1 TRID TRAIL antibodies western blots blotting WB antisera antiserum immunoblotting 0E-12
10005432 DDA 25152-84-5 ≥98% 2004-07-22 14.591668508287 dda trans-2,4-Decadien-1-al; Decadienealdehyde lipoxygenases diatoms alkyls linoleic acids dihomo-gamma-linolenic dihomo-g-linolenic arachidonic dihomo-.gamma.-linolenic carcinoma Caco2 apoptosis 14.591668508287
10010706 (−)-Deguelin 522-17-8 ≥98% 2008-09-18 15.940441988951 -deguelin (-)-cis-Deguelin rotenoids flavonids cancers antiproliferative chemoprevention parkinsons diseases Akt PKB PI3K COX-2 COX2 apoptosis PI3-K 15.940441988951
10961 Demethoxycurcumin New 22608-11-3 ≥98% 2011-09-23 5.153683373742 demethoxycurcumin DMC curcumin cancers transcription genes expressions p300 Wnt/β-catenin iNOS inflammation proliferation cells p300 coactivator inhibits lipopolysaccharides inhibitor inhibition 5.153683373742
700390 Demethylase (Jumonji-type) Activity Assay Kit - 2010-05-26 18.997207819804 demethylase-jumonji-type-activity-assay-kit kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC JHDM1 JHDM2 JHDM3 JARID1 UTX/UTY cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 18.997207819804
700400 Demethylase (LSD-type) Activity Assay Kit - 2010-08-05 16.238189950013 demethylase-lsd-type-activity-assay-kit kits assays measures measurements histones proteins nucleoproteins chromatins structures DNA deoxyribonuclease eukaryotics nucleus nucleosomals core particles H3 H4 H2B H2A octamers amino termini post-translationally acetylation phosphorylations ubiquitination methylations replication repair transcriptional activation repression dysregulation tumor suppressor genes cancers enzymes catalyze epigenetic marks therapeutics drugs development lysine-specific demethylases LSD1 KDM1 p110b BHC110 NPAO LSD2 flavin adenines dinucleotides FAD-dependent amines oxidases monoamines MAOs polyamines PAOs demethylates monomethylateds dimethylateds lysines 4 K4 repression deacetylases co-repressor complexes 1/2 CtBP neuronal CoREST p53 LYS370 53BP1 apoptosis C-terminal domains CW-type zinc finger motif zince-binding sites chromatin-remodeling fluorescence-based formaldehyde N-terminal tail acetoacetanilides ammonia 16.238189950013
10165 D-erythro-MAPP 143492-38-0 >98% 2004-02-23 22.426004455949 d-erythro-mapp (1S,2R-D-erythro-2-N-myristoylamino)-1-phenyl-1-propanol ceramides inhibitors sphingolipids HL60 HL-60 cancer cells G0/G1 G0-G1 inhibits ceramidase 22.426004455949
10012577 Diallyl Trisulfide 2050-87-5 ≥98% 2009-04-07 20.496370779619 diallyl-trisulfide DATS; NSC 651936 garlic hydrogen sulfides H2S cancers tumors smooth muscle cholesterol atherosclerosis donors supresses colon synthesis genes expression adenocarcinomas HCT-15 cells PC-3 xenografts 20.496370779619
10009081 Didox Exclusive 69839-83-4 ≥98% ✓ 2007-01-16 19.257632202051 didox antioxidants hydroxamic acids apoptosis cancers cells polyhydroxylated aromatic ocidative injury brains HIV dementia bcl-2 19.257632202051
10006876 Diethylstilbestrol 56-53-1 ≥98% 2005-10-03 4.034618784530 diethylstilbestrol synthetics receptors agonists pregnant pregnancies linked breasts cancers congenital abnormalities abnormality offspring 3H-estradiols binding affinities affinity sexes hormones globulins SHBG estrogens 4.034618784530
10009986 Dimethoxycurcumin 160096-59-3 ≥90% 2007-08-03 13.059432807345 dimethoxycurcumin curcumins cancers ASCJ9 antitumors anti-tumor phytochemicals turmeric inhibits inhibition inhibitory growth expression cells ASC-J9 13.059432807345
62237 Diphenyl-1-pyrenylphosphine 110231-30-6 ≥98% 2006-07-25 79.536961325967 diphenyl-1-pyrenylphosphine DPPP hydroperoxides oxidative stress injury fluorescence fluorescent lipids cholesterols LDL oxidation DPPPO DPPP=O atherosclerosis 79.536961325967
10005276 DL-threo-PDMP (hydrochloride) 80938-69-8 >98% 2004-08-10 2.303591160220 dl-threo-pdmp-hydrochloride analogs analogues inhibits inhibitors inhibition cytotoxicity glucosylceramides synthases chirality stereoisomers sphingosine 2.303591160220
71210 DMOG 89464-63-1 ≥98% 125.450453038674 dmog Dimethyloxallyl Glycine nuclear receptors cancer hypoxia HIF-1alpha Hif1α HIF-1α HIF1α Pro-angiogenic proangiogenic factors HIF-PH HIFPH prolyl hydroxylase inhibits inhibitors inhibition 125.450453038674
10009851 D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) - >98% 2007-06-04 8.561325966850 d-myo-inositol-1-3-4-5-6-pentaphosphate-ammonium-salt 1,2,4,5,6-IP5 (sodium salt); Ins(,1,3,4,5,6)P5 inositols phosphate IP5 signal transduction InsP phosphitidylinositol phospholipase C PLC phosphioinositide 3-kinase PI3-K Akt cancer angiogenesis PKB protein kinase B 8.561325966850
660990 DNA Laddering Kit - 3.107679558011 dna-laddering-kit kits assays apoptosis 3.107679558011
589324 DNA Methylation EIA Kit - 2009-04-23 96.743104600955 dna-methylation-eia-kit 5-methyl-2-deoxy Cytidine ELISA Kit solid plates DNA deoxyribonucleic acids CpG islands dinucleotides genes genomes cancers genomic hypomethylation hypermethylation tumors suppressors malignancy carcinogenesis plasma blood urine leukemia tissues differentiation aging methyltransferases DNMTs DNMT1 DNMT3a DNMT3b nucleosides analogs azacitidine decitabine zebularine drugs suppression competitive assays EIAs ELISAs culture supernatants sample matrices 96.743104600955
13479 DNA Methyltransferase 1 Monoclonal Antibody (Clone 60B1220.1) - 2009-06-29 1.436863106199 dna-methyltransferase-1-monoclonal-antibody-clone-60b1220-1 DNMT1 WB Western blots immunoblotting IHC ChIP IP DNMT 1 blotting immunohistochemistry immunoprecipitation 1.436863106199
13481 DNA Methyltransferase 2 Monoclonal Antibody (Clone 102B1259.2) - 2009-07-13 0.197316495659 dna-methyltransferase-2-monoclonal-antibody-clone-102b1259-2 DNMT2 WB Western blots immunoblotting DNMT-2 monoclonals blotting DNMT 2 blotting 0.197316495659
13480 DNA Methyltransferase 2 Polyclonal Antibody - 2009-07-13 0.235255524861 dna-methyltransferase-2-polyclonal-antibody DNMT2 WB Western blots immunoblotting DNMT 2 blotting DNMT-2 0.235255524861
13483 DNA Methyltransferase 3a Monoclonal Antibody - Biotinylated (Clone 64B814.1) - 2009-07-15 0.197316495659 dna-methyltransferase-3a-monoclonal-antibody-biotinylated-clone-64b814-1 DNMT3a ELISA DNMT3a Enzyme-linked immunosorbent assays 0.197316495659
13484 DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B1446) - 2009-07-15 0.197316495659 dna-methyltransferase-3a-monoclonal-antibody-clone-64b1446 DNMT3a WB Western blots immunoblotting DNMT3a blotting ICC immunocytochemistry IHC immunohistochemistry 0.197316495659
13482 DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B814.1) - 2009-07-01 0.235255524861 dna-methyltransferase-3a-monoclonal-antibody-clone-64b814-1 DNMT3a WB Western blots immunoblotting DNMT3a blotting ICC immunocytochemistry 0.235255524861
13485 DNA Methyltransferase 3b Monoclonal Antibody (Clone 52A1018) - 2009-07-01 0.235255524861 dna-methyltransferase-3b-monoclonal-antibody-clone-52a1018 DNMT3b WB Western blots immunoblotting DNMT3b immunoprecipitation immunofluorescence immunocytochemistry ChIP immunohistochemistry IHC IP ICC IF blotting 0.235255524861
10770 DNA Methyltransferase 3L (human recombinant) - ≥95% 2011-06-08 6.795327740263 dna-methyltransferase-3l-human-recombinant DNMT3L; DNMT3-Like Protein DNA methyltransferases s-adenosylmethionine CpG methylation lysines proteins DNMT3a DNMT3b histones cysteine ADD PWWP mTase 6.795327740263
10006305 D-NMAPPD Exclusive 35922-06-6 ≥98% ✓ 2005-02-23 23.469751239553 d-nmappd CAY10466; (1R,2R)-B13 ceramides inhibitors cancers cells inhibits inhibition ceramidase apoptosis colorectal keratinocytes melanoma lines viability inducers induces 23.469751239553
700210 DPP (IV) Inhibitor Screening Assay Kit - 2009-05-27 100.725449729094 dpp-iv-inhibitor-screening-assay-kit Dipeptidyl exopeptidases IV DPPIV DPP4 enzymes CD26 cluster of differentiation T-cells activation antigens adenosine deaminase complexing 2 membrane-bound glycoproteins immune regulation signal transduction apoptosis kidneys small intestines placentas humans serums seminal fluids proteolytic derivatives serines X-prolines X-alanines dipeptides N-terminus N-terminal polypeptides growth factors chemokines neuropeptides vasoactive inhibitors inhibits inhibition oral antidiabetic agents glucose homeostasis glucoregulatory hormones glucose-dependent insulinotropics GIP glucagon-like peptide-1 GLP-1 gastric therapeutics Type 2 tumors cancers markers neoplasms assays kits measures measurements fluorescences fluorescent fluorogenics substrates Gly-Pro-Aminomethylcoumarin AMC 100.725449729094
11178 DPY-30 (human recombinant) New - ≥95% 2012-01-05 92.125894302137 dpy-30-human-recombinant DPY-30-like protein; SAF19; hDPY-30 epigenetics methyltransferase histones H3K4 genes regulations MLL proteins subunits Ash2L MLL sore complex DPY30 methylation C. elegans XX mutations XO growth development homodimer monomers WDR5 WDR-5 WDR 5 RbBP5 basal rates DPY-30L DPY30L hDPY30 SAF-19 92.125894302137
10010302 DRB 53-85-0 ≥98% 2008-01-21 2.618351330989 drb Benzimidazole; NSC 401575 cancers HIV P53 apoptosis CDK7 CDK9 CTD CKI CKII adenosine inhibitors inhibits inhibition transcription RNA polymerase cell cycles adenocarcinoma transactivator tat 2.618351330989
10007963 E-64 66701-25-5 ≥98% 2009-11-12 53.556611418047 e-64 inhibitors cysteine proteases cathepsins papain calpain irreversible inhibition inhibited E64 E 64 53.556611418047
10007964 E-64c 76684-89-4 ≥98% 2006-08-02 51.483959484346 e-64c EP 475; Loxistatin Acid; NSC 694279 E-64 cysteine protease cell cycle inhibitor E-64d 51.483959484346
13533 E-64d 88321-09-9 ≥98% 2010-08-16 15.763895027624 e-64d EP 453; NSC 694281; EST; Loxistatin; E-64c ethyl ester; Aloxistatin cysteine protease proteins degradation lysosome inhibitors inhibits inhibition calpain cathepsin E64d E 64d 64 207396-71-2 cells cancers carcinomas A431 E-64d Morphinans 15.763895027624
10005732 EAF2 Blocking Peptide - >75% 2004-09-01 0E-12 eaf2-blocking-peptide ELL-Associated Factor 2; U19 WB western blots blotting IHC immunohistochemistry immunoblot formalin-fixed paraffin-embedded sections apoptosis inhibits ihibitors inhibition prostate tumors testosterone antibodies paraffins signaling signalling controls peptides 0E-12
10005190 EAF2 Polyclonal Antibody - 2004-08-12 2.012088397790 eaf2-polyclonal-antibody ELL-Associated Factor 2; U19 WB western blots blotting IHC immunohistochemistry immunoblots formalin-fixed paraffin-embedded sections apoptosis inhibits inhibitors inhibition prostate tumors testosterone suppressive supression leukemogenesis cancers endocrinology immunoblotting 2.012088397790
10628 EED (human recombinant) - 95 2010-12-03 0E-12 eed-human-recombinant Embryonic Ectoderm Development 0E-12
10569 Ellagic Acid 476-66-4 ≥95% 2010-10-13 5.897845303867 ellagic-acid Lagistase; TBBD; Gallogen polyphenols, antioxidants, cancers inflammation cytochrome P450s CYP450 epigenetics genes expression histones modifications alizarin yellow G 91006 elagostasine 77415-21-5 124590-32-5 PRMTs inflammatory anti-carcinogenic anti-mutagenic organ-preserving antimutagenic antiinflammatory Acid Benzoaric Benzoaric Acid Acid Ellagic Ellagic Acid 5.897845303867
10112 (±)-Enterolactone 78473-71-9 ≥98% 6.983867403315 -enterolactone HPMF lignans plants antioxidants cancer oxidative injury stress enterobacterial 6.983867403315
500520 Enterolactone EIA Kit - 2005-03-15 121.035776550030 enterolactone-eia-kit solid plates steroids measures kits eias enzyme immunoassays ELISAs endocrinology assays enterolactones mammalian lignans phytoestrogens estrogen-like diphenols diphenolics intestinal intestines bacterias plant matairesinol secoisolariciresinol diets dietary acute coronary hormone-dependent cancers osteoporosis serums plasmas fiber 121.035776550030
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 24.028158379373 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 24.028158379373
600410 EP4 Receptor (rat) STEP Plate Assay Kit (cAMP method) - 2011-06-28 6.580069060773 ep4-receptor-rat-step-plate-assay-kit-camp-method cell-based assays cells CBAs kits measures measurements prostaglandins E2 PGE2 prostanoids G protein-coupled receptors proteins GPCRs EP1 EP2 EP3 signals transductions mechanisms tissues localizations regulation expression intestines lungs kidneys thymus uterus brains cyclics AMP adenosines monophosphates pathways phosphatidylinositols 3-kinases G1 smooth muscles relaxation gastric secretions intestinal epithelial transportation adrenal aldosterone uterine immunity inflammation human colon cancers colorectal carcinogenesis in vivo neuroprotective excitotoxic injury injuries agonists antagonists therapeutics diseases surface transfections and expression protocols transient technology technologies University of Michigan UM U of M Originus, Inc. USPT United States patents 6897067 6902933 7056741 DNA deoxyribonucleic recombinant proteins cells receptor-mediated endocytosis solution-phase efficiency multiple plasmids constructs intracellular 6.580069060773
600490 EpiTrek SET7/9 SAM-Screener Assay Kit New - 2011-12-21 67.170715776550 epitrek-set7-9-sam-screener-assay-kit SET7/9 SAM-Binding Site Inhibitor Screening kits assays measures measurements chromatins posttranslational modifications histones DNA deoxyribonucleic acids lysines methylations epigenetics regulations genomes mono-methyltransferases MTs domains S-adenosyl-L-methionines SAM AdoMet co-factors epsilons amino groups Dot1 KMT7 domain-containing non-histones H3 TAF10 p53 viral Tat estrogens receptors alpha .alpha. α substrates humans diseases catalytic catabolism fluorescence polarizations fluorescent probes binding pockets endogenous cofactors sinefungin peptides high-throughput 67.170715776550
10924 Epothilone B 152044-54-7 ≥95% 2011-07-27 17.544972375690 epothilone-b macrolides inhibitors inhibits inhibition tubulin microtubules polymerization cancers cells cycle mitotic arrest mitosis Hs578T HeLa KB3-1 KB31 KBV-1 KBV1 cytoskeletal 17.544972375690
10007806 Epoxomicin 134381-21-8 ≥98% 2008-12-09 45.421790055249 epoxomicin BU 4061T inhibitors inhibits inhibition proteins degradation 20S proteasomes antitumors bones formation Parkinsons diseases anti-tumors 45.421790055249
13184 (±)-Equol 94105-90-5 ≥98% 2009-09-03 4.849244935543 -equol phytoestrogens estrogens daidzen genistein receptors cancers nonsteroidal ERα ERβ ERalpha ER.alpha. ERbeta ER.beta. breast cells proliferation 7,4'-homoisoflavone NV 07α 07alpha 66036-38-2 4.849244935543
10010238 Erbstatin Analog 63177-57-1 ≥98% 2008-06-06 0.934806629835 erbstatin-analog Methyl 2,5-dihydoxycinnamate analogs EGF EGFR inhibitors inhibits inhibition tyrosine kinase DNA synthesis cell cycle proliferation cancers 0.934806629835
10483 Erlotinib 183321-74-6 ≥98% 2010-08-11 35.212322543166 erlotinib Tarceva™; CP 358,774; NSC 718781 tyrosine kinase inhibitor inhibits inhibiting epidermal growth factor receptors EGFR cancers tumor cyclin-dependent cyclin dependent kinase 2 CDK-2 CDK 2 CDK2 JAK-2 JAK2 JAK JAK2V617F CP-358,774 CP-358774 CP 358774 CP358774 CP358,774 NSC-718781 NSC718781 OSI-744 OSI744 R-1415 R1415 R 1415 OSI 744 Quinazolines 35.212322543166
10006329 EUK 134 81065-76-1 ≥98% 2005-03-02 23.664198895028 euk-134 salen manganese SOD ROS catalse stroke oxidative injury porphyrin scavengers peroxynitrites superoxides hydrogen peroxides arteries artery cerebral H2O2 infarct volumes EUK 134 EUK-134 EUK134 23.664198895028
13487 EZH1 Polyclonal Antibody - 2009-07-14 0E-12 ezh1-polyclonal-antibody Western blots WB immunoblotting blotting 0E-12
10022 F16 36098-33-6 ≥98% 14.918618784530 f16 apoptosis induces apoptotic mitochodrial membranes tumors inhibitors fluorescent F-16 cancer inhibits fluorescence lipophilic binding HER-1/EGFR-expressing inhibition cells breast 14.918618784530
10010019 FABP2 Polyclonal Antibody - 2007-10-02 22.522340173638 fabp2-polyclonal-antibody Intestinal-Fatty Acid Binding Protein; Fatty Acid Binding Protein 2; I-FABP WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting 22.522340173638
10010364 FABP5 (human recombinant) - >95% 2007-08-08 16.979712707182 fabp5-human-recombinant DA11 FABP; E-FABP; Epidermal-FABP; Fatty Acid Binding Protein 5; Psoriasis-Associated FABP; Keratinocyte FABP proteins lipophilic ligands uptake metabolism cellular membranes FABP-5 FABPs cytosolic fatty acids bladders carcinoma prostates atherosclerosis endocrinology 16.979712707182
10009551 FABP7 (human recombinant) - >90% 2007-06-27 4.380059498512 fabp7-human-recombinant B-FABP; Brain-FABP; Fatty Acid Binding Protein 7 cytosolic FABPs amino acids lipophilic ligands tissues metabolism pathways docosahexanoic fatty binding proteins atherosclerosis endocrinology 4.380059498512
10610 F-Amidine (trifluoroacetate salt) Exclusive New - ≥95% ✓ 2011-09-23 17.646554670224 f-amidine-trifluoroacetate-salt proteins arginine deiminase 4 PAD4 cancers arthritis inhibitors histones genes expression cysteine PAD1 PAD3 cytotoxic HL-60 MCF7 HT-29 877617-46-4 PADs PAD-1 PAD-3 PAD-4 peptidyl arginine 17.646554670224
10010501 Farnesyl Thiosalicylic Acid 162520-00-5 ≥96% 2008-06-02 21.011473296501 farnesyl-thiosalicylic-acid Salirasib; FTS ras inhibitors inhibition inhibits cancer anti-cancer anticancer prenylation farnesylation signal transduction oncogene atherosclerosis farnesylthiosalicylic acid 21.011473296501
13175 Farnesyl Thiosalicylic Acid Amide Exclusive 1092521-74-8 ≥96% ✓ 2009-02-26 8.688549723757 farnesyl-thiosalicylic-acid-amide Salirasib Amide; FTS Amide Ras degradation cells signaling signalling tumors glioblastoma cancers inhibitors inhibits inhibition 8.688549723757
13287 FK-866 658084-64-1 ≥98% 2009-07-21 65.862497237569 fk-866 K 22.175 nicotinamides phosphoribosyltransferase NAMPT NamPRT PBEF visfatin mononucleotides adenine dinucleotide NAD+ inhibitors inhibitis inhibition cancers apoptosis SIRT1 autophagy FK866 FK 866 K22.175 K 22175 K22175 NamPRT PBEF visfatin carcinoma cells autophagy 65.862497237569
700380 Formaldehyde Assay Kit - 2010-05-14 10.412741181470 formaldehyde-assay-kit CH2O; Methanal HCHO kits assays measures measurements formaldehydes resins cells tissues fluids demethylation/methylation methionine-homocysteines cycles microsomal cytochromes CYP450-dependent oxidations xenobiotics oxidative deamination methylamines semicarbazides amines oxidases SSAO-mediated diabetes diabetic wood kerosene gas cigarettes emissions leukemia nasopharyngeal cancers quantification urine prostate bladder breath breast fluorescence-based acetoacetanilides ammonia fluorescent 10.412741181470
10011269 Fulvestrant 129453-61-8 ≥98% 2009-02-24 20.630497237568 fulvestrant ICI 182,780; Faslodex® estrogen receptors ER ERα agonist antagonist activator breast cancers hippocampus neurons ICI182780 ZD182780 ZD9238 ZM182780 20.630497237568
10353 G9a (human recombinant) - ≥70% 2011-03-08 24.173262345550 g9a-human-recombinant EHMT2; Euchromatic Histone-Lysine N-Methyltransferase 2; KMT1C lysines methylation methyltransferases genes silencing repression proteins recombinants set domain-containing pluripotency H3K9 GLP 24.173262345550
10755 G9a-like protein (human recombinant) New - ≥95% 2011-10-13 10.470629439620 g9a-like-protein-human-recombinant EHMT1; GLP; Eu HMTase 1; Euchromatic Histone-Lysine N-Methyltransferase 1; KMT1D lysine methylation methyltransferase genes silencing repression SET domain histones modifications GLP H3K9 BIX-01294 UNC0638 inhibitors inhibits inhibition SAR monomethylate dimethylate BIX01294 BIX 01294 UNC-0638 UNC 0638 10.470629439620
700500 G9a Methyltransferase Inhibitor Screening Assay Kit - 2011-03-10 32.897772790055 g9a-methyltransferase-inhibitor-screening-assay-kit EHMT2 Methyltransferase Inhibitor Screening Assay Kit kits assays measures measurements methylations molecules proteins signals transductions biosynthesis proteins repair genes silencing chromatin regulation S-adenosylmethionine SAM methyltransferases enzymes enzymatic cofactors ATP adenosine triphosphates AdoMet donors methyls groups DNA deoxyribonucleic acids Alzheimer's diseases depression Parkinson's multiple sclerosis livers failures cancers methylations lysines transcriptional activation respression histones functions SET domain-containing mammalian monomethylates dimethylates 9 27 H3 embryogenesis genomic imprinting lymphocytes lung cells HIV-1 H3K9 viral latency GLP G9a-like EHMT1 tumors suppressors p53 373 feedback inhibition methylation reactions 32.897772790055
10008346 Gabapentin 60142-96-3 ≥98% 2006-04-20 25.639433701658 gabapentin Neurontin® antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry 25.639433701658
13841 GANT 61 500579-04-4 ≥98% 2011-04-20 101.891187845304 gant-61 NSC 136476 Hedgehog transcription factors genes expression GLI cancer glioblastomas antagonists development regulation GANT61 GANT-61 pyridines pyrimidines NSC136476 NSC-136476 TFs 101.891187845304
10566 Garcinol New 78824-30-3 ≥95% 2011-10-25 11.820008090665 garcinol Camboginol inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics 11.820008090665
10782 Gcn5 (human recombinant) New - ≥80% 2011-12-05 32.762150742724 gcn5-human-recombinant Lysine acetyltransferase 2A; General control of amino acid synthesis protein 5-like 2; KAT2A; STAF97 epigenetics modifications histones acetylation cancers GNAT N-acetyltransferases enzymes STAGA TFTC SAGA ATAC H3K14 H3K9 H3K18 H4K8 H4K16 H3 H2B KAT2B p300/CBP associated factors Spt-Ada-GCN5-aceytltransferase Ada Two-A containing CoASH Gcn-5 N-acetyltransferases enzymatic subunits complexes proteins 32.762150742724
13166 Gefitinib 184475-35-2 ≥98% 2010-02-11 29.500864286676 gefitinib Iressa™; ZD1839 EGFR-TK EGFRs TKs epidermal growth factors inhibitors cancers signal transduction tyrosine kinases inhibits inhibited NSCLC Quinazolinones 29.500864286676
13355 Geldanamycin 30562-34-6 ≥98% 2010-07-29 28.262476142641 geldanamycin NSC 122750 NSC 212518 antibiotics heat shock proteins 90 Hsp90 GRP94 gp96 genes expression cells proliferation apoptosis angiogenesis c-jun adenocarcinoma cancers AP-1 steroids receptors 2,5-Cyclohexadiene-1,4-Diones 1,4-Benzoquinones 1,2-Benzoquinones p-Benzoquinones-o-Benzoquinones Benzoquinones Benzodiones Quinones 28.262476142641
10005167 Genistein 446-72-0 ≥98% 2004-08-04 8.238152240638 genistein isoflavonoids phytoestrogenics legumes glycosides carcinogenic tumors inhibits inhibition inhibitors estrogenic isoflavones uterine DES diethylstilbestrol histones H2B endocrine tyrosine chemopreventitive 8.238152240638
700300 Glucose-6-Phosphate Dehydrogenase Activity Assay Kit - 2011-07-28 88.061581423733 glucose-6-phosphate-dehydrogenase-activity-assay-kit G6PDH Activity Assay Kit kits assays measures measurements Glucose 6 six phosphates Glucose-6-phosphates dehydrogenases cytosolic enzymes catalyzes pentose pathway ribose-5-phosphates precursor RNA ribonucleic acids DNA deoxyribonucleic ATP adenosine triphosphates CoA coenzymes A NAD nicotinamides adenine dinucleotides FAD flavin NADPH phosphates energy cells fatty oxidations lipids biosynthesis substrates oxidases macrophages polymorphonuclear leukocytes oxygen radicals pathogens intracellular metabolic de novo amino red blood RBC mitochondria pentose oxidative damage stress hemolytic anemia neonatal hyperbilirubinemia acute hemolysis chronic X-linked sex-linked hereditary genetics defect mutations G6PD genes malaria Plasmodium falciparum upregulated rat mouse murine obesity hyperglycemia hyperinsulinemia mediator insulin resistance post-translationally preneoplastic lesions tumors suppressors p53 human dimers fluorescence-based erythrocytes lysates tissues homogenates cultures samples 6-phospho-D-gluconate fluorometrics fluorescent 88.061581423733
600450 Glycolysis Cell-Based Assay Kit Exclusive New - ✓ 2011-08-18 94.624869332632 glycolysis-cell-based-assay-kit CBAs assays kits measures colorimetric colorimetric-based L-lactate culture media mediums cellular metabolic pathways glucose metabolisms cells ATP adenosines triphosphates oxygen exercise erythrocytes mitochondria glucoeogenesis intracellular molecules amino acids insulin glycolytic neurons aerobic energy muscles anaerobic cancers lactate pyruvate tricarboxylic acids cycles oxidizes carbon dioxide CO2 water H2O tumor aggressiveness embryonic stem activity hypoxia-inducible transcriptional factors HIF-1 extracellular inhibition inhibits inhibitors chemotherapeutic strategies strategy metabolomic drugs discovery anticancer 94.624869332632
10948 GN25 New 1227401-27-5 ≥98% 2011-11-30 112.199901780233 gn25 tumors suppressors p53 cancers K-Ras Snail inhibitors mutations exocytosis cells proliferatiion analogs MKN-45 MKN45 MKN 45 A549 HCT116 GN-25 GN 25 genes humans 2-thio-dimethoxy naphthoquinone binding tumors 112.199901780233
10008886 (+)-Goniothalesdiol Exclusive 204975-45-1 ≥98% ✓ 2009-03-02 0E-12 -goniothalesdiol antitumor gonoiothalaus borneensis leukemia P338 cells tetrahydrofuran 0E-12
10007206 GPR40 Blocking Peptide - 2007-04-12 2.269558011050 gpr40-blocking-peptide immunohistochemistry peptide insulin diabetes breast cancer 2.269558011050
10007205 GPR40 Polyclonal Antibody - 2007-04-04 14.011123388582 gpr40-polyclonal-antibody Free Fatty Acid Receptor; FFAR1; G Protein-Coupled Receptor 40 immunohistochemistry antibody insulin diabetes breast cancer endocrinology IHC 14.011123388582
10008313 GW 610 872726-44-8 ≥98% 2006-05-10 24.549723756906 gw-610 NSC 721648 antitumors benzothiazoles inhibits inhibitors inhibition cancers antiproliferative isoflavones quercetin genistein cells MCF-7 MDA 468 NCI 60 24.549723756906
10010556 H-89 127243-85-0 ≥98% 2008-07-08 23.672541436465 h-89 5-Isoquinolinesulfonamide; Protein Kinase Inhibitor H-89 inhibitors inhibits inhibition PKA cAMP cell signaling protein kinase S6K1 MSK1 ROCK-II ROCKII PKB.alpha. PKBalpha PKBa MAPKAP-K1b MAPKAPK1b H89 H 89 23.672541436465
10010249 H-8 (hydrochloride) 113276-94-1 ≥98% 2008-07-17 12.649364640884 h-8-hydrochloride Protein Kinase Inhibitor H-8 PKA PKG PKC MLCK cyclin C CDK8 cyclin H CDK7 p36 signal transduction inhibitor inhibits inhibition transcription 84478-11-5 12.649364640884
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 68.667826887661 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 68.667826887661
10006515 HAT Inhibitor Screening Assay Kit - 2006-12-06 10.786730507081 hat-inhibitor-screening-assay-kit Histone Acetyltransferase Inhibitor Screening Assay Kit therapeutics histones p300/CBP-Associated Factors pCAF GNAT GCN5-related N-acetyltransferases acetylates lysines N-terminal terminus tails H3 H4 tumors suppressor genes PTEN human cancers apoptosis fluorescence fluorescent inhibitors fluorometric assays 10.786730507081
10576 HC Toxin 83209-65-8 ≥95% 2010-11-10 39.402900552486 hc-toxin Toxin I (Helminthosporium carbonum) inhibitors histones deacetylases HDACs cancers genes regulation regulates regulators epigenetics HC-toxins cell-permable cells permable 15-lipoxygenase-1 15-LO-1 LOs lipoxygenase 15 1 tetrapeptides peptides helminthosporium carbonums cochliobolus maize pathogens Isomerases Amino Acid Acid Isomerases Amino Racemases Amino Acid Amino Acid Isomerases Acid Racemases Amino Amino Acid Racemases 39.402900552486
13504 HDAC11 Polyclonal Antibody - 2009-07-31 1.729558011049 hdac11-polyclonal-antibody Histone Deacetylase 11 wb western immunoblotting HDACs HAT histones antibodies peptides blots blotting 1.729558011049
10009231 HDAC1 (human recombinant) - >10% by SDS-PAGE 2006-12-06 50.729545183328 hdac1-human-recombinant Histone Deacetylase 1 HDAC 1 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus GST-tagged baculovirus Sf9 50.729545183328
10011564 HDAC1 Inhibitor Screening Assay Kit - 2008-04-10 29.774175874769 hdac1-inhibitor-screening-assay-kit HDAC 1 histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes license:cyclex fluorometric assays cancer 29.774175874769
13491 HDAC1 Polyclonal Antibody - 2009-07-24 0.652209944751 hdac1-polyclonal-antibody Histone Deactylase 1 HDAC-1 HDACs HDAC 1 antibodies WB western blots HATs immunoblotting blotting 0.652209944751
10009377 HDAC2 (human recombinant) - >70% by SDS-PAGE 2006-12-06 30.033031327577 hdac2-human-recombinant Histone Deacetylase 2 HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 30.033031327577
10009232 HDAC3/NCOR2 (human recombinant) - ≥50% 2006-12-06 36.582402415386 hdac3-ncor2-human-recombinant Histone Deacetylase 3 HDAC 3 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 36.582402415386
13493 HDAC3 Polyclonal Antibody - 2009-07-19 0.652209944751 hdac3-polyclonal-antibody Histone Deacetylase 3 HDACs antibodies HATs histones acetyltransferase deacetylases western blotting WB IP immunoprecipation ChIP immunoblots immunoblotting blots 0.652209944751
13494 HDAC4 Polyclonal Antibody - 2009-07-17 0.652209944751 hdac4-polyclonal-antibody Histone Deacetylase 4 WB Western blots immunoblotting IP ChIP antibodies HDACs HATs histones immunoprecipitation blotting 0.652209944751
10009379 HDAC5 (human recombinant) - >90% by SDS-PAGE 2006-12-06 32.722880320849 hdac5-human-recombinant Histone Deacetylase 5 HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 32.722880320849
10009465 HDAC6 (human recombinant) - >80% 2007-06-14 34.076717974908 hdac6-human-recombinant GenBank Accession No. BC069243; Histone Deacetylase 6 HDAC 6 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways proteins Class II cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers N-terminal N-terminus GST-tagged Sf9 34.076717974908
13499 HDAC6 Polyclonal Antibody - 2009-07-14 2.647434885556 hdac6-polyclonal-antibody Histone Deacetylase 6 HDAC-6 HDACs HDAC 6 antibodies WB western blots IP ChIP immunoblotting blotting immunoprecipitation 2.647434885556
13500 HDAC7 (Phospho-Ser155) Polyclonal Antibody - 2009-07-29 1.659826361484 hdac7-phospho-ser155-polyclonal-antibody Histone Deacetylase 7 antibodies MMP AR receptors matrix metalloproteinase androgens Nur77 histones deacetylases N-terminal immunoblotting blots western blotting WB 1.659826361484
19380 HDAC8 (human recombinant) - ≥95% 2009-04-03 28.960491880560 hdac8-human-recombinant HDAC 8 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 28.960491880560
700230 HDAC8 Inhibitor Screening Assay Kit - 2009-05-15 15.651749539594 hdac8-inhibitor-screening-assay-kit Histone Deacetylase 8 Inhibitor Screening Assay Kit histone deacetylases inhibits inhibitors inhibition angiogenesis cycling apoptosis differentiation tumors proliferation anticancers genes epigenetic trichostatin A human class I tissues nucleus cytosolic smooth muscle neuroblastoma pathogenesis kits assays measures measurement fluorescent fluorescence-based 15.651749539594
10009466 HDAC9 (human recombinant) - >95% 2007-06-14 19.292480384419 hdac9-human-recombinant GenBank Accession No. NM 178423; Histone Deacetylase 9 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 19.292480384419
10011563 HDAC Activity Assay Kit - 2008-04-10 38.146413862381 hdac-activity-assay-kit histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes license:cyclex fluorometric assays cancer 38.146413862381
600150 HDAC Cell-Based Activity Assay Kit - 2009-11-09 33.903448434622 hdac-cell-based-activity-assay-kit Histone Deacetylase Cell-Based Activity Assay Kit assays kits measuring measurement histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes fluorometric assays cancer modulators whole cells proteins lysine-specific HDAC1 homogenous inhibitor/activator TSA 33.903448434622
100024 Hepsin Blocking Peptide (aa 241-260) - 15.729889502762 hepsin-blocking-peptide-aa-241-260 antibodies western blots blotting WB antisera antiserum ICC IHC protease immunohistochemistry immunocytochemistry apoptosis cancer peptides controls 15.729889502762
100022 Hepsin Polyclonal Antibody (aa 241-260) - 12.009696132596 hepsin-polyclonal-antibody-aa-241-260 antibodies western blots blotting WB antisera antiserum protease immunohistochemistry apoptosis IHC cancer formalin fixed paraffin embedded immunoblotting 12.009696132596
10006084 Hesperetin 520-33-2 ≥98% 2005-02-16 10.781558011049 hesperetin hesperitin hesperidin atherosclerosis citrus nutraceuticals flavonoids flavanoids hypocholesterolemic ACAT2 ACAT-2 mRNA transcription inhibits inhibition inhibitors ApoB proteins histamines azelastine atherosclerosis 10.781558011049
16834 Hexadecanal-d5 - ≥99% deuterated compound 2009-03-02 64.385497237569 hexadecanal-d5 Palmitaldehyde; 16-Hexadecanal deuterated deuterium sphingosine-1-phosphate S1P palmitic acids S1P lyase 1 plasmalogen cell proliferation GC/MS GC-MS LC/MS LC-MS mass spectrometry 64.385497237569
300003 HIF-1α (C-Term) Blocking Peptide - 2005-04-15 52.125966850829 hif-1-c-term-blocking-peptide Hypoxia Inducible Factor 1α HIF-1alpha factors HIF1.alpha. antibodies peptides cancer hypoxia transcription factors low-oxygen hypoxic stimulus cytoplasmic accumulation cells nucleus stress-adaptive proteins oxidative physiology tumors EPAS-1 family phosphorylation prolyl hydroxylases western blotting blots signaling signalling WB controls proteins 52.125966850829
10006421 HIF-1α (C-Term) Polyclonal Antibody - 2005-04-15 69.095730071034 hif-1-c-term-polyclonal-antibody Hypoxia Inducible Factor-1α HIF-1alpha factors antibodies western blots blotting WB antisera antiserum cancers hypoxia transcription factors low-oxygen hypoxic stimulus cytoplasmic accumulation cells nucleus stress-adaptive proteins oxidative physiology tumors EPAS-1 family phosphorylation prolyl hydroxylases immunoblotting HIF1 HIF1alpha HIF1 alpha HIF-1 alpha 69.095730071034
10347 HIF-1α Monoclonal Antibody (Clone H1α67) - 2011-05-09 48.470917127071 hif-1-monoclonal-antibody-clone-h1-67 Hypoxia Inducible Factor-1α WBs western blots IHC immunohistochemistry antibodies HIF-1alpha HIF1a HIF-1a antisera serum cancers H1α67 transcription factors oxidative tumors EPAS-1 EPAS1 EPAS 1 DMOG 2,4-DPD desferrioxamine CoCl2 48.470917127071
10006910 HIF-1α Transcription Factor Assay Kit - 2007-10-31 61.615784974418 hif-1-transcription-factor-assay-kit Hypoxia Inducible Factor-1α tf HIF-1alpha factors HIF1.alpha. cancers basic-helix-loop-helix bHLH cellular oxygen homeostasis cells tissues ischemia infections embryos tumors drugs target breast prostate cardiovascular diseases nuclear extracts whole lysates assays kits ELISAs enzyme-linked immunosorbent double stranded dsDNA HIF1 HIF1alpha HIF1 alpha HIF-1 alpha 61.615784974418
13535 Histone H2A Polyclonal Antibody - 2009-07-31 2.314682204373 histone-h2a-polyclonal-antibody H1 H2B H3 H4 histones antibodies DNA WB western blots immunoblotting ELISA enzyme-linked immunosorbent assays blotting 2.314682204373
13538 Histone H2B (C-Term) Polyclonal Antibody - 2009-08-04 1.166129718185 histone-h2b-c-term-polyclonal-antibody histones antibodiesarginine lysine DNA WB western blots immunoblotting blotting 1.166129718185
13539 Histone H2B (N-Term) Polyclonal Antibody - 2009-08-04 1.166129718185 histone-h2b-n-term-polyclonal-antibody histones antibodies WB western blots immunoblotting DNA arginine lysine blotting 1.166129718185
13540 Histone H3 (Phospho-Ser28) Monoclonal Antibody (Clone 117C826) - 2009-08-10 1.225365925375 histone-h3-phospho-ser28-monoclonal-antibody-clone-117c826 PHH3 H1 H2B H3 H4 histones antibodies WB western blots immunoblotting serine phosphos phosphorylation blotting 1.225365925375
10530 Histone H3 Trimethyl Lys9 Peptide - 2010-06-29 5.313711702662 histone-h3-trimethyl-lys9-peptide H3K9(Me)3 Peptide JMJD2A JMJC JMJD2D acetylation methylation phosphorylation genes transcription substances regulation H3K9Me3 5.313711702662
13543 Histone H4 Polyclonal Antibody - 2009-08-10 0.358922651933 histone-h4-polyclonal-antibody antibodies H1 H2A H2B H3 amino acids WB western blots immunblotting blotting 0.358922651933
11512 HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New - 2012-01-16 135.277777777777 hmgb1-monoclonal-antibody-clone-img19n10b7 High Mobility Group Protein B1; HMG1 high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB 135.277777777777
11514 HMGB1 Monoclonal Antibody (Clone IMG19N12A1) - 79.444444444444 hmgb1-monoclonal-antibody-clone-img19n12a1 High Mobility Group Protein B1; HMG1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 79.444444444444
11513 HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New - 2012-01-16 135.277777777777 hmgb1-monoclonal-antibody-clone-img19n15f4 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 135.277777777777
11515 HMGB1 Polyclonal Antibody (aa 100-150) New - 2012-01-20 138.611111111111 hmgb1-polyclonal-antibody-aa-100-150 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 138.611111111111
11516 HMGB1 Polyclonal Antibody (aa 25-75) New - 2012-01-30 146.944444444444 hmgb1-polyclonal-antibody-aa-25-75 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 146.944444444444
13295 HNHA 926908-04-5 ≥98% 2009-09-03 41.180156099272 hnha Histone Deacetylase Inhibitor VI inhibitors inhibits inhibition histones deacetylase HDACs cancers fibrosarcoma HT1080 cells hyperacetylation p21 genes expressions transcription cycles arrest tumor growth murine xenograph human umbilical vein endothelial HUVECs tubes formation migration vascular endothelial factors VEGF retinal neovascularization angiogenesis 41.180156099272
10011384 Hsc70 (Hsp73) Polyclonal Antibody - 2008-03-26 0.660405156537 hsc70-hsp73-polyclonal-antibody Heat Shock Cognate 70 heat shock stress protein antibodies antiserum WB immunoblotting western blots immunoprecipation immunofluorscence IP IF blotting 0.660405156537
10011383 Hsp40 Polyclonal Antibody - 40 kDa 2008-03-26 0.619129834254 hsp40-polyclonal-antibody Heat Shock Protein 40; HDJ1 DnaJ WB translation folding unfolding translocation degradation heat shock stress chaperone antibodies antiserum Hsps immunoblotting western blots blotting 0.619129834254
10202 Hsp90α (human recombinant) - ≥80% 2010-03-16 4.193473062643 hsp90-human-recombinant Hsp86; Heat Shock Protein 90α heat shock proteins molecular chaperones Hsp90.alpha. Hsp90AA1 HspCAL4 HspN 90kDa cytosolic class A member 2 heat-shock 1 Hsp90AA2 Hsp86 Hsp90a 4.193473062643
10342 Hsp90β (human recombinant) - ≥85% 2010-03-16 4.650139746506 hsp90-human-recombinant Hsc90; Hsp90 AB1; Heat Shock Protein 90β heat shock proteins molecular chaperones Hsp90.beta. 90kDa alpha cytosolic class B member 1 Hsp90beta Hsp90AB1 Hsp90b 4.650139746506
10005673 HU-331 137252-25-6 ≥95% 2005-09-09 28.399345201555 hu-331 cannabidiols analogs antiproliferative activity endocannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology receptors memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation hydroxylquinone antineoplastic human cancer cells lines inhibits inhibitors inhibition growth Raji Jurkat lymphomas in vitro HT-29 colon carcinomas neuroscience neurochemistry cannabinoids cbs sythetic 28.399345201555
13624 Icariin 489-32-7 ≥97% 2010-02-11 1.738950276242 icariin PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction 2-Phenyl-Benzopyrans 2 Phenyl Benzopyrans 2-Phenyl-Chromenes 2 Phenyl Chromenes Bioflavonoids Flavonoids 1.738950276242
10008207 IGFBP5 Polyclonal Antibody - 2007-07-19 18.782697974217 igfbp5-polyclonal-antibody IGF-Binding Protein 5; IBP-5; Insulin-like Growth Factor Binding Protein 5 IGF-1 cell growth differentiation apoptosis receptors kidney heart placenta skeletal cancers amino acids neuroblastoma mammary glands antibodies wb western blots immunocytochemistry IGF1 IGFBP-5 endocrinology blotting immunoblotting 18.782697974217
13139 Imatinib (mesylate) 220127-57-1 ≥98% 2009-04-21 48.988077607623 imatinib-mesylate CGP57148B; Glivec; Gleevec; STI-571 inhibitors tyrosine kinase cancer chronic myelogenous leukemia CML c-ABL kits c-kit platelet-derived growth factor receptors imatinib mesilate 152459-95-5 75-75-2 gleevec 48.988077607623
10739 Isoliquiritigenin 961-29-5 ≥98% 2011-04-01 39.793348066298 isoliquiritigenin ISL; GU 17 antioxidants flavonoids chemoprevention quinones reductase-1 reductase1 hepatoprotection hepatoma cells flavanoids 39.793348066298
13325 Iso-Olomoucine 101622-50-8 ≥98% 2011-07-27 2.253867403315 iso-olomoucine cyclin dependent kinases Cdks cells cycles dopamine inhibitors inhibits inhibition inactive controls regulators iso olomoucine transporter diseases neurodegenerative signaling rats dorsal striatal synaptosomes cancers neuroscience 2.253867403315
13288 Itraconazole 84625-61-6 ≥95% 2011-02-22 81.213278084714 itraconazole hedgehogs signaling cancer antifungal inverse agonist patched smoothened Canditral Cladosal 100 Itralek Itrizole Oriconazole Orungal R 51211 Sempera Spherazole CR IR Sporal Sporamelt Sporanox Sporonox Traconal Triasporin Janssen-Cilag Brand of Itraconazole Janssen Cilag Brand of Itraconazole Janssen Brand of Itraconazole Itraconazole Janssen Brand Itraconazole Sporanox R-51211 R 51211 Orungal R51211 81.213278084714
13659 IWR-1-endo 1127442-82-3 ≥98% 2010-03-23 11.205267034991 iwr-1-endo Wnt cancers embryonic developments tissues homeostasis embryogenesis tumorigenesis stem cells β-catenin genes expression transcription inhibitors inhibits inhibition proteasomes Apc Axin2 Ck1 Gsk3β IWR-1-exoendo-1,3(4)-beta-D-glucanase Endo-1,3(4)-beta-Glucanase Endo-1,3(4)-B-Glucanase beta-(1-3,1-4)glucanase 11.205267034991
13598 IWR-1-exo 1127442-87-8 ≥98% 2010-03-23 9.123314917128 iwr-1-exo Wnt cancers embryonic developments tissues homeostasis embryogenesis tumorigenesis stem cells β-catenin genes expressio Cellobiohydrolase, 1,4-beta-D-Glucan 1,4-beta-D-Glucan Cellobiohydrolase 1,4 beta D Glucan Cellobiohydrolase 1,4-beta-Cellobiosidase, Cellulose Cellulose 1,4-beta-Cellobiosidase Cellulose 1,4 beta Cellobiosidase Beta-Glucancellobiohydrolase Beta Glucancellobiohydrolase Exo-Cellobiohydrolase Exo Cellobiohydrolase Cellobiohydrolase II Cellobiohydrolase I Cellobiohydrolase A Cellobiohydrolase Exoglucanase II CEL1 Protein CbhI Proteinn transcription inhibitors inhibits inhibition controls 9.123314917128
10011246 Janex 1 202475-60-3 ≥98% 2008-12-17 2.433149171271 janex-1 WHI-P131 inhibitors inhibits inhibition JAK3 apoptosis leukemias anti-inflammatory antiinflammatory lymphocytes WHIP131 Janex 1 2.433149171271
9000059 (±)-Jasmonic Acid methyl ester 39924-52-2 ≥95% (mixture of isomers) 2009-04-01 4.540696132596 -jasmonic-acid-methyl-ester (±)-Methyl Jasmonate cancers plants apoptosis survival inflammation hexokinase jasmonic acids jasmonates stress hormones proteins inhibitors inhibition inhibited mitochondrial hexokinase anti-inflammatory 4.540696132596
10009172 JC-1 Mitochondrial Membrane Potential Assay Kit - 2007-04-12 198.117806454442 jc-1-mitochondrial-membrane-potential-assay-kit apoptosis cells mitochondria caspases cytochrome C electrons transport transmembranes Dym DELTApsim .DELTA..psi.m fluorscence fluorescent cationic dyes rhodamine-123 Rh123 DiOC6 cytofluorimetric lipophilic tetrachloro-1,1',3,3'-tetraethylbenzimidazoylcarbocyanine iodide green red J-aggregates monomeric assays kits measures measurements microscopy flow cytometry plate readers fluorometric cancer JC1 cell-based assays cell based assay cba JC 1 198.117806454442
10641 JGB1741 Exclusive 1256375-38-8 ≥98% ✓ 2011-06-20 17.558934490923 jgb1741 ILS-JGB-1741 inhibitors SIRT1 breasts cancers cells proliferation apoptosis p53 histones acetylation genes energy homeostasis regulation deacetylases sirtuins NAD+ inhibits inhibition SIRT2 SIRT3 ILS JGB 1,741 1741 SIRTs JGB-1741 JGB-1,741 17.558934490923
10336 JMJD2A (human recombinant) - ≥95% 2010-12-01 7.241041831097 jmjd2a-human-recombinant JHDM3A; KDM4A; Jumonji Domain Containing 2A lysine (K)-specific demethylase 4A Epigenetics Histone Demethylase chromatin regulator dioxygenase JmjC 7.241041831097
700360 JMJD2A Inhibitor Screening Assay Kit - 2010-05-25 16.783220534069 jmjd2a-inhibitor-screening-assay-kit Jumonji Domain Containing 2A Inhibitor Screening Assay Kit kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC JHDM1 JHDM2 JHDM3 JARID1 UTX/UTY cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 trimethylated 16.783220534069
10335 JMJD2D (human recombinant) - ≥75% 2011-02-09 6.456906077347 jmjd2d-human-recombinant Jumonji Domain Containing 2D; KDM4D; Lysine-Specific Demethylase 4D epigenetics histones demethylases chromatin regulators dioxygenases JmjC proteins jumanjis 6.456906077347
700370 JMJD2D Inhibitor Screening Assay Kit - 2010-05-25 9.933009848666 jmjd2d-inhibitor-screening-assay-kit Jumonji Domain Containing 2D Inhibitor Screening Assay Kit kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation FLJ10251 replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 trimethylated 9.933009848666
10008131 JNJ-10198409 627512-69-0 ≥98% 2006-10-18 13.251093922652 jnj-10198409 PDGF-BB tyrosine kinases inhibits inhibition inhibitors growth factors receptors platelet-derived antiangiogenic antiproliferative coronary artery smooth muscle cells antagonists ATP binding hydrolysis tumors angiogenesis 13.251093922652
11511 JNK2 Polyclonal Antibody New - 2011-11-18 8.888888888889 jnk2-polyclonal-antibody SAPK1a; p54a; c-Jun Amino Terminal Kinase 2; MAPK9 antibody c-Jun kinases JNKs MAP phosphorylation JNK1 JNK3 nuclear signals transduction proteins transcription factors p53 Western blots WB blotting JNKs JNK-1 JNK-2 JNK-3 8.888888888889
10741 (±)-JQ1 Exclusive New 1268524-69-1 ≥98% ✓ 2011-12-08 98.322771263766 -jq1 BET bromodomain inhibitors BRD4 BRD2 transcriptions cancers BRD-4 BRD-2 BRDs extra terminal domains proteins BRD4 BRD2 BRD3 BRD-3 inflammatory genes viral hosts expressions mitosis 98.322771263766
10009458 JTE-013 383150-41-2 ≥98% 2007-01-18 96.168348680171 jte-013 reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers 96.168348680171
10010239 Kenpaullone 142273-20-9 >98% 2007-09-04 11.902090239410 kenpaullone NSC 664704; 9-Bromopaullone GSK-3.beta. cyclin-dependent kinase cyclin CDK inhibitors inhibits inhibition proliferations cell cycle cancers 11.902090239410
10012659 Ki16425 355025-24-0 ≥95% 2008-11-06 131.013149171270 ki16425 LPA1 LPA2 LPA3 LPA4 LPA5 lysophosphatidic acids cancers antagonist receptors selective 131.013149171270
10640 KM 233 Exclusive 628263-22-9 ≥98% ✓ 2011-07-07 35.828508287292 km-233 KM233 KM-233 CBs cannabinoids CB2 agonists recptors CB1 gliomas anti tumors cancers 35.828508287292
10011011 KT 5720 108068-98-0 ≥98% 2009-01-20 121.509313338595 kt-5720 PKAs cAMPs signaling proteins kinase inhibitors inhibits inhibition phosphorylase kinase PDK1 MEK MSK1 PKα GSK3β KT5720 KT-5720 121.509313338595
10010329 Lavendustin C 125697-93-0 ≥98% 2008-07-08 13.292955801105 lavendustin-c HDBA; NSC 666251 EGFR kinases tyrosine pp60c-src pp60csrc CamKII SOD neutrophil activation erbstatin inhibitor inhibits inhibition Lavendustin-C 13.292955801105
10008882 LDH Cytotoxicity Assay Kit - 2006-12-15 263.193825879154 ldh-cytotoxicity-assay-kit Lactate Dehydrogenase Cytotoxicity Assay Kit cells death apoptosis necrosis measuring measurement cystolic enzymes cells membranes integrity cancer cell-based assays cell based assay cba 263.193825879154
10010265 LFM-A13 244240-24-2 >98% 2008-01-23 9.567366482504 lfm-a13 BTK Bruton's Tyrosine kinases signal transduction leukemia cancers polo-like anti-cancer chemosensitivity apoptosis CD95 9.567366482504
10245 LSD1 (human recombinant) - ≥50% 2009-06-03 4.834206860993 lsd1-human-recombinant AOF2; NPAO; BHC110; p110b; KDM1; Lysine-Specific Demethylase 1 recombinant humans E.coli histones tumors suppressor CoREST lysine specific demethylase 1 proteins enzymes 4.834206860993
700120 LSD1 Inhibitor Screening Assay Kit - 2008-10-16 22.858973025674 lsd1-inhibitor-screening-assay-kit Lysine-Specific Demethylase 1 lysines 4 demethylases histones residues repression transcription chromosomal DNA chromosomes inhibits inhibitors inhibition tumors suppressors activity cells cycles progression cancers fluorescent fluorescence enzymes enzymatic reactions H2O2 hydrogens peroxides peptides N-terminal tails H3 horseradish peroxidases ADHP resorufins assays 22.858973025674
13554 LSD1 Polyclonal Antibody (aa 100-150) - 2009-08-10 0.156169429097 lsd1-polyclonal-antibody-aa-100-150 Amine Oxidase (flavin containing) Domain 2 WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 AOF2 amine oxidase flavin containing domain 2 peptide affinity blotting 0.156169429097
13553 LSD1 Polyclonal Antibody (aa 400-450) - 2009-08-10 0.156169429097 lsd1-polyclonal-antibody-aa-400-450 antibodies WB western blots immunoblotting lysine histones demethylase FAD-binding SWIRM domains blotting 0.156169429097
13486 LSD1 Polyclonal Antibody (aa 450-500) - 2009-08-11 0.133859510655 lsd1-polyclonal-antibody-aa-450-500 WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 blotting 0.133859510655
13555 LSD1 Polyclonal Antibody (aa 800-850) - 2009-08-13 0.156169429097 lsd1-polyclonal-antibody-aa-800-850 WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 immunohistochemistry IHC paraffin AOF2 amine oxidase flavin containing domain 2 blotting 0.156169429097
10007502 Luminex® Thromboxane B2 Kit - 2009-07-13 30.124530386740 luminex-thromboxane-b2-kit Luminex® TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 30.124530386740
10009768 LY293111 Exclusive 161172-51-6 ≥98% ✓ 2009-02-09 89.908545119705 ly293111 Etalocib; VML 295 LTBs LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis pancreatic cancers 89.908545119705
13341 LY364947 396129-53-6 ≥98% 2009-07-23 46.258232044199 ly364947 TGF-β RI Kinase Inhibitor; HTS 466284 TGF-β receptor inhibitors antagonists Smad p38 MAPK MLK-7 cells growth fibroblasts NIH 3T3 cells phosphorylation fibronectin PAI-1 uPA matrigel invasion MDA-MB-231 cells transforming factors LY 364947 LY-364947 HTS-466284 HTS466284 HTS 466284 ALK5 Inhibitor I TβR-I inhibitor Transforming Growth Factor-β Type I Receptor Kinase Inhbitor [3-(Pyridin-2-yl)-4-(4-quinoynyl)]-1H-pyrazole 46.258232044199
600310 Lysosome/Cytotoxicity Dual Staining Kit - 2010-06-15 45.903354380425 lysosome-cytotoxicity-dual-staining-kit lysosomes membrane-bound acidic intracellular compartments cells waste products fats carbohydrates proteins macromolecules mobilize recycle organelles microorganisms animals leukocytes degradative enzymes hydrolases pH 5 cytoplasm homeostasis Tay-Sachs diseases arthritis neurodegeneratives Parkinson's brains cathepsin D genes therapeutics kits assays measures measurements 4-Nitro-7-(1-piperazinyl)-2,1,3-benzoxadiazole NBD-PZ membranes permeable carboxylic acids luminal cultured propidium iodides death chloroquine inhibitors positive controls fluorescence fluorescent microscopy plates reader detections flow cytometry 45.903354380425
13174 M 344 251456-60-7 ≥98% 2009-07-24 55.764148250460 m-344 D237; Histone Deacetylase Inhibitor III; MS 344 HDACs inhibitors inhibits inhibitions histones deacetylases HDAC1 HDAC6 cancers squamous carcinoma radiation cells cycles arrest apoptosis endometrial ovarian M344 MS344 M-344 MS-344 55.764148250460
10010497 Manumycin A 52665-74-4 ≥98% 2008-06-25 19.969640883978 manumycin-a UCF 1C; NSC 622141 farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB 19.969640883978
10009645 Maslinic Acid Exclusive 4373-41-5 >98% ✓ 2007-11-02 15.264751381216 maslinic-acid 2α-Hydroxyoleanoic Acid; Crategolic Acid cancer apoptosis antiproliferative antioxidant HIV inhibition inhibitor inhibits leukemia cells astrocytoma CaCo-2 colon HIV-1 aids 15.264751381216
10005174 Matairesinol 580-72-3 >95% 2004-07-28 143.902679558011 matairesinol lignans plants antioxidants cancer oxidative injury stress enterobacterial fiber dietary enteric isoprostanes enterolactone 143.902679558011
13847 MEK2 Polyclonal Antibody - 2010-11-18 0E-12 mek2-polyclonal-antibody MAPKK2; MAP Kinase Kinase 2; Dual Specificity MAP Kinase Kinase 2; MAP Kinase/ERK Kinase 2 MEKs MEK-2 MEK2 MAPKs kinases MAP ERKs phosphorylation antibodies serine cytokines growth factors tranduction mitogenic signals western blots blotting immunoblotting 0E-12
13778 Metastasis Associated 1 Family Member 2 Polyclonal Antibody - 2010-05-04 19.913443830570 metastasis-associated-1-family-member-2-polyclonal-antibody p53 Target Protein in Deacetylase Complex; MTA2; MTA-L1 Protein; PID WB IHC western blotting blots immunoblotting immunohistochemistry MTA-2 MTA 2 MTA-1 MTA 1 MTA-3 MTA 3 HDAC2 HDAC-2 HDAC 2 HDAC1 HDAC-1 HDAC 1 proteins chromatin deacetylase activity activities northern p53 19.913443830570
9000332 Methylcarbamyl PAF C-8 Exclusive - ≥98% ✓ 2009-02-25 13.135165745856 methylcarbamyl-paf-c-8 Methylcamyl PAF Methylcamyl PAF C-8 Methylcamyl PAF C-16 PAF C-16 PAF-AH Platelet aggregation c-myc c-fos MAP kinase Mitogen-activated kinase G1 Cell cycle PAF 13.135165745856
700140 Methyltransferase Colorimetric Assay Kit - 2009-04-07 28.908593469554 methyltransferase-colorimetric-assay-kit MT Colorimetric Assay Kit assays kits measures measuring monitoring monitors MTs methylation signal transduction biosynthesis repair gene silencing chromatin regulation S-adenosylmethionine SAM-dependent methyltransferases enzymatic cofactors AdoMet donor modifications DNA Alzheimer's diseases depression Parkinson's multiple sclerosis liver failure cancers enzyme-coupled AdoHcy positive control S-adenosylhomocysteine 28.908593469554
700150 Methyltransferase Fluorometric Assay Kit - 2009-04-08 40.581738746213 methyltransferase-fluorometric-assay-kit MT Fluorometric Assay Kit assays kits measures measuring monitoring monitors MTs methylation signal transduction biosynthesis proteins repair gene silencing chromatin regulation S-adenosylmethionine SAM-dependent methyltransferases enzymes enzymatic cofactors AdoMet donor proteins modifications DNA Alzheimer's diseases depression Parkinson's multiple sclerosis liver failure cancers enzyme-coupled AdoHcy positive control S-adenosylhomocysteine 40.581738746213
10007188 Microcystin-LR 101043-37-2 >95% 2005-07-20 20.820000000000 microcystin-lr Cyanoginosin-LR proteins phosphatases inhibitors microcystins toxins hepatotoxic cyclics heptapeptides cyanobacteria poisonings humans livestock fresh water blue-green algae endemic PP-2A inhibits enzymes PP-1 serine/threonine nodularins okadaic acids 20.820000000000
10006317 Mifepristone 84371-65-3 >98% 2005-01-25 109.021487766377 mifepristone RU-486 progesterones estrogens estradiol cancers apoptosis RU486 uterine uterus pregnancy hormones receptors glucocorticoids steroids PR GR HRE response elements binding endocrinology 109.021487766377
63280 Miltefosine 58066-85-6 >98% 10.653204419889 miltefosine HePC CTP:phosphocholines cytidylyl transferases antimetastatic ceramides apoptosis inhibits inhibitors inhibition cancers 10.653204419889
13208 Mirin 299953-00-7 ≥95% 2009-04-15 37.759944751381 mirin DNA damage ATM histone nuclease MRN Mre11 Rad50 Nbs1 repair 37.759944751381
13600 MK 0457 639089-54-6 ≥98% 2010-08-16 7.923729281768 mk-0457 Tozasertib; VX 680 mitosis aurora kinase inhibitors inhibits inhibition MK0457 MK-0457 MK-457 MK457 cells cycles cancers apoptosis tumor A B C MK 0457 VX-680 VX680 Piperazines 7.923729281768
10658 MLL1 (human recombinant) New - ≥95% 2011-12-21 87.675756087579 mll1-human-recombinant Lysine Methyltransferase 2A; ALL1; Mixed Lineage Leukemia 1; KMT2a; HRX epigenetics methyltransferase histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY30 mixed lineage leukemia methylation lysine HOX Pol II WAR c-terminal SET1 WIN binds binding DPY-30 WARD genomic 87.675756087579
10756 MLL1/WAR complex (human recombinant) New - ≥90% 2012-01-04 91.115793292036 mll1-war-complex-human-recombinant Mixed-Lineage Leukemia-1; MLL Core Complex epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY-30 upregulate transcriptions catalytic basal RNA polymerases chromosomes Pol II N-terminus leukemia Hox menin 91.115793292036
10945 MLL1/WARD complex (human recombinant) New - ≥90% 2012-01-04 91.115793292036 mll1-ward-complex-human-recombinant Mixed-Lineage Leukemia-1; KMT2A; MLL Core Complex epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY-30 upregulate transcriptions catalytic basal RNA polymerases chromosomes Pol II N-terminus leukemia Hox menin WAR 91.115793292036
10011389 Mn SOD (rat) Polyclonal Antibody - 2008-03-27 130.939568056253 mn-sod-rat-polyclonal-antibody Manganese Superoxide Dismutase SOD1 SOD2 SOD3 EC-SOD oxidative stress superoxide ROS WB IP IHC EIA western blots immunoprecipitation immunohistochemistry immunoblotting blotting enzyme immunoassays 130.939568056253
10212 Monoacylglycerol Lipase (FL) Polyclonal Antibody - 2010-03-23 29.409715864245 monoacylglycerol-lipase-fl-polyclonal-antibody MAGL; MGL WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting 29.409715864245
10004910 Mouse Macrophage Microsomal Immunoblot Control - 2004-11-09 30.082074892572 mouse-macrophage-microsomal-immunoblot-control Mouse macrophage microsomes protein western blots blotting microsomes immunoblots immunoblotting positive controls COX-2 COX2 PGHS-2 PGHS2 cyclooxygenases prostaglandins synthases cultures SDS-PAGE 30.082074892572
13284 MS-275 209783-80-2 ≥98% 2009-11-05 58.412796193983 ms-275 Entinostat; SNDX 275 inhibitors histone deacetylases HDACs HDAC1 HDAC3 HDAC8 cyclin-dependent kinase inhibitor 1A p21 CIP1 WAF1 cell growth differentiation tumors cancers apoptosis adriamycin PARP Hsp90 ms275 MS 27-275 SNDX-275 SNDX275 MS27275 58.412796193983
10009365 MTT Cell Proliferation Assay Kit - 2007-02-15 102.575623081645 mtt-cell-proliferation-assay-kit assays kits screen measures measurements cells cellular growth factors signaling signalling molecules transcription DNA pathological cancers aging cycles progression regulatory cytokines mitogens drugs inductions inhibitors inhibits inhibitions in vitro plasma membranes formazan intracellular NAD(P)H-oxidoreductases NADPH-oxidoreductases proteins enzymes enzymatic cleavage microtiter plates tertrazolium salts mitochondrial dehydrogenases cancer cell-based assay cell based assay cba 102.575623081645
600330 Multi-Parameter Apoptosis Assay Kit - 2010-08-18 93.896418705603 multi-parameter-apoptosis-assay-kit assays kits measures measurements apoptosis cells death cycles tissues homeostasis dysregulation neurodegenerative diseases ischemic damages autoimmune disorders cancers drugs discovery signaling pathways membranes phospholipids phosphatidylserines phosphatidylethanolamines leaflets bilayers externalizations residues plasma phospholipids binding proteins fluorochrome-labeled fluorochromes annexin V fluorescence microscopy flow cytometry FC plate readers TUNEL TdT-mediated dUTP Nick-End Labeling analysis ISEL in situ end labeling DNA deoxyribonucleic acids mitochondrial transmembranes tetramethylrhodamines ethyls esters TMRE lipophilics probes laddering detection fragmentation FITC-conjugated fluoresceins 93.896418705603
13779 MutL Protein Homolog 1 Monoclonal Antibody (Clone 164C819) - 2010-04-29 4.707845303867 mutl-protein-homolog-1-monoclonal-antibody-clone-164c819 HNPCC; MLH1 antibodies western blots bloting immunobloting WB Mut-L Mut L MLH 1 MLH-1 DNA genes cancers colons 4.707845303867
10012600 Myricetin 529-44-2 >98% 2009-02-20 15.315801104972 myricetin NSC 407290; Cannabiscetin flavonoid antioxidant oxLDL CD36 atherosclerosis cancers JAK1 STAT3 MEK1 15.315801104972
10008581 Myristoleic Acid methyl ester 56219-06-8 >98% 2007-04-17 0.552486187845 myristoleic-acid-methyl-ester cytotoxic Serenoa S. repens apoptosis necrosis prostate cancers cheese whey fatty acids Candida C. albicans MIC minimal inhibitory concentration in vivo esters hydrophobic 0.552486187845
579040 Nampt/Visfatin (mouse/rat) EIA Kit - 2011-08-08 31.308690332549 nampt-visfatin-mouse-rat-eia-kit Nicotinamide Phophoribosyltransferase/Visfatin Pre-B-Cell Colony-Enhancing Factor/Visfatin immunometric kits measures measurements EIA enzymes immunoassays nicotinamides phosphoribosyltransferases coenzymes salvage pathways adenine dinucleoties NAD+ cellular metabolisms pre-B-cell cells colony enhancing factors PBEF visceral fats plasmas obesity insulin receptors proteins intracellular extracellular mesangial kidneys glucose uptake diabetic nephropathy exercise skeletal muscles NAD+-dependant sirtuin-dependant circadian oscillations cancers apoptosis serums body mass index mass inflammation livers cirrhosis beta .beta. β leukocytes tissues mouse 31.308690332549
13055 Naphthofluorescein 61419-02-1 ≥98% 2009-03-20 0.670534069981 naphthofluorescein CCG 8295 furin matrix metalloproteinase MTA-MMP MMP2 motility invasion cancer metastasis MMP inhibitors naphthafluorescein 0.670534069981
10387 Naringenin-4'-O-β-D-Glucuronide 158196-35-1 ≥88% 2010-04-23 0E-12 naringenin-4-o-d-glucuronide flavanone inhibits inhibition inhibitor CYP1A2 CYP 1A2 cytochrome P450 158196-35-1 0E-12
10388 Naringenin-7-O-β-D-Glucuronide - ≥98% 2010-04-24 0E-12 naringenin-7-o-d-glucuronide 158196-34-0 inhibits inhibition cytochrome P450 inhibitor CYP1A2 0E-12
10584 (−)-Neplanocin A Exclusive 72877-50-0 ≥98% ✓ 2011-03-25 54.408595106551 -neplanocin-a S-adenosylhomocysteines hydrolases SAH inhibitors S-adenosylmethionines SAM methyltransferases antitumor antiviral cancer virus methylation Neplanocin A neplanocinA anti-tumor 54.408595106551
13755 NF-κB (p50) Monoclonal Antibody (Clone 2J10D7) - 2010-02-05 11.545441988950 nf-b-p50-monoclonal-antibody-clone-2j10d7 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors cytokines UV radiations stress injury bacterial viral cells growth differentiation proliferation apoptosis inflammation DNA AIDS cancers arthritis western blots blotting immunoblotting IHC WB immunohistochemistry 11.545441988950
13754 NF-κB (p50) Polyclonal Antibody - 2010-04-27 11.545441988950 nf-b-p50-polyclonal-antibody NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors DNA p65 N-terminal binding western blots blotting immunoblotting WB antibodies 11.545441988950
13756 NF-κB (p65) Monoclonal Antibody-biotin (Clone 112A1021) - 2010-02-11 21.176685082872 nf-b-p65-monoclonal-antibody-biotin-clone-112a1021 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones 21.176685082872
13752 NF-κB (p65) Monoclonal Antibody (Clone 112A1021) - 2010-02-11 24.160110497237 nf-b-p65-monoclonal-antibody-clone-112a1021 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC 24.160110497237
13751 NF-κB (p65) NLS Polyclonal Antibody - 2010-02-11 23.340662983425 nf-b-p65-nls-polyclonal-antibody Nuclear Factor-κB (p65) Nuclear Localization Signal NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies 23.340662983425
13757 NF-κB (p65) Polyclonal Antibody (aa 2-17) - 2010-02-11 16.387419100236 nf-b-p65-polyclonal-antibody-aa-2-17 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 16.387419100236
13753 NF-κB (p65) Polyclonal Antibody (aa 538-546) - 2010-02-11 21.176685082872 nf-b-p65-polyclonal-antibody-aa-538-546 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 21.176685082872
10011250 NH125 278603-08-0 ≥95% 2008-11-21 5.868977900552 nh125 antibacterial histidine kinase cancer cell cycle eEF-2K drug resistance imidazoles 5.868977900552
10649 Niclosamide 50-65-7 ≥95% 2011-01-12 1.259751381215 niclosamide antihelminthic helminth tapeworms inhibitors STAT3 cancers proliferation anti-helminthic salicylanilide Du 145 DU145 DU-145 Niclosamide, 2-Aminoethanol (1:1) Aventis Brand of Niclosamide Bayer Brand of Niclosamide Clonitralide Niclosamide Bayluscide Bayer 2353 Trédémine Niclocide Radewerm Phenasal Bayer 73 Yomesan Fenasal 1.259751381215
10010422 Nilotinib 641571-10-0 ≥98% 2009-10-23 33.306325966850 nilotinib AMN107 tyrosine kinases inhibitors therapy cancer Bcr/Abl chronic myeloid leukemia MLL philadelphia chromosomes acute lymphoblastic ALL imatinib gleevec genes expression DNA helicase complex cyclins cyclin-dependent cells proliferation 33.306325966850
10006966 Nitrotyrosine Monoclonal Antibody - Biotinylated - 2005-04-15 16.365000000000 nitrotyrosine-monoclonal-antibody-biotinylated antibodies western blots blotting WB antisera antiserum peroxynitrite western blots blotting nitric oxide nitration proteins NO superoxide alzheimer's diseases oxidative injury stress IHC immunohistochemistry IP immunoprecipitation EIA enzyme immunoassay species independent detection immunoblotting Enzyme-linked immunosorbent assays 16.365000000000
10005705 NO-Indomethacin Exclusive 301838-28-8 >98% ✓ 2004-10-20 6.229944751381 no-indomethacin NCX 2121 inhibition inhibitors NSAIDs non-steroidal anti-inflammatory drugs inhibits nitric oxides cancer chemopreventative donor gastrointestinal NOs PaCa-2 PaCa2 pancreatic analgesic 6.229944751381
10011255 NSC 210902 51726-83-1 ≥95% 2008-09-15 4.363314917128 nsc-210902 Inhibitor inhibits inhibition CK2 kinase cell signaling apoptosis cancers NSC210902 4.363314917128
13196 NSC 23766 (hydrochloride) 1177865-17-6 ≥98% 2010-07-20 19.350024554941 nsc-23766-hydrochloride 733767-34-5 GTPases cells cycles growth proliferations cell-cell adhesions motility differentiation guanine nucleotides exchange factors GEFs inhibitors inhibits inhibition cell migration Aminoquinolines angiogenesis leukemia cancers gene expression Rac1 Inhibitor 19.350024554941
13303 NSC 663284 383907-43-5 ≥98% 2010-04-01 13.948812154696 nsc-663284 Cdc25 Phosphatase Inhibitor II; DA-3003-1 dual specificity phosphatases CDC25 Cdc25A Cdc25B Cdc25C proto-oncogenes cancers inhibitors VHR PTP1B MKP-1 Cdk1 Cdk2 cells proliferation tumors inhibits inhibition Cdcs potent cell-permeable irreversible 13.948812154696
10758 NSD2 (human recombinant) New - ≥90% 2012-02-01 92.222222222222 nsd2-human-recombinant Histone-lysine N-methyltransferase NSD2 isoform 1; MMSET; TRX5; Wolf-Hirschorn Syndrome Candidate 1; Multiple myeloma SET domain-containing protein; Protein trithorax-5; WHSC1; KIAA1090; Nuclear Receptor SET domain-containing protein 2 NSD2 SET-Domains Lysine methyltransferases chromatin WHSC1 MMSET WHSCH1-like multiple myeloma translocations histones H3 H4 H3K36 H4K44 H4K20 53BP1 dimethylation DNA damages NSDs NSD-2 92.222222222222
13308 NU 7026 154447-35-5 ≥95% 2009-09-21 33.071795580110 nu-7026 DNA-PK Inhibitor II; LY293646 DNA-dependent proteins kinase DNA-PK strand breaks ionizing radiation DNA repair inhibitors inhibitis inhibitions PI3K ATM ATR PAPR-1 PARP1 cytotoxicity topoisomerase II leukemia mitoxantrone NU-7026 NU 7026 ataxia telangiectasia mutated Rad3 related Rad3-related Rad 3 Rad-3 DNA-Dependent Protein Kinase 33.071795580110
18585 (−)-Nutlin-3 - ≥98% 2008-08-06 214.400556578678 -nutlin-3 Nutlin 3a P53 cellular stress proliferation cells cycle apoptosis tumor suppressor MDM2 agents Nutlin-3 enantiomer a 214.400556578678
10009816 (+)-Nutlin-3 - ≥98% 2008-08-11 97.367323511357 -nutlin-3 Nutlin 3b p53 cellular stress proliferation cells cycle apoptosis tumer suppressor MDM2 inactive inhibitors inhibits inhibition Nutlin-3 enantiomer b 97.367323511357
10004372 (±)-Nutlin-3 548472-68-0 >98% 2004-04-06 82.977892997119 -nutlin-3 apoptosis cancers p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts license:hoffmanlaroche Nutlin3 nutlins 82.977892997119
13641 NVP-AEW541 (hydrochloride) - 98% 2010-07-28 41.811016574586 nvp-aew541-hydrochloride 475488-34-7 IGF-1R Insulin-like growth factor I receptors tyrosine kinases angiogenesis cells proliferation cancers inhibitors inhibition inhibits 701294-63-5 Ins-R NWT-21 Pyrroles 41.811016574586
10565 NVP-BEZ235 915019-65-7 ≥98% 2010-10-12 39.595886102847 nvp-bez235 phosphatidylinositols 3-kinases PI3Ks Akt/PKB mTORs cancers inhibitors inhibits inhibition angiogenesis genes expressions apoptosis differentiation rapamycin phosphatidyls inositols phosphatidylinositols-3-kinase Imidazoles BEZ235 39.595886102847
11176 O6-methylguanine-DNA Methyltransferase (human recombinant) New - ≥80% 2011-12-06 28.888888888889 o6-methylguanine-dna-methyltransferase-human-recombinant MGMT DNA repair cancers 06-demethylases suicide enzymes guanine thymine cytosine replication mutations cysteine oligo nucleotides PvuII dsDNA full-length full length demethylating thymine 28.888888888889
10010547 O-Arachidonoyl Glycidol Exclusive 439146-24-4 >98% ✓ 2008-03-31 18.387469613259 o-arachidonoyl-glycidol 2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL cannabinoids 18.387469613259
10010299 Oleoyl 3-carbacyclic Phosphatidic Acid Exclusive - ≥95% ✓ 2009-10-14 14.788045580110 oleoyl-3-carbacyclic-phosphatidic-acid 3-ccPA 18:1 cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA oleate transcellular migration MM1 cells mesothelial autotoxin cancer survival growth migration invasion metastasis antagonist LPA1 LPA2 LPA3 476310-24-4 14.788045580110
10010240 Olomoucine 101622-51-9 >98% 2007-09-13 11.387229676401 olomoucine inhibitors inhibits inhibition cyclin-dependent kinases cdks spinal cord injury SCI G1 cell cycle 11.387229676401
14070 ONO-8711 216158-34-8 ≥98% 2011-06-15 20.939585635358 ono-8711 ONO 8711 ONO8711 prostaglandins EPs EP1 receptors potent PGs antagonists AH-6809 AH 6809 AH6809 14060 14050 SC-19220 SC19220 SC 19220 20.939585635358
13176 Oxamflatin 151720-43-3 ≥95% 2010-11-16 51.957311233886 oxamflatin Metacept 3 HDACs histones deacetylases genes expressions morphology motility apoptosis cells cycles cancers reducing reduction proliferation Acids Hydroxamic Hydroxamic Acids Acid Hydroxamic Hydroxamic Acid 51.957311233886
600008 p53 Cell-Based Activation/Translocation Assay Kit - 2009-03-10 11.527535297728 p53-cell-based-activation-translocation-assay-kit p53 dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts assays cell-based assay cell based assay cba 11.527535297728
600030 p53 Designer Transcription Factor Assay Kit - 2009-01-08 20.930555834588 p53-designer-transcription-factor-assay-kit dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts ELISAs assays enzyme-linked immunosorbent TFs T.F. factors assays 20.930555834588
10004806 p53 Monoclonal Antibody (Clone BP53-12) - 2004-06-17 8.366588909351 p53-monoclonal-antibody-clone-bp53-12 proteins WB western blots blotting antibodies antisera antiserum DNA anti-oncogenic apoptosis cancers p53 apoptotic antioncogenic flow cytometry immunocytochemistry ICC IHC immunohistochemistry transcription factors cellular stress damage hypoxia shock guardian of the genome special:month specialdiscount:15 specialstart:2008-01-01 specialend:2008-01-31 immunoblotting FC 8.366588909351
10004807 p53 (Phospho-Ser392) Polyclonal Antibody - Affinity-purified 2004-05-18 13.511438138289 p53-phospho-ser392-polyclonal-antibody phosphorylateds proteins WB western blots blotting antibodies antisera antiserum DNA binding anti-oncogenic apoptosis cancer p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic phospho-specific immunoblotting 13.511438138289
10005291 p53 Product Pack - 2004-09-08 20.465334561080 p53-product-pack DNA binding anti-oncogenic apoptosis cancer p53 re-activators reactivators induces apoptotic re-activation reactivation antioncogenic packs 20.465334561080
600060 p53 Total and p53 (Phospho-Ser392) Dual Staining Assay Kit - 2009-03-10 8.710684468999 p53-total-and-p53-phospho-ser392-dual-staining-assay-kit kits assays measuring measurements tumors treatments DyLightTM (-)-Nutlin-3 positive ontrols p53(Phospho-Ser392) dsDNA double-stranded suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous autosomal Li Fraumeni Syndromes nuclear extracts cell-based assays cell based assay cba 8.710684468999
600020 p53 Transcription Factor Assay Kit - 2008-10-27 23.426236688286 p53-transcription-factor-assay-kit dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 bcl-X cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts ELISAs assays enzyme-linked immunosorbent TFs T.F. factors assays 23.426236688286
10009317 PAC-1 315183-21-2 >98% 2007-07-12 17.072633517495 pac-1 Procaspase-activating Compound 1 in vitro procaspase-3 apoptosis cancers cells death drugs treatment acivators procaspases PAC1 17.072633517495
10461 Paclitaxel 33069-62-4 ≥98% 2010-08-23 23.946795580110 paclitaxel Taxol®; NSC 125973 Microtubules cancers cervical HeLa lung A549 breast MCF-7 colon HT-29 ovarian OVG-1 pancreatic PC-Sh carcinomas chemotherapy mitotic arrest apoptosis JNK BCL-2 p53 Pacific yew tree c-Jun cyclin-dependent kinases multipolar spindle formation Abraxane Capxol Mitotax Onxal QW 8184 Yewtaxan Tocosol Taxus Liberte Genexol-PM Genetaxyl EndoTAG 1 Ebetaxwl DHP 107 ABI 007 Bristol-Myers Squibb Brand of Paclitaxel Bristol-Myers Brand of Paclitaxel Paclitaxel (4 alpha)-Isomer Lemery Brand of Paclitaxel Ivax Brand of Paclitaxel Bull Brand of Paclitaxel 7-epi-Taxol 7 epi Taxol Paclitaxel NSC-125973 NSC 125973 Bris Taxol NSC125973 Taxol A Anzatax Praxel Paxene Taxol Onxol 23.946795580110
10500 PAD4 (human recombinant) - ≥95% 2010-05-27 31.893059698245 pad4-human-recombinant Peptidylarginine Deiminase 4; Protein Arginine Deiminase 4 guanidino modifying enzymes citrillination histones deiminase MS multiple sclerosis Alzheimer's diseases glaucoma IOP intraocular pressure cancers peptidylarginine deiminase 31.893059698245
700560 PAD4 Inhibitor Screening Assay Kit - 2011-05-04 25.162733706613 pad4-inhibitor-screening-assay-kit Protein Arginine Deiminase 4; Peptidylarginine Deiminase 4 kits assays measures measurements proteins arginines deiminases PADs guanidine-modifying enzymes peptidylarginine deiminase amidinotransferases nucleus homodimers transcriptional coregulator catalyzes residues citrulline calcium-dependent substrates histones H2A H3 H4 post-translational modifications genes regulations autocitrullination inhibits enzymatic activity cells rheumatoid arthritis citrulline-containing immune response autoantibodies tissues multiple sclerosis Alzheimer's diseases glaucoma cancers human deiminates N-α-benzoyl-L-arginine ethyl esters BAEE kinetic ammonia detectors fluorescent fluorescence 25.162733706613
10007358 Palmitic Acid methyl ester 112-39-0 >99% 2006-02-17 10.489467604218 palmitic-acid-methyl-ester MP; Methyl Palmitate esters saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 16-carbon dietary fats plasma lipoproteins expression COX-2 cyclooxygenase-2 cyclooxygenases proteins acylation lipids anchoring signaling signalling molecules 10.489467604218
10010298 Palmitoleoyl 3-carbacyclic Phosphatidic Acid Exclusive 910228-13-6 ≥95% ✓ 2009-11-03 12.485142371440 palmitoleoyl-3-carbacyclic-phosphatidic-acid 3-carbacyclic PA; 3-ccPA 16:1 cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA palmitoleate transcellular migration MM1 cells mesothelial autotoxins cancer survival growth migration invasion metastasis NPP2 ENPP2 ectonucleotide pyro phosphatase/phosphodiesterase 2 12.485142371440
10010293 Palmitoyl 3-carbacyclic Phosphatidic Acid Exclusive 476310-22-2 ≥95% ✓ 2009-10-07 15.636132596685 palmitoyl-3-carbacyclic-phosphatidic-acid 3-ccPA 16:0 cyclic acids cPAs lysophosphatidic LPA ccPA 3ccPA palmitate transcellular migration MM1 cells mesothelial autotoxins cancers survival growth migration invasion metastasis 15.636132596685
13557 PARP (Cleaved) Monoclonal Antibody - 2009-08-11 16.591970534070 parp-cleaved-monoclonal-antibody poly ADP ribose polymerase ADP-ribose DNA western blots immunoblotting WB flow cytometry intracellular antibodies FC blotting 16.591970534070
10994 Paxillin (Phospho-Tyr118) Polyclonal Antibody New - 2012-01-13 71.111111111111 paxillin-phospho-tyr118-polyclonal-antibody proteins LIM domains ERK-regulated scaffolds vinculin-binding phosphorylation Western blots blotting WB ERKs binds binding vinculin JNK 71.111111111111
10009115 pCAF Histone Acetyltransferase - ≥95% 2006-10-18 29.470713812688 pcaf-histone-acetyltransferase HAT; p300/(CREB binding protein) Associated Factor proteins binding GCN5 nuclear acetyltransferases C-terminal C-terminus acetyl-lysine N-terminal N-terminus histones H3 H4 transcriptional activators MyoD E2F1 p53 acetylates PTEN K125 K128 catalytic cleft in vivo enzymes cancers 29.470713812688
10004805 PCNA Monoclonal Antibody (Clone IPO-38) - 2004-08-27 4.435215469613 pcna-monoclonal-antibody-clone-ipo-38 Nuclear Antigen of Proliferating Cells; Proliferating Cell Nuclear Antigen WB western blots blotting IHC immunohistochemistry immunoblots proliferating cells nuclear antigens ipo38 flow cytometry immunocytochemistry ICC mitosis DNA polymerases holoenzymes antibodies antisera antiserum cancers immunoblotting FC 4.435215469613
10007185 PCSK9 (human) Polyclonal Antibody - 2005-11-30 19.247595369639 pcsk9-human-polyclonal-antibody Proprotein Convertase Subtilisin Kexin 9; NARC-1 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases family lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols livers kidneys lungs spleens jejunums ileums colons muscles golgi tissues atherosclerosis immunoblotting 19.247595369639
10008811 PCSK9 (mouse) Polyclonal Antibody - 2007-01-22 16.586432102355 pcsk9-mouse-polyclonal-antibody Proprotein Convertase Subtilisin Kexin 9; NARC-1 immunoblot neural apoptosis regulated convertase 1 atherosclerosis proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols atherosclerosis PCSK-9 immunoblotting 16.586432102355
10009581 PCSK9 (murine) Blocking Peptide - 2007-01-22 9.598540515653 pcsk9-murine-blocking-peptide Proprotein Convertase Subtilisin Kexin 9; NARC-1 neural apoptosis regulated convertase 1 proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols cancer cells 9.598540515653
13034 PD 0325901 391210-10-9 ≥98% 2009-03-13 51.907984264086 pd-0325901 MEK ERK RAS RAF MAPK tumors stem cells cancers differentiation signaling GSK3 kinase inhibitors inhibits inhibition pd325901 pd 325901 PD0325901 51.907984264086
9000988 PD 166326 New 185039-91-2 ≥98% 2011-11-30 104.234373027606 pd-166326 inhibitors cancers c-abl c-src Bcl/Abl tyrosine receptors kinases cells signaling leukemia CML chronic myelogenous leukemia PD-166326 PD166326 pyridopyrimidine STI571 mesylate 104.234373027606
13032 PD 173074 219580-11-7 ≥98% 2009-07-29 50.421466489133 pd-173074 fibroblast growths factors receptors FGFRs FGFR1 tyrosine kinase activity activities activation signals propagation inhibitors inhibition inhibits autophosphorylation PDGFR c-Src cSrc c Src EGFR InsR MEK PKC FGFR2 FGFR3 FGFR4 FGFR5 angiogenesis cancers tumors self-renewal self renewal stems cells ERK1/2 ERK-1/2 ERK 1/2 50.421466489133
10012431 PD 184161 Exclusive 212631-67-9 ≥98% ✓ 2009-06-09 35.923654363257 pd-184161 MEK inhibitors MAP kinase ERK signaling cancer MEK 1/2 inhibition inhibited ERK 1/2 potent selective pd184161 35.923654363257
10006726 PD 98059 167869-21-8 >98% 2005-09-12 32.463905633514 pd-98059 potent selective MAPK mitogen-activated proteins kinases family serines threonines cellular PD-98059 programs cells proliferation differentiation movement death noncompetitive inhibits inhibitors inhibition pathways activation MAPKK1 Raf MEK MAPKK2 MAPKK-1 PD98059 MAPKK-2 ERK 32.463905633514
10006341 PDM 11 Exclusive - >98% ✓ 2005-03-23 22.117226519337 pdm-11 resveratrol analogs analogues aryl hydrocarbons receptors anatagonists AhRs ligand-dependents ligands xenobiotics PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar 22.117226519337
10006342 PDM 2 Exclusive 688348-25-6 >98% ✓ 2005-03-29 22.271790055248 pdm-2 AhRs antagonists stilbenes dioxins aryl hydrocarbons receptors ligand-dependent transcription factors resveratrol analogs ligands xenobiotics PDM2 PDM-2 estrogen poisonings xenobiotics polyaromatics soot coal tar cancers 22.271790055248
62595 PDMP (hydrochloride) 73257-80-4 >98% 2004-08-10 9.868999858337 pdmp-hydrochloride analogs analogues inhibits inhibitors inhibition cytotoxicity glucosylceramides aynthases chirality stereoisomers sphingosine 9.868999858337
10005983 Pentafluorobenzenesulfonyl fluorescein 728912-45-6 >98% 2005-02-22 18.734751381216 pentafluorobenzenesulfonyl-fluorescein fluoresceins hydrogen peroxides oxidative stress fluorescents probes ROS reactive oxygen species perhydrolysis H2O2 18.734751381216
500290 Phagocytosis Assay Kit (IgG FITC) - 2009-04-09 155.281033196392 phagocytosis-assay-kit-igg-fitc kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba 155.281033196392
600540 Phagocytosis Assay Kit (IgG PE) New - 2012-01-10 162.121421884591 phagocytosis-assay-kit-igg-pe kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba phycoerythrins probes fluorescence 162.121421884591
10007191 PH Domain Leucine-rich Repeat Protein Phosphatase 1 Polyclonal Antibody - 2006-01-04 3.916111878452 ph-domain-leucine-rich-repeat-protein-phosphatase-1-polyclonal-antibody Suprachiasmatic Nucleus Circadian Oscillatory Protein; SCOP; PLEKHE1 Protein; PHLPP1; KIAA0606 Protein proteins diseases antibodies antisera antiserum western blots blotting immunocytochemistry ICC immunohistochemistry IHC cancers WB immunoblotting PH Domain Leucine-rich Repeat Protein Phosphatase Polyclonal Antibody 3.916111878452
10007192 PH Domain Leucine-rich Repeat Protein Phosphatase Blocking Peptide - 2006-01-30 2.861933701657 ph-domain-leucine-rich-repeat-protein-phosphatase-blocking-peptide Suprachiasmatic Nucleus Circadian Oscillatory Protein; SCOP; PLEKHE1 Protein; PHLPP; KIAA0606 Protein western blotting blots signaling signalling WB IHC ICC immunohistochemistry formalin-fixed paraffin-embedded immunocytochemistry proteins kinases Akt cells growth death serine residues Ser473 C-terminal hydrophobic motifs human cancers dephosphorylates dephosphorylation reduces activity apoptosis apoptotic colon glioblastomas lines tumors brain 2.861933701657
10735 Phthalazinone pyrazole Exclusive 880487-62-7 ≥98% ✓ 2011-07-27 1.862578268876 phthalazinone-pyrazole inhibitors inhibits inhibition auroras kinases cells cycle cancers centrosomes mitosis spindles cancers proliferation cells growth phosphorylation Auroroa-A Aurora-B Aurora-C A B C HCT116 HCT-116 Colo 116 HCT 116 Colo116 Colo-116 MCF7 MCF-7 MCF 7 1.862578268876
10009209 PI-103 371935-74-9 >98% 2007-01-19 30.675849853753 pi-103 phosphoinositides PI3-kinases Phosphatidylinositols cancers Glioma DNA-PK mTOR inhibitors inhibits inhibition anti-proliferatives proliferation PI103 30.675849853753
10010177 PI3-Kinase α Inhibitor 2 Exclusive 371943-05-4 >98% ✓ 2007-08-02 27.150063748405 pi3-kinase-inhibitor-2 PI3Kα Inhibitor 2; Phosphatidylinositol 3-Kinase α Inhibitor 2 phosphoinositides 3-kinases PI3-kinase phosphatidylinositols cancers proliferations inhibits inhibitors inhibition PI3-K PI3K inhibitory A375 melanoma cell proliferation 27.150063748405
13326 Pifithrin-α 63208-82-2 ≥95% 2009-07-16 30.771595303867 pifithrin p53 apoptosis DNA damage cyclin D1 C8 cells HUVECs endothelial cells dependent independent inactivator 30.771595303867
10748 Pifithrin-μ 64984-31-2 ≥98% 2011-06-20 17.138273480662 pifithrin PFT-μ; 2-Phenylethynesulfonamide p53 apoptosis Bcl-xL Bcl-2 mitochondria inhibitors nutlin heat shock proteins 70 HSP70 PES PAS pifithrin-mu pifithrin mu PFTμ PFTu 2-phenylacetylenylsulfonamide 2-phenylacetylenesulfonamide BclxL Bc12 17.138273480662
10009210 PIK-75 372196-67-3 ≥98% 2010-03-10 17.030299505670 pik-75 p110α PI3K insulin signaling signals cancers inhibitors inhibits inhibition signalling p110a phosphatidylinositol 3-kinase phosphorylation Akt activation mTORC1 PIP2 PIP3 p110β p110α p110γ p110beta p110 alpha p110.beta. p110.alpha. p110gamma p110.gamma.p110g Mixtures, Sulfonamide Sulfonamide Mixtures Sulfonamides 17.030299505670
89130 Pimonidazole 70132-50-2 >98% 2008-04-23 12.871988950276 pimonidazole NSC 380540; Ro 03-8799 hypoxia hypoxic cells radiosensitizer tumors marker hypoxia hypoxyprobe 12.871988950276
10006284 PINK1 Blocking Peptide - 2005-01-18 7.573020257827 pink1-blocking-peptide PTEN Induced Putative Kinase 1; PARK6; BRPK antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides phosphatases tensin homolog dephosphorylates lipids human cancers tumor-suppressive pathway mRNA mitochondria C-terminus Parkinson's diseases phosphatidylinositols phosphates 7.573020257827
10006283 PINK1 Polyclonal Antibody - 2004-12-28 20.473591160220 pink1-polyclonal-antibody PARK6; BRPK; PTEN Induced Putative Kinase 1 proteins antibodies antisera antiserum wb western blots blotting IHC immunohistochemistry Parkinson's diseases cancers tumor-suppressive phosphatases tensin homologs dephosphorylates human signaling signalling pathway mRNA mitochondria c-terminus phosphatidyl inositols phosphates special:month specialdiscount:15 specialstart:2008-05-01 specialend:2008-05-31 immunoblotting 20.473591160220
11006 Piperlongumine New 20069-09-4 ≥98% 2011-10-24 59.448247902599 piperlongumine Piplartine 2859-009- 11042-67-4 25343-05-9 Keap1 Nrf2 antioxidants ROS cancers redox platelet aggregation tumorigenesis 59.448247902599
13368 Piroxicam 36322-90-4 ≥95% 2010-01-06 17.779795918367 piroxicam NSC 666076; Larapam; Feldene inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory Piroxicam CP-16171 CP 16171 Feldene CP16171 17.779795918367
10728 PIT-1 Exclusive 53501-41-0 ≥98% ✓ 2011-03-25 14.798237569061 pit-1 PIP3 PtdIns-(3,4,5)-P3 PH domains cancers inhibitors Akt PDK1 PTENs proteins binding pituitary-specific transcription factors pit-1 pituitary-specific pit 1 GHF-1 GHF 1 pit-oct-unc pit oct unc POU growth hormones 14.798237569061
10459 PKC 412 120685-11-2 ≥98% 2010-07-27 31.739482811540 pkc-412 CGP 41251; N-Benzoylstaurosporine; Midostaurin; CGP 41231 inhibitors inhibits inhibition PKC412 PKC-412 serine/threonine serine threonine tyrosines kinases PKCα PKCβ PKCγ PKC-α PKC-β PKC-γ Syk Flk-1 Flk1 Akt PKA c-Kit cKit C-Fgr cFgr FLT3 FLT-3 PDFRβ PDFR-β VEGFR1 VEGF2 nitric oxide synthase eNOS apoptosis cancers angiogenesis signal transduction Staurosporine 31.739482811540
10011332 Plerixafor (hydrochloride hydrate) 155148-31-5 ≥98% 2009-02-10 58.760906077348 plerixafor-hydrochloride-hydrate Mobozil™; SID 791; JM 3100; AMD 3100 stem cells hematopoiesis HIV lymphocyte replication metastasis cancers growth antagonist CXCR4 SDF-1 SDF1 CXCL12 ireversible virus inhibits inhibition inhibitor 58.760906077348
13786 PMS2 Monoclonal Antibody (Clone 163C1251) - 2010-05-10 0E-12 pms2-monoclonal-antibody-clone-163c1251 PMS1 Protein Homologue 2; Mismatch Repair Endonuclease PMS2; DNA Mismatch Repair Protein PMS2 antibodies PMS-1 PMS 1 PMS 2 PMS-2 proteins DNA cancers HNPCC hereditary nonpolyposis non-polyposis western blots blotting immunoblotting WB cancer DNA damage repair 0E-12
11004 Podoplanin Monoclonal Antibody (Clone NZ-1.2) - 2011-08-05 0E-12 podoplanin-monoclonal-antibody-clone-nz-1-2 T1A; Aggrus; gp38 mucin glycoproteins T1A gp38 aggrus tumors cells ligands CLEC-2 metastases tissues Th17 CD4+ humans PBMC antibodies 0E-12
11005 Podoplanin Monoclonal Antibody (Clone pmab-1) - 2011-08-05 0E-12 podoplanin-monoclonal-antibody-clone-pmab-1 T1A; Aggrus; gp38 gp38 glycoproteins tissues lymphatic endothelial cells tumors lymphangiogenesis Th17 autoimmune diseases antibodies myelin antigens migration inflammation 0E-12
13198 PP2 172889-27-9 ≥98% 2010-09-20 30.229679558011 pp2 AGL 1879 PTK inhibitors inhibits inhibition Src kinase T cells T-cells enzymes AG1879 AG 1879 PP-2 PP 2 signalling tyrosine kinases tyrosine focal Tyr 577 adhesion kinases AG-1879 AGL1879 AGL 1879 thaliana Proteins Arabidopsis Proteins Arabidopsis thaliana Arabidopsis thaliana Proteins Hemagglutinins Plant Thale Cress Proteins Plant Hemagglutinins Arabidopsis Proteins Agglutinins Plant Plant Agglutinins Proteins Plant Phytagglutinins Plant Proteins Lectins Plant Plant Lectins 30.229679558011
13643 PP242 1092351-67-1 ≥95% 2011-04-22 23.770323599052 pp242 mTORs mTORC1 mTORC2 inhibitors cancer leukemia rapamycin PP 242 PP-242 inhibited inhibition 23.770323599052
11209 PRDM9 (human recombinant) Exclusive New - ≥65% ✓ 2012-01-11 69.897176181706 prdm9-human-recombinant PR Domain-containing Protein 9; MSBP3; ZNF899; PFM6; Meisetz histones methyltransferases zinc-fingers hotspots recombination genomes genetics meiosis trimethylation H3K4 nucleosomes PR/SET HTMase c-terminal C2-H2 PR domain zinc finger protein 9 69.897176181706
63520 PRIMA-1 5608-24-2 >95% 23.134593528018 prima-1 DNA binding anti-oncogenic apoptosis cancer p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic cancers 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one 23.134593528018
10350 PRMT1 (human recombinant) - ≥80% 2011-01-25 81.677550644567 prmt1-human-recombinant Protein Arginine Methyltransferase 1 PRMT1 brucei Prmt1 TbPRMT1 brucei Silencing Factors Transcriptional Transcriptional Silencing Factors Transcription Factors Repressor Molecules Proteins Repressor Repressor Proteins arginine methyltransferase histones modification glycine arginine rich GAR motifs SAM-dependent GST-tagged 81.677550644567
10750 PRMT4 (human recombinant) New - ≥70% 2011-12-21 56.635113566605 prmt4-human-recombinant Protein Arginine Methyltransferase 4; CARM1; Coactivator-associated Arginine Methyltransferase 1 PRMT arginine methyltransferases epigenetics PRMT4 CARM1 SAM MMA aDMA Arg-17 Arg-26 proteins enzymes catalytic domains S-adenosyl-L-methionine histones H3 binding binds p160 SRC-1 SRC1 GRIP1 TIF2 pCIP RAC3 ACTR AIB1 TRAM1 nuclear receptors phosphorylation Ser217 hormones regulation lipids metabolism ω-NG,NG-dimethylarginine ω-NG-monomethylarginine 56.635113566605
13552 PRMT4 Polyclonal Antibody - 2009-07-24 21.481481481481 prmt4-polyclonal-antibody CARM1; Protein Arginine Methyltransferase 4 antibodies WB western immunoblotting blots coactivator associated arginine methyltransferase 1 steroids receptors SRC proteins co-activators blotting 21.481481481481
13559 PRMT5 Polyclonal Antibody - 2009-07-24 23.700772457540 prmt5-polyclonal-antibody Protein Arginine Methyltransferase 7; Skb1HS; JBP1 proteins PRMTs signaling WB western immunoblotting blots ADMA blotting janus kinase-binding kinase binding fission yeast 1 23.700772457540
10752 PRMT6 (human recombinant) New - ≥80% 2012-01-24 92.621298342541 prmt6-human-recombinant Protein Arginine Methyltransferase 6; HRMT1L6; Histone Arginine N-methyltransferase PRMT6; Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-like Protein 6 PRMTs arginine methyltransferases epigenetics PRMT6 histones SAM MMA aDMA H3R2 HMA H3K4 MLL HMGA1a 92.621298342541
13558 PRMT6 Polyclonal Antibody - 2009-07-24 23.700772457540 prmt6-polyclonal-antibody Protein Arginine Methyltransferase 6 antibodies WB HeLa proteins western immunoblotting blots blotting 23.700772457540
13551 PRMT7 Polyclonal Antibody - 2009-07-24 23.700772457540 prmt7-polyclonal-antibody Protein Arginine Methyltransferase 7 PRMTs antibodies proteins western blotting immunoblotting blots SRC steroid receptor co-activator coactivator GRIP-1 GRIP1 WB 23.700772457540
10009762 Progesterone Receptor (Phospho-Ser190) Monoclonal Antibody - 2007-04-05 124.100497237569 progesterone-receptor-phospho-ser190-monoclonal-antibody antibodies WB western blots phospho-specific Progesterones receptors phosphorylation Ser190 cancers breast mammary glands endocrinology blotting immunoblotting IHC immunohistochemistry 124.100497237569
10009763 Progesterone Receptor (Phospho-Ser294) Monoclonal Antibody - 2007-04-05 124.100497237569 progesterone-receptor-phospho-ser294-monoclonal-antibody antibodies WB western blots phospho-specific progesterone receptors cancers breast mammary glands endocrinology blotting immunoblotting IHC immunohistochemistry 124.100497237569
13365 Programmed Cell Death Protein 4 (C-term) Blocking Peptide - 2008-08-25 0E-12 programmed-cell-death-protein-4-c-term-blocking-peptide PDCD4 antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots PDCD4 PCDC-4 PDCDP4 PDCDP-4 0E-12
10250 Programmed Cell Death Protein 4 (C-Term) Polyclonal Antibody - 2008-09-15 2.868508287292 programmed-cell-death-protein-4-c-term-polyclonal-antibody PDCD4; Neoplastic Transformation Inhibitor western blots WB KLH genes tumors antibodies antiserum antisera PDCD4 PCDC-4 PDCDP4 PDCDP-4 blotting immunoblotting 2.868508287292
500940 Progranulin (human) EIA Kit - 2011-04-26 27.182131321716 progranulin-human-eia-kit PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 27.182131321716
500950 Progranulin (mouse) EIA Kit - 2011-04-26 35.967159811745 progranulin-mouse-eia-kit murine mice PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 35.967159811745
10010 Prostaglandin A1 14152-28-4 >98% 138.539896408840 prostaglandin-a1 PGA1 prostaglandins renal vasodilation pge1 dehydration semen antimitotic antiproliferative 138.539896408840
9000184 Prostaglandin A1 methyl ester Exclusive 26771-94-8 ≥98% ✓ 2010-11-08 18.494516574585 prostaglandin-a1-methyl-ester PGA1 methyl ester hypertension cancers lipophilic analogs PGA1 prostaglandins 18.494516574585
12010 Prostaglandin D2 41598-07-6 >99% 178.027590124731 prostaglandin-d2 PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry 178.027590124731
512031 Prostaglandin D2 EIA Kit - 2010-07-19 267.367895948434 prostaglandin-d2-eia-kit PGD2 ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 267.367895948434
512041 Prostaglandin D2 Express EIA Kit - 2010-07-19 124.974589885252 prostaglandin-d2-express-eia-kit PGD2 Express ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 124.974589885252
10007202 Prostaglandin D2 Lipid Maps MS Standard 41598-07-6 >99% 2008-10-27 18.311861453463 prostaglandin-d2-lipid-maps-ms-standard PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry mass spectrometry standards GC LC MS 18.311861453463
10007939 Prostaglandin E Synthase-1 (microsomal) (human recombinant) - 16,000 x g supernatant 2009-03-15 24.290810313076 prostaglandin-e-synthase-1-microsomal-human-recombinant Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 24.290810313076
10009734 Prostaglandin E Synthase-1 (microsomal) Western Ready Control - 2007-05-01 8.289095303867 prostaglandin-e-synthase-1-microsomal-western-ready-control mPGE Synthase-1; PIG12; Memebrane-Associated PGES-1; Prostaglandin H/E Isomerase; MGST-L1 western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 8.289095303867
10011237 Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) Exclusive - ✓ 2008-07-17 15.944143646408 protein-phosphatase-2a-c-subunit-human-recombinant-l309-deletion PP2A Cα; PP2A Δ309; PP2A L309 proteins phosphatases serine threonine cellular tumors enzyme kinetics regulations substrates phosphorylasion PP2As octahistidine-tag streptactin-tag 15.944143646408
10010896 Protein Tyrosine Phosphatase 1B (human recombinant) - ≥95% 2008-08-25 4.471215469613 protein-tyrosine-phosphatase-1b-human-recombinant PTP1B proteins recombinant PTPs phosphates tyrosines pNPP enzymes diabetes insulin leptin signaling signalling 4.471215469613
13527 Pseudolaric Acid B 82508-31-4 ≥98% 2009-12-04 9.385994475137 pseudolaric-acid-b PAB Pseudolarix kaempferi traditional Chinese fungal fungus infections cancers apoptosis angiogenesis tumors inhibits inhibitors inhibition P. therapy apoptosis cells 9.385994475137
10009817 PtdIns-(3,4,5)-P3 Binding Protein - ≥95% 2008-02-14 0.694779005524 ptdins-3-4-5-p3-binding-protein PI(3,4,5)-P3 Binding Protein; Phosphatidylinositol-(3,4,5)-triphosphate Binding Protein; GRP1 PH Domain; PIP3 Binding Protein lipids recognition proteins GST-tagged PIPs phosphatidylinositols triphosphates 0.694779005524
10009815 PtdIns-(4,5)-P2 Binding Protein - ≥95% 2008-02-13 2.467911602210 ptdins-4-5-p2-binding-protein PIP2 Binding Protein; PI(4,5)-P2 Binding Protein; Phosphatidylinositol-(4,5)-diphosphate Binding Protein; PLC-δ1-PH domain lipid recognition protein human recombinant GST-tagged proteins E. coli PIPs phosphatidylinositols diphosphate PLCdelta PLCd 2.467911602210
10009241 PtdIns-(4)-P1 Binding Protein - ≥90% 2008-02-21 0.457182320442 ptdins-4-p1-binding-protein SidC; PIP Binding Protein; PI(4)-P1 Binding Protein; SidC 3C GST-tagged EDTA PIPs PtdIns phosphoinositols PIP2 PIP3 PI3-kinase cancers proteins 0.457182320442
10007073 PTEN Blocking Peptide - 2005-06-28 1.731270718232 pten-blocking-peptide Phosphatase and Tensin Homology on Chromosome 10 western blotting blots signaling signalling WB IHC immunohistochemistry formalin-fixed paraffin-embedded sections controls proteins dephosphorylates lipids AKT phosphatidylinositols triphosphates PIP3 tissues acids regulates cells division migrations apoptosis mutations cancers melanomas prostates carcinomas A431 HEK293 signals transductions 1.731270718232
10009746 PTEN (human recombinant) - ≥95% 2008-09-04 7.611226519336 pten-human-recombinant TEP1; Phosphatidylinositol 3-phosphatase; MMAC1; Phosphatase and Tensin Homology on Chromosome 10 proteins PTENs phosphatase homology tensin chromosomes enzymes lipids Sf21 cells recombinant N-terminal tumor suppressor cancers phosphoinositide hexahistidine His-tag His-tagged 7.611226519336
10005059 PTEN Polyclonal Antibody - 2005-05-04 4.439481512962 pten-polyclonal-antibody TEP1; Phosphoinositide 3-phosphatase; MMAC1; Phosphatase and Tensin Homolog on Chromosome 10 proteins antibodies antisera antiserum wb western blots blotting IHC immunohistochemistry dephosphorylates lipids AKT phosphatidylinositols triphosphates PIP3 tissues acids regulates cells division migrations apoptosis mutations cancers melanomas prostates carcinomas A431 HEK293 signals transductions cancers endocrinology immunoblotting 4.439481512962
10009747 PTEN Western Ready Control - 2007-05-30 0E-12 pten-western-ready-control TEP1; MMAC1; Phosphatidylinositol 3-phosphatase; Phosphatase and Tensin Homology on Chromosome 10 western blot WB AKT phosphatidylinositol 3,4,5-triphosphate PIP3 enzyme transduction pathway endocrinology 0E-12
13000 Pterostilbene 537-42-8 ≥98% 2009-09-09 34.225351223362 pterostilbene 3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory 34.225351223362
10005169 Quercetin 117-39-5 >95% 2004-08-04 6.795322283609 quercetin flavonoid plants fruits glycosides carcinogens carcinogenic inhibits inhibitors inhibition phosphodiesterases antioxidants rutin 6.795322283609
10011620 Raloxifene (hydrochloride) 82640-04-8 ≥98% 2009-01-07 5.893867403314 raloxifene-hydrochloride Evista; LY156758; Keoxifene (hydrochloride) breasts cancers osteoporosis SERM estrogen evista bone remodeling formation IL-6 IL6 25-OH vitamin D parathyroid hormones cardiovascular protection 5.893867403314
13346 Rapamycin 53123-88-9 ≥95% 2009-10-21 71.327139349293 rapamycin Sirolimus immunosuppresssants transplants rejection inhibitors IL-2 lymphocytes B cells T FKBP12 mTOR mTORC1 cancer adipogenesis diabetes tuberous sclerosis cardiovascular diseases 71.327139349293
10947 RbBP5 (human recombinant) New - ≥90% 2012-01-06 93.135995312238 rbbp5-human-recombinant Retinoblastoma binding Protein 5; RBQ3; SWD1, Set1c WD40 repeat protein, homolog epigenetics methyltransferases histones H3K4 genes regulation MLL proteins complex subunits nuclear WD40 domains tumors supressors RB cells proliferation E1A SET1 lysine MLL1 MLL1-4 dimethylation trimethylation H3 H3K4me2/me3 retinoblastoma-binding protein RBQ-3 RBBP-5 RBBP5 93.135995312238
10010172 (R)-Equol Exclusive 221054-79-1 ≥98% ✓ 2009-08-27 7.679378453039 -r-equol Isoequol; (+)-Equol phytoestrogens estrogens daidzen genistein receptors cancers R-Equol +equol + equol agonist activity R equol (R) equol 7.679378453039
11017 Retinoic Acid New 302-79-4 ≥98% 2011-10-25 10.670543966541 retinoic-acid ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578 ligans receptor cancers development reproduction immunity gene expressions 7005-78-9 56573-65-0 187175-63-9 NSC-122758 NSC122758 AGN 100335 AGN100335 AGN-100335 aberel airol aknoten atragen cordes vas dermairol epi-aberel eudyna NSC 122578 NSC-122578 NSC122578 renova retacnyl retin A ro 1-5488 tretin M vesanoid vesnaroid vitamins A1 all trans 10.670543966541
10006606 Retreversine - >98% 2005-09-15 23.148024861878 retreversine inactive isomers reversine purine analogs cells stem organogenesis derivatives C2C12 myoblasts osteogenic bones adipogenic adipose de-differentiation dedifferentiation re-differentiation progenitors 23.148024861878
10004412 Reversine 656820-32-5 >98% 2005-03-25 33.948591160220 reversine purine analogs cells stem organogenesis derivatives C2C12 myoblasts osteogenic bones adipogenic adipose de-differentiation dedifferentiation progenitors fate cancers 33.948591160220
10010309 RG-13022 149286-90-8 >98% 2008-01-24 2.523634569850 rg-13022 protein tyrosine kinase PTK inhibitors inhibits inhibition antiproliferatives tyrphostin epidermal growth factors EGFs receptors cancers 2.523634569850
10010310 RG-1462 136831-49-7 >98% 2008-02-08 2.215150871228 rg-1462 protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative tyrphostin epidermal growth factors EGFs receptors proliferation cancers 2.215150871228
13293 Rhapontigenin Exclusive 500-65-2 ≥98% ✓ 2009-11-10 27.254779005525 rhapontigenin resveratrols antioxidants cancers cytochromes P450 CYP450 proliferation anti cancers anti-oxidants 27.254779005525
160785 RICK Polyclonal Antibody - 8.515303867402 rick-polyclonal-antibody Ripk2; Rip2; CARDIAK apoptosis antibodies kinase CARD domains RIP Fas western blots blotting WB antisera antiserum RIP-2 cancers immunoblotting CCK CCKs CCCK 8.515303867402
10006426 RITA 213261-59-7 >98% 2006-01-11 26.929828115408 rita NSC 652287; 2,5-bis(5-hydroxymethyl-2-thienyl) Furan HDM-2 human double minute-2 MDM-2 mouse murine negative regulator p53 proteasomal degradation tumors cancers apoptosis cells reactivation molecules inhibitors wild-type DNA-protein human renal SCID mice HCT116 A-498 xenografts nude HDM2 HDM-2 MDM2 26.929828115408
10311 (R)-(−)-Mellein New 480-33-1 ≥98% 2012-01-13 71.111111111111 -r-mellein Ochracin antibacterial antimalarial antifungal anticancer dihydroisocoumarin A. ochraceus wilhelm proliferation humans breasts cancers melanoma cells 21499-22-9 isocoumarin R-mellein MCF-7 MDA-MB-468 SK-MEL-28 (R)-mellein malme-3M 71.111111111111
13697 (R)-MG132 Exclusive 1211877-36-9 ≥98% ✓ 2010-06-22 91.049502762430 -r-mg132 ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited 91.049502762430
10006415 Ro 48-8071 161582-11-2 >98% 2005-06-01 6.389431728492 ro-48-8071 monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis 6.389431728492
10009569 (R)-Roscovitine 186692-46-6 >98% 2007-09-04 13.421473296501 -r-roscovitine Seliciclib cell cycle cyclin-dependent kinase cdk proliferation cancer renal disease 13.421473296501
13664 S32826 1096770-84-1 ≥98% 2010-06-18 27.835154696132 s32826 Autotaxins lysophospholipase D lysophosphatidylcholine lysophosphatidic acids LPAs inhibitors src phosphatase 1B adipocytes plasma inhibited inhibition inhibits Esters, Phosphonic Acid Phosphonic Acid Esters Phosphonic Acids Phosphonates 27.835154696132
13603 S-Adenosylhomocysteine 979-92-0 ≥98% 2010-04-22 9.372193370165 s-adenosylhomocysteine SAH; AdoHcy amino acids derivatives cysteine methyl cycle biosynthesis risk factors metabolic pathways cancers by-products by products neurodegenerative diseases Adenosylhomocysteine, S S-Adenosylhomocysteine S Adenosylhomocysteine 9.372193370165
9000372 S-Adenosylhomocysteine-d4 Exclusive - ≥99% deuterated product ✓ 2009-12-02 18.024254143646 s-adenosylhomocysteine-d4 SAH-d4 deuteriums GC/MS LC/MS mass spectrometry GC-MS LC-MS deuterateds amino acids derivative cysteine methyl cycle biosynthesis 979-92-0 risk factors s-adenosyl-l-homocysteine-d4 18.024254143646
10009929 SAHA 149647-78-9 >98% 2007-08-07 162.177383297301 saha Vorinostat; Suberoylanilide Hydroxamic Acid; Zolinza™ HDACs inhibitors cancers inhibits inhibition 162.177383297301
13178 Salermide 1105698-15-4 ≥98% 2009-04-27 20.115193370165 salermide Sirtuin SIRT1 SIRT2 inhibitors cancers apoptosis leukemias histone deacetylases HDACS inhibition inhibited 20.115193370165
13628 Salidroside 10338-51-9 ≥97% 2010-05-28 12.325948434623 salidroside Rhodioloside glycosides plants Rhodiola Chinese medicine memory infections inflammation cancers diabetes fatigue apoptosis Glucosides 12.325948434623
13579 Salinomycin (sodium salt) 55721-31-8 ≥90% 2011-03-14 8.068784530387 salinomycin-sodium-salt cancers stem cells breasts inhibitors tumors anticancer pyrans anti-cancer inhibited inhibits inhibition CSCs 8.068784530387
13031 SB 431542 301836-41-9 ≥98% 2009-08-10 83.932799263352 sb-431542 inhibitors inhibits inhibitions TGF-β1 TGFβ1 receptors ALK5 ALK4 ALK7 ALKs BMP ALK2 ALK3 ALK6 kinases Smad fibrosis cancers renewal embryonic stems cells induced pluripotent differentiation SB431542 83.932799263352
10443 SB 939 New 929016-96-6 ≥98% 2012-02-06 105.529711479435 sb-939 Pracinostat; 3-[2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl]-N-hydroxy-(2E)-2-propenamide inhibits inhibitions inhibitor HDACs pan-HDAC panHDAC SB939 SB-939 histones deacetylase proliferation voronistat cancers tumors SAHA 105.529711479435
10011561 SC-51089 146033-02-5 ≥95% 2010-02-02 7.593480662983 sc-51089 CID132748 prostaglandins E2 PGE2 receptors EP1 pain antagonists analgesia glioma cells cancers tumors growth neuroprotection neurons oxidative stress SC51089 SC 51089 PGs Oxazepines 7.593480662983
10876 SC-66 871361-88-5 ≥98% 2011-06-21 17.464767955801 sc-66 SC66 SC 66 analogs cyclohexanone curcumin cancers Akts inhibitors inhibits inhibition cancers ubiquitination cells death tumors tumorigenesis 17.464767955801
10010173 (S)-Equol 531-95-3 ≥98% 2009-08-27 11.167541436464 -s-equol 4',7-Isoflavandiol; 4',7-Dihydroxyisoflavan; (-)-Equol phytoestrogen estrogens daidzen genistein receptors cancers (S) equol S-equol -Equol (-) Equol antagonist 11.167541436464
10005260 Serine Palmitoyltransferase Polyclonal Antibody - 2004-12-02 27.698353591160 serine-palmitoyltransferase-polyclonal-antibody Serine-palmitoyl-CoA transferase, long chain base subunit 2; SPT antibodies antisera western blots blotting WB sphingolipids SPT2 immunohistochemistry immunohistochemical analysis IHC nuclear proteins nucleus immunoblotting 27.698353591160
13780 SET7/9 (FL) Polyclonal Antibody - 2010-03-08 5.921430325352 set7-9-fl-polyclonal-antibody SET Domain-Containing Protein; KMT7; SETD7/9 antibodies SET 7/9 SET-7/9 7 9 histones H3 lysines 4 western blotting WB blots immunoblotting 5.921430325352
10320 SET7/9 (human recombinant) - ≥95% 2009-08-11 19.064765500306 set7-9-human-recombinant KMT7; SETD7/9; SET Domain-containing Protein 7/9 SET-7/9 SET 7/9 7 9 recombinant His-tagged proteins SETs methylation methyltransferase 19.064765500306
700270 SET7/9 Methyltransferase Inhibitor Screening Assay Kit - 2009-12-04 18.331372153526 set7-9-methyltransferase-inhibitor-screening-assay-kit methyltransferases SET Domain-containing Protein 7/9 lysines 7 KMT7 methylation signal transduction biosynthesis proteins repair genes silencing chromatins S-adenosylmethionine SAM AdoMet methyl donors Alzheimer's depression Parkinson's Diseases multiple sclerosis liver cancers substrates histones histone 3 lysine residue 4 H3K4 p53 transcription factors TAF10 mono-methylated mono-methylase DNA damage acetylation human tumorigenesis inhibitors acceptor peptides S-adenosylhomocysteine S-ribosylhomocysteine adenine nucleosidase hypoxanthine deaminase urate hydrogen peroxide H2O2 ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin fluorescence measures measurement assays kits 18.331372153526
10319 SET8 (human recombinant) - ≥95% 2010-01-07 27.419612537464 set8-human-recombinant SETD8; SET domain-containing (lysine methyltransferase) 8; KMT5a; PR-Set7 SET-8 SET 8 recombinant His-tagged proteins SETs methylation methyltransferase MTs domain containing 27.419612537464
700350 SET8 Methyltransferase Inhibitor Screening Assay Kit - 2010-03-09 15.849895318406 set8-methyltransferase-inhibitor-screening-assay-kit SET domain-containing (lysine methyltransferase) 8; PR-Set7; SETD8 assays kits measures measurement methyltransferases MTs inhibits inhibitors inhibition methylation signal transduction biosynthesis protein repair genes silencing chromatins regulation S-adenosylmethionine (SAM)-dependent AdoMet DNA deoxyribonucleic acids Alzheimer's diseases depression Parkinson's multiple sclerosis livers cancers KMT5A lysines PR-Set 7 methylates histones H4 residues 20 H4K20 transcriptional p53 tumors suppressors tumorigenesis inhibits inhibition inhibitors peptides S-adenosylhomocysteines S-ribosylhomocysteines adenines nucleosidases hypoxanthines deaminases hydrogen peroxides H2O2 ADHP 10-acetyl-3,7-dihydroxyphenoxazines fluorescent fluorescence resorufin 15.849895318406
13332 (S)-Glycyl-H-1152 (hydrochloride) Exclusive 913844-45-8 ≥98% ✓ 2010-01-27 51.846950276243 -s-glycyl-h-1152-hydrochloride Rho Kinase Inhibitor IV Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV h1152 h-1152 h 1152 51.846950276243
13277 (S)-HDAC-42 935881-37-1 ≥95% 2009-12-03 43.057291701546 -s-hdac-42 AR42 histones deacetylases HDACs cancers inhibitors prostate p21 Akt Bcl-XL tumors inhibition inhibits OSU-HDAC-42 43.057291701546
10006211 Silybin 22888-70-6 >98% 2005-02-16 14.015611681136 silybin Silymarin; Silibinin flavanoids flavonoids 5-LOs 5-lipoxygenases inhibits inhibitors inhibition flavonolignans Silybum marianum superoxides Kupffer cells leukotrienes LTB4 synthesis PMA-activated milk thistle 14.015611681136
10011190 SIRT1 (human recombinant) - ≥60% 2008-09-24 14.447391708064 sirt1-human-recombinant NAD-dependent Deacetylase 1; hSIRT1; SIR2L1; SIR2-like Protein 1; SIR2; Sirtuin 1; Silent Information Regulator 2 SIRT 1 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 1 SIR2alpha sirtuin type 1 14.447391708064
700280 SIRT2 Direct Fluorescent Screening Assay Kit - 2009-12-10 31.017449840069 sirt2-direct-fluorescent-screening-assay-kit Nucleosomes chromosomal deoxyribonucleases DNA histones H2A H2B H3 H4 octameric cores transcription amino termini acetylation phosphorylation methylation ε-amino lysines acetyltransferases HATs chromatins genes activation deacetylases HDACs catalyzes hydrolytic acetyls sirtuins trichostatins A-insensitive lysyl-deacetylases class III catalyzes deacetylation nicotinamides O-acetyl-ADP-ribose NAD+ human SIRT1 SIRT2 SIRT3 SIRT4 SIRT5 SIRT6 SIRT7 cytoplasmic proteins H4 lysine-16 lysine-40 α-tubulin a-tubulin alpha-tubulin HDAC6 microtubules mitotic chromosomal hyperpolid cells tissues skeletal muscle heart oligodendroglia brain tumor suppressor gliomas Down-regulation gene chromosomal region diagnostic marker fluorescence-based inhibitors activators p53 Gln-Pro-Lys-Lys(ε-acetyl)-AMC recombinant NAD+ fluorescent fluorescence kits assays measures measurement 31.017449840069
10011191 SIRT2 (human recombinant) - ≥90% 2009-07-31 13.480449997678 sirt2-human-recombinant Silent Information Regulator 2; SIR2; Sirtuin 2; SIR2-like Protein 2; NAD-dependent Deacetylase 2; SIR2L2 SIRT 2 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers His-tagged His tag sirtuin silent mating type information regulation 2 homolog 2 sirtuin type 2 13.480449997678
10011194 SIRT3 (human recombinant) - ≥90% 2008-12-15 17.712549607688 sirt3-human-recombinant hSIRT3; SIR2L3; Mitochondrial Nicotinamide Adenine Dinuclear-dependent Deacetylase; SIR2-like Protein 3; NAD-dependent Deacetylase 3; SIR2; Silent Information Regulator 3; Sirtuin 3 SIRT 3 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 3 sirtuin type 3 sir2-like 3 17.712549607688
10317 SIRT4 (human recombinant) - ≥95% 2010-01-06 4.119463531268 sirt4-human-recombinant Sirtuin 4; Silent Information Regulator 4; SIR2L4; SIR2-like Protein 4; NAD-dependent ADP-ribosyltransferase Sirtuin 4 SIRTs Sirtuins HDACs proteins His-tagged hexahistidines HDACS histone decatylases GDH glutamate dehydrogenase sirtuin silent mating type information regulation 2 homolog 4 sirtuin type 4 4.119463531268
10318 SIRT5 (human recombinant) - ≥90% 2009-07-31 16.776628395004 sirt5-human-recombinant Silent Information Regulator 5; SIR2L5; SIR2-like Protein 5; Sirtuin 5; NAD-dependent Deacetylase 5 SIRTs proteins HDACs CSP1 GST-tagged silent mating type information regulation 2 homolog 5 sirtuin type 5 16.776628395004
700290 SIRT6 Direct Fluorescent Screening Assay Kit - 2010-02-18 41.324765193370 sirt6-direct-fluorescent-screening-assay-kit SIRT 6 SIRT-6 assays kits measures sirtuins trichostatins A-intensive lysyl-deacetylases class III HDACs human mitochondrial nuclear proteins mitochondrias translocated nucleus cells cellular stress lysine deacetylation nicotinamides O-acetyl-ADP-ribose NAD+ abstracted ADP-ribosyl transferases deacetylases telomeres chromatins NF-κB NF-kappaB NF-.kappa.B signaling signalling mammalian cells Werner Syndromes aging disorders anti-cancers anti-inflammatory drugs apoptosis screening fluorescence activators Arg-His-Lys-Lys(ε-acetyl)-AMC fluorescent fluorometric 41.324765193370
10315 SIRT6 (human recombinant) - ≥95% 2009-07-31 11.934426795579 sirt6-human-recombinant Sirtuin 6; NAD-dependent Deacetylase 6; Silent Information Regulator 6; SIR2L6; SIR2-like Protein 6 SIRTs Sirtuins HDACs proteins His-tagged hexahistidine silent mating type information regulation 2 homolog 6 sirtuin type 6 11.934426795579
10316 SIRT7 (human recombinant) - ≥85% 2009-12-22 9.639567621523 sirt7-human-recombinant NAD-dependent deacetylase 7; SIR2L7; Sirtuin 7; Silent Information Regulator 7; SIR2-like protein 7 SIRTs Sirtuins HDACs proteins His-tagged hexahistidine histone deacetylases silent mating types information regulators 2 homologs 9.639567621523
10822 SMAD1/5/8/9 Polyclonal Antibody - 2011-04-14 1.483314917126 smad1-5-8-9-polyclonal-antibody WBs western blots immunoblotting SMADs 1 5 8 9 SMAD-1-5-8-9 1/5/8/9 antibodies serum 1,5,8,9 1.483314917126
10821 SMAD1/5/8/9 Polyclonal Antiserum - 2011-03-31 0.422541436464 smad1-5-8-9-polyclonal-antiserum WBs western blots immunoblotting SMADs 1 5 8 9 SMAD-1-5-8-9 1/5/8/9 antibodies serum 0.422541436464
10823 SMAD2 Polyclonal Antibody - 2011-05-05 0.422541436464 smad2-polyclonal-antibody WBs western blots immunoblotting SMADs SMAD-2 SMAD 2 antibodies serum IHC immunohistochemistry TGF-β TGFβ cancers 0.422541436464
10832 SMAD3 Polyclonal Antibody - 2011-05-03 1.165082872927 smad3-polyclonal-antibody WBs western blots immunoblotting SMADs SMAD-3 SMAD 3 antibodies serum IHC immunohistochemistry TGF-β TGFβ Tcells signaling TGF-β MH1 domains DNA proteins SARA ECM apoptosis proliferation differentiation 1.165082872927
10838 SMAD4 Polyclonal Antibody - 2011-05-05 1.154475138121 smad4-polyclonal-antibody WBs western blots immunoblotting SMADs SMAD-4 SMAD 4 antibodies serum IHC immunohistochemistry TGF-β TGFβ cancers 1.154475138121
10839 SMAD6 Polyclonal Antibody - 2011-05-02 0.422541436464 smad6-polyclonal-antibody WBs western blots immunoblotting SMADs MAD SMAD-6 SMAD 6 antibodies serum IHC immunohistochemistry TGF-β TGFβ Tcells intracellular proteins signaling serine threonine apoptosis bones cancers genes signal transduction 0.422541436464
10845 SMAD7 Polyclonal Antibody - 2011-05-05 0.422541436464 smad7-polyclonal-antibody WBs western blots immunoblotting SMADs SMAD-7 SMAD 7 antibodies serum TGF-β TGFβ Tcells 0.422541436464
10840 SMAD7 Polyclonal Antibody (azide-free) - 2011-05-05 0.422541436464 smad7-polyclonal-antibody-azide-free WBs western blots immunoblotting SMADs SMAD-7 SMAD 7 antibodies serum TGF-β TGFβ Tcells 0.422541436464
10012628 (S)-MG132 133407-82-6 ≥98% 2009-02-18 189.475193370165 -s-mg132 Z-Leu-Leu-Leu-CHO ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132 mg-132 2-LLL-CHO 189.475193370165
13121 Sodium Butyrate 156-54-7 ≥95% 2009-07-31 78.506795580110 sodium-butyrate Butyric Acid (sodium salt) fatty acids short chains inhibitors inhibits inhibition histones deacetylases HDACs epigenetics growth arrest differentiation apoptosis cancers inflammation genes expressions pro-inflammatory proinflammatory cytokines IFN-γ IL-6 IFNγ IL6 IL-1β IL1β IFNg 78.506795580110
10010466 SP 600125 129-56-6 ≥98% 2009-01-07 11.958232044199 sp-600125 1PMV; Pyrazolanthrone; NSC 75890 c-Jun cJun JNKs inhibitors inhibits inhibition reversible cell-permeable cells COX-2 COX2 MAP kinase MAPK genes expressions apoptosis autophagy differentiation IL-10 IL10 TNF-α TNFα IFN-γ IFNγ T-cells Tcells HeLa sp600125 11.958232044199
10348 Sphingosine Kinase 1 (human recombinant) - ≥90% by SDS-PAGE 2011-04-12 42.816187845303 sphingosine-kinase-1-human-recombinant SPHK1; SK1 sphingosines phosphates ceramides apoptosis acids cells death kinases sphingomyelin growth calcium 42.816187845303
700430 Sphingosine Kinase 1 Inhibitor Screening Assay Kit - 2010-09-16 58.930165745856 sphingosine-kinase-1-inhibitor-screening-assay-kit SPHK 1 kits assays measures measurements SK1 SPHK1 sphingolipids metabolic pathways phosphorylates D-erythro-sphingosines sphingosine-1-phosphates S1P cells proliferations migrations cytoskeletal morphogenesis SPHK2 2 mammalian signalling signaling masts TNF-a TNFa TNF-alpha TNFalpha TNF-α TNFα-triggered Tumors Necrosis Factor-α fibroblasts epithelial mRNA messenger ribonucleic acids levels brains oncogenics erythroleukemias therapy therapeutics cancers inflammation up-regulated phagocytes peritoneal sepsis mice murine mouse inhibition inhibitors inhibits septic shock fluorescence-based fluorescent ATP adenosine triphosphates phosphorylates phosphorylation C-18 ADP diphosphates hydrogen peroxides H2O2 resorufin 58.930165745856
10006822 Sphingosine Kinase 1 Polyclonal Antibody - 2006-12-21 38.851727246292 sphingosine-kinase-1-polyclonal-antibody SPHK 1 proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry sphingosines kinases enzymes sphingolipids metabolisms catalyzes phosphorylation sphingosine-1-phosphates cells proliferation death tissues kidneys livers spleen hearts platelets tumors cytosolic membranes amino acids post translational modifications SK1 SPK1 cancers immunoblotting 38.851727246292
10012201 Sphingosine Kinase 1 Polyclonal FITC Antibody Exclusive - ✓ 2008-06-06 7.574102209944 sphingosine-kinase-1-polyclonal-fitc-antibody SPHK 1 SPHK-1 metabolism sphingolipids phosphorylation sphingosine-1-phosphate cell proliferation death immunofluorescence IF flow cytometry FC western blots WB SPHKs blotting immunoblotting 7.574102209944
10009237 Sphingosine Kinase 2 (human recombinant) - >80% by SDS-PAGE 2007-01-18 30.036590370954 sphingosine-kinase-2-human-recombinant SPHK 2; SK2 signalling inflammatory enzymes proteins GenBank Accession No AF245447 SK2 SPK2 kinases sphingolipids SPHKs D-erythro-sphingosines phosphorylates sphingosine-1-phosphates S1Ps isoforms mammalian cells signals signaling pathways cancers inflammation proliferation apoptosis calcium homeostasis angiogenesis vascular maturation diseases 30.036590370954
10009222 Sphingosine Kinase Inhibitor 2 312636-16-1 >95% 2007-01-18 47.329959819186 sphingosine-kinase-inhibitor-2 SKI II; SPHK 2 cancers Anti-proliferative Sphingosine-1-phosphates S1Ps SK1 SK2 SKI2 SPHK1 SPHK2 sphingosines sphingolipids inhibits inhibitors inhibition proliferation 47.329959819186
13084 STF-62247 315702-99-9 ≥98% 2009-10-07 36.305745856353 stf-62247 autophagy lethality renal cells carcinoma cancers von Hippel-Lindau VHL tumors supressors genes growth rates kidneys metastasize syndrome diseases 36.305745856353
13338 SU 6656 330161-87-0 ≥95% 2009-08-04 26.442674033149 su-6656 inhibitors Src kinases Src Yes Lyn Fyn cells growth development nervous system fibrosis cancers inhibits inhibition CNS SU6656 26.442674033149
10574 Suberohydroxamic Acid 38937-66-5 ≥98% 2010-09-28 48.508630294659 suberohydroxamic-acid Suberic bis-Hydroxamic Acid; SBHA histones deacetylases HDACs inhibitors genes expression regulation epigenetics nucleosomes HDAC1 HDAC3 differentiation cells cycle arrest apoptosis cancers suberodihydroxamic acid suberoyl bishydroxamic acid inhibited inhibition Warner-Lambert Brand of Mefenamic Acid Warner Lambert Brand of Mefenamic Acid Pharmascience Brand of Mefenamic Acid First Horizon Brand of Mefenamic Acid Parke Davis Brand of Mefenamic Acid Farmasierra Brand of Mefenamic Acid Ashbourne Brand of Mefenamic Acid Pinewood Brand of Mefenamic Acid Nu-Pharm Brand of Mefenamic Acid Nu Pharm Brand of Mefenamic Acid Chemidex Brand of Mefenamic Acid Gödecke Brand of Mefenamic Acid Clonmel Brand of Mefenamic Acid Antigen Brand of Mefenamic Acid Pfizer Brand of Mefenamic Acid Apotex Brand of Mefenamic Acid Rowa Brand of Mefenamic Acid Elan Brand of Mefenamic Acid APS Brand of Mefenamic Acid PMS-Mefenamic Acid PMS Mefenamic Acid Acid Mefenaminic Mefenaminic Acid Acid Mefenamic Mefenamic Acid Forte Ponstan Ponstan Forte Apo-Mefenamic Apo Mefenamic Nu-Mefenamic Nu Mefenamic ApoMefenamic NuMefenamic Pinalgesic Contraflam Ponalgic Parkemed Ponstel Ponstan Ponalar Mefacit Pontal Ponsyl Ponmel Dysman Coslan Mefic Mefac 48.508630294659
10928 SUCNR1 Polyclonal Antibody New - 2011-11-03 1.671428571429 sucnr1-polyclonal-antibody GPR91 membranes receptors G-proteins coupled 1 family cells communications citric acids cycles succinate developments injury angiogenic factors VEGF proliferative ischemic retinopathy diabetic Western blots blotting immunohistochemistry IHC WB SUCNR-1 SUCNRs 1.671428571429
10763 SUV4-20H1 (human recombinant) - ≥60% 2011-07-13 16.045662983425 suv4-20h1-human-recombinant KMT5B; Suppressor of Variegation 4-20 Homolog 1; Lysine N-methyltransferase 5B methyltranferases histones H3K20 SET-domain containing s-adenosylmethionine s-adenosylhomocysteine lysines methylation epigenetics genes regulations KMT5B trimethylation H4K20 GRIP1 KMT5C KMT-5B KMT-5C KMTs 16.045662983425
10764 SUV4-20H2 (human recombinant) - ≥95% 2011-06-06 16.536685082873 suv4-20h2-human-recombinant Suppressor of Variegation 4-20 Homolog 2; KMT5C methyltransferases histones H3K20 SET-domain containing s-adenosylmethionine s-adenosylhomocysteine lysine methylation epigenetics genes regulation SETD8 Pr-SET7 SUV420H2 SUV-420H2 SUV 420H2 SUV420H1 SUV-420H1 SUV 420H1 16.536685082873
16860 Swainsonine 72741-87-8 ≥98% 2009-06-12 209.353397790056 swainsonine Tridolgosir Alkaloid N-linked glycoside hydrolases asparagine-linked glycoproteins glycoproteins inhibitor lysosomal α-mannosidase glycosidases Golgi α-mannosidase II N-linked glycosylation antiproliferative proliferation growth antimetastatic metastasis cancer α-mannosidase lysosomes oligosaccharides glycoproteins lysosomal storage disease toxicity locoism 209.353397790056
13258 Tamoxifen 10540-29-1 ≥98% 2010-01-21 80.431224677716 tamoxifen nuclear receptors 17β-estradiol estrogen ERα ERβ modulators antagonists breast cancers tumors agonists bones osteoporosis cardiovascular disease menopause women uterus uterine endometrial carcinomas Nolvadex Istubal Valodex Savient brand of Tamoxifen Citrate Citrate Tamoxifen Tamoxifen Citrate Zitazonium Tomaxithen ICI-4 474 ICI 46 474Tamoxifen ICI-47699 ICI-46474 ICI46474ICI 47699 ICI 46474 Soltamox Novaldex Nolvadex ICI47699 ICI46474 80.431224677716
10009911 Tangeritin 481-53-8 ≥98% 2008-12-16 11.958232044199 tangeritin Ponkanetin; NSC 618905; NSC 53909 flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma 11.958232044199
13085 Tenovin-1 Exclusive 380315-80-0 ≥98% ✓ 2008-09-18 28.039926335175 tenovin-1 histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition melonoma lymphoma 28.039926335175
13086 Tenovin-6 1011557-82-6 ≥95% 2009-02-12 62.346787687451 tenovin-6 histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition SIRTs transcription factors TFs 62.346787687451
10011619 Terbinafine (hydrochloride) 78628-80-5 ≥98% 2010-02-16 4.016298342541 terbinafine-hydrochloride antifungals squalene epoxidase antitumor tumors antiangiogenic anticancer cancers inhibitors inhibits inhibition Naphthalenes 4.016298342541
10007565 Tetradecyl Phosphonate 4671-75-4 >98% 2005-10-17 41.177671665351 tetradecyl-phosphonate pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter 41.177671665351
70302 tetramethyl Nordihydroguaiaretic Acid Exclusive 24150-24-1 ≥98% ✓ 2008-09-24 5.184364640883 tetramethyl-nordihydroguaiaretic-acid tetramethyl NDGA; TMNDGA; Tetrameprocol; M4N; EM-1421 tumors inhibitor inhibits inhibition cancers NDGAs survivin apoptosis Cdc2 HIV growing growth glioma brains antitumor organic melonomas 5.184364640883
10007207 tetranor-12(S)-HETE 121842-79-3 ≥98% 2005-12-07 33.299116022099 tetranor-12-s-hete neuroscience peroxisomes metabolites arachidonic acids metabolisms 12-lipoxygenases 12-LOs platelets leukocytes smooth muscle cells tumors adhesion endothelial fibronectin subendothelial matrix b-oxidation .beta.-oxidation tissues Lewis lung carcinomas controlling inflammations inflammatory responses injured corneas Zellweger's syndromes peroxisomal abnormalities inability metabolizes symptoms diseases derivatives reasearch tools elucidations metabolic fate cancers ophthalmology 33.299116022099
10522 Thapsigargin New 67526-95-8 ≥97% 2011-09-23 104.944405893668 thapsigargin calcium, ATPases, sarco/endoplasmic calcium ATPases SERCAs cells signaling activation histamine cancers tumorigenesis inflammation reticula sarcoplasmic endoplasmic 104.944405893668
10009813 thio-Miltefosine - >98% 2007-08-13 10.919558011049 thio-miltefosine analogs inhibitors inhibit inhibition CTP phosphocholine cytidylyl transerases antimetastatic antiproliferatives ceramides apoptosis antiprotazoal thiomiltefosine sulfurs thios 10.919558011049
10038 TMS 24144-92-1 >98% 54.109889502762 tms 2,3',4,5'-Tetramethoxystilbene cytochromes inhibitors tetramethoxystilbene antimutagenesis CYP450-1B1 inhibits selective selectivity apoptosis cell growth 54.109889502762
11105 TNF Receptor-Associated Protein 1 (human recombinant) New - ≥95% 2011-11-29 21.758624923265 tnf-receptor-associated-protein-1-human-recombinant HSP75; HSP90L; Mitochondrial Heat Shock Protein 75 kDa; TRAP1 metabolism insulin non-insulin-dependent (type 2) diabetes mellitus glucose kinases tumors necrosis factor type 1 receptors-associated proteins TNFR-associated protein 1 ATP mitochondrial HSP90 heat shock ATPase cancers cardiomyocytes geldanamycin SNX-0723 SNX0723 SNX 0723 TNFR1 21.758624923265
700240 Total Phosphatidic Acid Assay Kit - 2009-08-24 66.403141278610 total-phosphatidic-acid-assay-kit PA Assay Kit assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin 66.403141278610
160750 TRAIL Polyclonal Antibody - 0E-12 trail-polyclonal-antibody Apo-2L apoptosis cell death TNF DR4 DR5 NF-.kappa.B NF-kappab NF-kappab antisera antiserum antibodies WB western blots blotting cancers immunoblotting 0E-12
9000784 (−)-trans-C75 Exclusive 1234694-22-4 ≥98% ✓ 2011-07-20 11.679447513812 -trans-c75 (2S,3R)-C75 trans C75 transC75 inhibitors inhibits inhibition fatty acids synthases FAS apoptosis cancers obesity C-75 apoptosis 11.679447513812
9000783 (+)-trans-C75 Exclusive 1234694-20-2 ≥98% ✓ 2011-07-20 11.679447513812 -trans-c75 (2R,3S)-C75 transC75 trans C75 fatty acids synthases FAS apoptosis cancers obesity inhibitors inhibits inhibition C-75 11.679447513812
10188 trans-trismethoxy Resveratrol 22255-22-7 >98% 2004-03-03 20.685299617510 trans-trismethoxy-resveratrol (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS Prostaglandins synthases antioxidants oxidative injury stress sirtuins 3,5,4'-trihydroxy stilbene 3,5,4'-trihydroxystilbene 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene trimethoxy AHR antagonists aryl hydrocarbon receptors 20.685299617510
13129 trans-trismethoxy Resveratrol-d4 - ≥99% deuterated product 2009-02-09 17.055893186003 trans-trismethoxy-resveratrol-d4 (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins AHR antagonists aryl hydrocarbon receptors 17.055893186003
13791 TRF2 Polyclonal Antibody - 2010-06-24 0E-12 trf2-polyclonal-antibody TTAGGG Repeat Binding Factor 2; TRBF2; Telomeric Repeat Binding Factor 2; TERF2 antibodies proteins TRF-2 TRF 2 factors repeat DNA binding cells apoptosis western blots blotting immunoblotting telomere WB ICC IP ChIP IF immunoprecipitation immunofluorescence immunocytochemistry cancers apoptosis 0E-12
89730 Trichostatin A 58880-19-6 >98% 155.424917127071 trichostatin-a TSA reversible inhibitors histone deacetylase nuclear receptors inhibitions inhibits hdacs TSAs cancers 155.424917127071
10010237 Triciribine 35943-35-2 >98% 2007-09-11 7.209392265193 triciribine Tricyclic Nucleoside; NSC 154020; API 2 Akt cancers inhibitors inhibition inhibits Akt-1 Akt1 Akt-2 Akt2 Akt-3 Akt3 PI3-kinase PI3kinase PI3K PI-3-kinase phosphorylation activation signalling pathway signaling 7.209392265193
10009083 Trimidox Exclusive 95933-74-7 >98% ✓ 2008-02-13 5.938674033149 trimidox VF 233 apoptosis ribonucleotide reductases cells cycles cancers dNTP HIV caspase DNA synthesis chemotherapy dGTP HL-60 5.938674033149
10011124 Trimidox (hydrochloride) Exclusive - >98% ✓ 2008-06-10 5.938674033149 trimidox-hydrochloride CF 233 (hydrochloride) apoptosis ribonucleotides reductases cells cycles cancers dNTP HIV caspases DNA synthesis chemotherapy dGTP HL-60 HCls 5.938674033149
10011659 Trolox 53188-07-1 ≥98% 2008-12-02 294.043436464088 trolox 6-hydroxy-2,5,7,8-tetramethylchroman-2-Carboxylic Acid antioxidants vitamins E oxidative injury injuries neurodegeneration aging cancers adjunctive 294.043436464088
10774 UTX (human recombinant) - ≥85% 2011-05-24 5.626011049723 utx-human-recombinant Ubiquitously Transcribed Tetratricopeptide Repeat X; KDM6A epigenetics histones lysines demthylases chromatins regulators dioxygenases JmjC proteins enzymes recombinants UTY genes chromosomes 5.626011049723
13033 Valproic Acid (sodium salt) 1069-66-5 ≥95% 2009-10-21 26.618733885819 valproic-acid-sodium-salt Sodium Valproate; 2-Propylvaleric Acid valeric acids anticonvulsant seizures inhibitors histones deacetylases HDAC glycogen synthase kinases GSK3 inositol-1,4,5-trisphosphate IP3 combination therapy cancers Alzheimer's diseases stem differentiation self-renewal 26.618733885819
160840 VE-Cadherin Polyclonal Antibody - 26.912154696132 ve-cadherin-polyclonal-antibody Cadherin-5; CD144 Western blots blotting antibodies WB antisera antiserum ICC IP immunocytochemistry immunoprecipitation apoptosis cancers immunoblotting 26.912154696132
13131 VER-49009 Exclusive 940289-57-6 ≥98% ✓ 2010-07-09 3.563255985266 ver-49009 heat shock proteins Hsp90 inhibitors Hsp27 Hsp72 cells cycle arrest apoptosis inhibits inhibition isoxazole survivin C-RAF B-RAF PRMT5 molecular chaperones folding signalling signaling VER49009 VER 49009 cancers pyrazoles 3.563255985266
13132 VER-50589 Exclusive 747413-08-7 ≥98% ✓ 2010-04-06 2.552573664825 ver-50589 heat shock proteins Hsps Hsp90 cancers inhibitors inhibits inhibition Hsp27 Hsp72 C-RAF B-RAF survivin PRMT5 cells cylce arrest apoptosis tumors growth glioblastoma molecular chaperones protein folding signaling signalling pharma Isoxazoles 2.552573664825
10944 WDR5 (human recombinant) - ≥95% 2011-08-05 38.221011217143 wdr5-human-recombinant BMP2-induced 3-kb Gene Protein; SWD3, Set1c WD40 repeat protein, homolog; WD-Repeat Protein 5; BIG3 epigenetics binding proteins methyltransferase MLL complex subunits 38.221011217143
10010591 Wortmannin 19545-26-7 ≥98% 2008-11-21 43.323739906501 wortmannin KY 12420 phosphoinositide 3-kinase PI3K cells growth differentiations cancers motility inhibitors inhibits inhibition irreversible polo-like kinases PLK1 PLK3 mTOR DNA-PK DNAPK PL4K MLCK p38 MAPK 43.323739906501
13671 Wortmannin-Rapamycin Conjugate - ≥98% 2010-05-11 25.334042357274 wortmannin-rapamycin-conjugate phosphoinositides 3-kinases PI3K mammalian targets mTOR cancers inhibitors inhibits inhibition complex 1 mTORC1 tumors bevacizumab VEGF colons A498 HT29 53123-88-9 sirolimus prodrug linkers links 19545-26-7 KY 12420 renal phosphatidyl inositols 25.334042357274
10008883 WST-1 Cell Proliferation Assay Kit - 2006-09-07 66.389027308603 wst-1-cell-proliferation-assay-kit assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements cancers cell-based assay cell based assay cba 66.389027308603
10010199 WST-8 Cell Proliferation Assay Kit - 2007-09-11 76.864127861089 wst-8-cell-proliferation-assay-kit assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microwell plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay cell based assay cba 76.864127861089
13604 WYE-354 New 1062169-56-5 ≥98% 2012-01-12 82.616138121546 wye-354 mTOR mTORC1 mTORC2 inhibitors inhibits inhibition PI3K cancers cells growth PTENs tumors rapamycin complex 1 2 G1 phosphatidylinositol 3-kinase α PI3Kα kinases 82.616138121546
13639 WZ811 55778-02-4 ≥95% 2010-03-22 14.248908839779 wz811 CXC chemokines receptors CXCR4 stromal cell-derived factor-1 SDF-1 CXCL12 hematopoietic stem cells chemotaxis lymphocytes growth metastasis cancers T cells HIV infection inhibitors antagonist cAMP Matrigel invasion breast cancer adenocarcinoma inhibition alpha-Aminotoluene alpha Aminotoluene Phenylmethylamine Benzylamines 14.248908839779
10010895 Xanthine Oxidase Assay Kit - 2008-03-13 229.050637865568 xanthine-oxidase-assay-kit XO Assay Kit; Xanthine Oxidoreductase Assay Kit assays kits plasma serum tissues homogenates oxidoreductases molybdoflavoenzymes human purine catabolism catalyzing catalyzes hydroxylation hypoxanthine uric acids NADH superoxides reactive oxygen species ROS hydrogen peroxides H2O2 inschemia-reperfusion injury molecular cells death degeneration apoptosis mammalian livers intestines diseases horseradish HRP ADHP fluorescence fluorescent resorufin excitation emission wavelengths special:quarterly specialdiscount:50 specialstart:2007-03-01 specialend:2008-05-31 fluorometric 229.050637865568
13596 XAV939 284028-89-3 ≥98% 2009-12-03 12.641767955801 xav939 Wnt cancers β-catenin APC axin GSK3 poly-ADP-ribosylation tankyrases TNKS1 TNKS2 inhibitors inhibition inhibits 12.641767955801
10010200 XTT Cell Proliferation Assay Kit - 2007-09-11 56.790546746071 xtt-cell-proliferation-assay-kit assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay cell based assay cba 56.790546746071
11168 (−)-YK-4-279 New - ≥98% 2011-12-19 65.849631675874 -yk-4-279 ES-FLI1 oncogenes Ewing's sarcomas RNA helicases tumors cancers inhibitors apoptosis ETS transcription factors ERG ETV1 prostate fusion proteins diseases YK4279 YK 4279 growth xenografts cells chemotherapy resistant Ewings ESFLI1 ES FLI1 prostate 65.849631675874
11167 (+)-YK-4-279 New 1261038-93-0 ≥98% 2011-12-16 64.182965009208 -yk-4-279 ES-FLI1 oncogenes Ewing's sarcomas RNA helicases tumors cancers inhibitors apoptosis ETS transcription factors ERG ETV1 prostate YK4279 YK 4279 fusion proteins diseases growth orthotopic xenografts cells chemotherapy resistant Ewings EWS-FLI1 reduces in vitro in vivo family prostate cancers enantiomers EWSFLI1 EWS FLI1 64.182965009208
13661 YK-4-279 1037184-44-3 ≥98% 2010-02-05 46.699263351749 yk-4-279 ES-FLI1 oncogene Ewing's sarcomas RNA helicases A RHAs tumors cancers inhibitors apoptosis inhibition inhibited Ewings YK 4-279 YK4279 YK 4279 YK 4 279 Pentaacetic Acid, Diethylenetriamine Acid, Diethylenetriamine Pentaacetic Diethylenetriamine Pentaacetic Acid calcium trisodium pentetate Pentetic Acid DTPA pentacin penthanil 46.699263351749
10975 Zebularine New 3690-10-6 ≥98% 2011-08-23 14.934144729715 zebularine DNMTs inhibitors DNA methyltransferases cancers cells analogs cytidines methylation carcinomaTK6 jurkat KG-1 HCT116 14.934144729715
71800 (Z)-Guggulsterone 39025-23-5 ≥98% 2009-12-01 0.489963167587 -z-guggulsterone anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt 0.489963167587
10010367 ZM 336372 208260-29-1 >98% 2008-01-09 2.180683073832 zm-336372 Raf-1 c-raf inhibitors inhibition inhibits cancers anti-cancer MEK 1/2 MAPK signals transductions proliferations cells cycles ERK1 ERK2 ERK1/2 ATP adenosine triphosphate signaling carcinoid tumor 2.180683073832
13601 ZM 447439 331771-20-1 2010-08-03 2.736657458563 zm-447439 auroras A B C kinases mitosis cytokinesis centromere inhibitors inhibits inhibition cancers Benzamides 2.736657458563
300013 β-Catenin Blocking Peptide - 3.482375690607 -catenin-blocking-peptide b-catenin beta-catenin immunoanalysis western blots immunoblotting controls peptides cancer cell .beta.-catenin wb 3.482375690607
100029 β-Catenin Polyclonal Antibody - 3.394435674822 -catenin-polyclonal-antibody antibodies antisera antiserum western blots blotting wb icc immunocytochemistry b-catenin cancers cell immunoblotting IHC immunohistochemistry 3.394435674822
10009137 β-Gal-NONOate 357192-77-9 ≥98% 2007-11-10 25.289198895027 -gal-nonoate nitric oxides NOs donors anti-cancer anticancers .beta.-galatosidases cytoxic bactericidal cell-lines genes cytotoxicity 25.289198895027
10010621 γ-CEHC EIA Kit (plasma and serum) - 2008-03-21 21.072380692847 -cehc-eia-kit-plasma-and-serum 2,7,8-trimethyl-2-(β-Carboxy-Ethyl)-6-Hydroxychroman EIA Kit solid plates competitive quantification kits eias enzymes immunoassays gammaCEHC gCEHC gamma-CEHC g-CEHC tocopherol tocotrienols vitamins E g-tocopherols .gamma.-tocopherol gamma-tocopherol lipid soluble antioxidants diets metabolites livers cytochrome p450 CYP450 natriuretic acitvity nitric oxides NO radicals inhibits inhibitions inhibitors COX cyclooxygenases macrophages epithelial cells plasma serums blood cardiovascular diseases prostate cancers assays 21.072380692847
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?